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Pro veritate adversa diligere etprospera formidando declinare 
(For the truth, love adversity and be cautious with the success)
san Gregorio Magno, Regula Pastoralis, VI century
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ABSTRACT
Mechanisms contributing to the inflammatory cascade, including vascular modifications 
and immune cell recruitment/activation, act with high dynamism within a three- 
dimensional space, thus being ideally investigated by in vivo two-photon microscopy (2- 
PM). In this thesis I applied in vivo 2-PM and quantitative bright field and confocal 
microscopy to explore cerebrovascular remodelling, immune cell dynamism and phenotype 
in two models of ischemia in mice achieved by transient or permanent middle cerebral 
artery occlusion. To specifically visualize microglia and T-cells, I used cx3cri  eGFP and 
hCD2_eGFP mice, respectively.
I imaged animals before and at different time points after ischemia, and quantified blood 
flow velocity and extravasation in individual vessels. After reperfusion, blood flow 
exhibited >80% drop in most vessels and extravasation established as early as 20min after 
ischemia onset. In this ischemic territory, I analyzed motility and morphology of GFP+ 
microglia. Microglia were stationary and became ameboid at 24h after injury. The absence 
of fractalkine receptor (CX3CR1) prevented the ameboid switch and favoured a protective 
M2 microglia polarization, characterized by decreased CD68 and iNOS expression and 
increased Yml expression. To assess the temporal evolution of microglia/macrophage 
polarization in the ischemic brain, I investigated the expression and coexpression pattern of 
CDllb, CD45, CD68, Yml, CD206 and iNOS after ischemia by conventional 
immunohistochemistry. Microglia/macrophages showed multiple polarization states, with a 
specific pattern of distribution and association with globular or ramified CD llb 
morphology. M2 microglia/macrophage peaked at 24h after injury, whereas Ml cells 
peaked at 48h. The phagocytic activity (CD68), mainly confined at the lesion borders at 
6h-48h, dramatically increased and occupied all the ischemic territory at 7d.
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I finally investigated T-cells dynamism within the ischemic territory by in vivo 2-PM. I 
described two populations characterized by different track velocities and found that motile 
cells preferentially moved along the perivascular space, where they contacted astrocytes 
and perivascular macrophages.
These data provide novel information on the inflammatory response after stroke and pave 
the way for developing strategies resulting in promotion of a protective inflammatory 
phenotype.
23
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1. INTRODUCTION
1.1 Epidemiology of stroke
Ischemic brain injury is a global health problem, representing the third leading cause of 
morbidity and mortality in the Western countries. Globally there are 50 million stroke and 
transient ischemic attack survivors, whose 20% will suffer a subsequent stroke in the 
following 5 years and 15-20% suffer permanent disability (Adams et al. 1993; Lloyd-Jones 
et al. 2010).
In UK there are 110 000 all-cause strokes every year (Flynn et al. 2008). In Italy, recent 
data collected from registers on stroke incidence in different areas (distributed equally 
from Northern to Southern Italy), indicate that there are approximately 134 000 strokes per 
year (Sacco et al. 2011). The incidence rates increase linearly with age, peaking in subjects 
>85 years of age. This observation, along with the census data that show that the 
proportion of elderly people in Italy has been growing over the last three decades (ISTAT, 
14° censimento, 21 October 2001, http://dawinci.istat.it/daWinci/jsp/MD/misc.jsp?p=2) 
suggests that the annual incidence of stroke is due to further increase.
The economic burden of stroke in Italy has been analyzed by the EcLIPSE study in 2005 
(Gerzeli et al. 2005). The cost of stroke per patient for the first six-month period is 
equivalent to € 11 600, 53% of which are health care costs, 39% non-health care costs and 
the remaining 8% productivity losses (Gerzeli et al. 2005). Overall across the EU the cost 
of cerebrovascular disease for 2003, including those for informal care and productivity 
loss, were estimated at € 34 billion (Leal et al. 2006). In the US the estimated combined 
direct and indirect costs of stroke for 2007 were US$ 62.7 billion (Rosamond et al. 2007).
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1.2 Pathophysiology of stroke
The brain is the most metabolically active organ in the body. While representing only 2% 
of the body’s mass, it requires 15-20% of the total resting cardiac output to provide the 
necessary glucose and oxygen for its metabolism. Ischemic strokes result from events that 
limit or stop blood flow, such as embolism, thrombosis in situ, or relative hypoperfusion. 
As blood flow decreases, neurons cease functioning, and irreversible neuronal ischemia 
and injury begin at blood flow rates of less than 18 mL/100 mg/min (Doyle et al. 2008).
1.2.1 Classification
In humans, two different types of stroke exist: haemorrhagic stroke and ischemic stroke 
(Fatahzadeh and Glick 2006, Fig. 1.1).
1.2.1.1 Haemorrhagic stroke
Haemorrhagic stroke on the whole accounts for 10-15% of all strokes (Gebel and 
Broderick 2000) and is associated with higher mortality rates than cerebral infarctions. 
Haemorrhagic stroke can be divided in:
i. Intracerebral haemorrhage (1CH). In intracerebral haemorrhagic stroke (Aronowski 
and Zhao 2011; Qureshi et al. 2009) bleeding occurs directly into the brain 
parenchyma. The usual mechanism is thought to be leakage from small 
intracerebral arteries damaged by chronic hypertension. This kind of stroke has a 
predilection for certain sites in the brain, including the thalamus, putamen,
25
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cerebellum, and brain stem. In addition to the area of the brain injured by the 
haemorrhage, the surrounding brain areas may be damaged by the pressure 
produced by the mass effect of the hematoma. Generally, with intracerebral 
haemorrhagic stroke, there is an increase in intracranial pressure,
ii. Subarachnoid haemorrhage (SAIT). The term subarachnoid haemorrhage (SAH) 
refers to extravasation of blood into the subarachnoid space between the pial and 
arachnoid membranes. SAH comprises half of spontaneous atraumatic intracranial 
haemorrhages (Rhoney et al. 2010; Wong et al. 2010). SAH is a devastating 
condition with high morbidity and mortality. SAH occurs in various clinical 
contexts, the most common being head trauma. However, the familiar medical use 
of the term SAH refers to nontraumatic (or spontaneous) haemorrhage, which 
usually occurs in the setting of a ruptured cerebral aneurysm or arteriovenous 
malformation.
1.2.1.2 Ischem ic stroke
Ischemic stroke is characterized by a sudden interruption of the cerebral blood flow due to 
an occlusion of a cerebral vessel and accounts approximately for 80% of all strokes (Stoll 
et al. 2008). There are 3 types of ischemic strokes:
i. Embolic stroke. Emboli may either be of cardiac or arterial origin. Cardiac sources 
include atrial fibrillation, recent myocardial infarction, prosthetic valves, native 
valvular disease, endocarditis, mural thrombi, dilated cardiomyopathy, or patent 
foramen ovale allowing passage of venous circulation emboli. Arterial sources can 
be atherothrombotic or cholesterol emboli that develop in the arch of the aorta and 
in the extracranial arteries (ie, carotid and vertebral arteries). Embolic strokes tend
26
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to have a sudden onset. In these cases neuroimaging may demonstrate previous 
infarcts in several vascular territories or calcified emboli.
ii. Thrombotic stroke. Thrombotic strokes can be divided into large vessel, including 
the carotid artery system, or small vessel comprising the intracerebral arteries, 
including the branches of the Circle of Willis and the posterior circulation (lacunar 
stroke). The most common sites of thrombotic occlusion are cerebral artery branch 
points, especially in the distribution of the internal carotid artery. Arterial stenosis 
(ie, turbulent blood flow), atherosclerosis (ie, ulcerated plaques), and platelet 
adherence cause the formation of blood clots that occlude the artery. Any process 
that causes dissection of the cerebral arteries also can cause thrombotic stroke, such 
as trauma, thoracic aortic dissection, arteritis. The great majority of stroke are 
related to hypertension.
iii. Watershed stroke. These strokes, also known as border zone infarcts, develop from 
relative hypoperfusion in the most distal arterial territories and can produce 
bilateral symptoms. Frequently, this type of stroke occur perioperatively or in 
situations of prolonged hypotension.
In this thesis I will only discuss about ischemic stroke.
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Figure 1.1 The major types o f  stroke and cerebral accident (Richard Green et al. 2003).
1.2.3 Molecular aspects
Ischemic strokes are characterized by an initial insult which is followed by a complex 
sequelae of events that evolve over time and space (Fig. 1.2). These events do not affect 
the ischemic territory homogeneously. The centre of perfusion deficit, where residual 
blood flow is 20% below normal, is defined as the core area (Fig. 1.2). In this area, 
permanent and anoxic depolarization develops minutes after the onset of ischemia and cells 
are killed rapidly by lipolysis and proteolysis due to the total bioenergetic failure. Between 
this lethally damaged core and the normal brain lies an area where perfusion is partially 
preserved and supports basal ATP levels and oxygen metabolism (Hossmann 1994;
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Moskowitz et al. 2010; Obrenovitch 1995). This area, defined as ischemic penumbra, could 
be classified as an ‘at risk’ region being functionally impaired but still potentially 
salvageable. Given time and without treatment, the penumbra can progress to infarction 
owing to ongoing excitotoxicity (see below) or to secondary deleterious phenomena, such 
as spreading depolarization, post-ischemic inflammation and apoptosis (see below, Lo 
2008b; Lo 2008a), and therapeutic opportunity is lost. It is, thus, evident that the prime 
goal of neuroprotection is to salvage the ischemic penumbra. Although there is ample 
evidence that the penumbra exists in human stroke patients (Read et al. 1998), the extent 
and temporal dynamics of this area are less well defined: it might be smaller and exist for a 
shorter time period in humans (Kaufmann et al. 1999).
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Figure 1.2 Spatio-temporal evolution o f  the ischemic damage.
Diffusion-weighted Imaging (DWI), on the top left image, shows the severely damaged ischemic core as an 
hyperintense area (white); Perfusion-weighted Imaging (PWI), top middle image, shows the spatial extent o f  
the blood flow impairment. Top right image depicts the mismatch between the core area with a diffusion 
lesion (dark blue) and the large area with low perfusion (light blu). I f  no treatment is applied, over hours to 
days the core territory expands due to the physiopathological cascades that follow the initial insult. The 
resulting infarct is shown in the bottom image and is almost sized as the initial perfusion deficit (Moskowitz 
et al. 2010).
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Figure 1.3 Temporal cascade o f  the main pathogenetic events in stroke.
Importantly, inflammation evolves in time, being a crucial clinical target (Saenger and Christenson 2010).
1.2.3.1 Excitotoxicity
The large amount of oxygen required by the brain is necessary to generate sufficient ATP 
by oxidative phosphorylation to maintain and restore ionic gradients. One estimate 
suggests that the Na+/K+ATPase found on the plasma membrane of neurons, consumes 
70% of the energy supplied to the brain. This ion pump maintains the high intracellular K+ 
concentration and the low intracellular Na+ concentration necessary for the propagation of 
action potentials. After global ischemia, mitochondrial inhibition of ATP synthesis leads to 
ATP being consumed within 2 min, this causes neuronal plasma membrane depolarization, 
release of potassium into the extracellular space and entry of sodium into cells. Energy 
failure also prevents the plasma membrane Ca2+ ATPase from maintaining the very low
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concentrations of calcium that are normally present within each cell. The extracellular 
calcium concentration is approximately 1.2 mM and most cellular processes regulated by 
calcium have a Km value in the range of 0.1-1 jiM . During ischemia intracellular calcium 
levels rise to 50-lOOpM, activating many, if not all calcium dependent proteases, lipases 
and DNases. Activation of these enzymes causes many cells in the ischemic core to die 
from simple catabolism. Because no ATP is available for the re-synthesis of cellular 
constituents these catabolic enzymes cause the necrosis of essential cellular structures. 
Membrane depolarization also leads to neurotransmitter release, with the release of the 
excitatory neurotransmitter glutamate playing a critical role in ischemic pathology. A large 
concentration gradient of glutamate is maintained across the plasma membrane by sodium- 
dependent glutamate transporters located on presynaptic and postsynaptic membranes. The 
synaptic glutamate concentration is in the micro molar range, whereas the cytosolic 
concentration of glutamate is approximately 10 mM. Membrane depolarization and 
accumulation of sodium inside cells during ischemia causes reversal of glutamate 
transporters and allows glutamate to exit cells along its concentration gradient. The effect 
of an increase in synaptic glutamate concentration is the activation of N-methyl-D- 
aspartate (NMDA) and AMPA receptors. NMDA receptors are calcium permeable and the 
opening of these channels leads to further membrane depolarization and greater calcium 
influx, exacerbating intracellular calcium overload (excitotoxicity, Olney and Sharpe 
1969). AMPA receptors are not normally calcium permeable by virtue of their GluR2 
subunit, however, this subunit is reduced after ischemia increasing the calcium 
permeability of these receptors by up to 18-fold, allowing AMPA receptors to contribute to 
delayed calciumdependent cell death (Liu et al. 2006). Blocking glutamate binding sites on 
NMDA and AMPA receptors has repeatedly been shown to provide robust neuroprotection 
in models of focal ischemia, where receptor blockade is thought to prevent calcium entry 
from reaching a toxic threshold. Recent findings indicate that NMDA receptors are also
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involved in neuroprotective effects depending on their subcellular localization 
(Hardingham and Bading 2010; Tymianski 2011). Whereas stimulation of extrasynaptic 
NMDA receptors is deleterious via different pathways acting downstream, such as death- 
associated protein kinase 1 (DAPK1) and PTEN (phosphatase and tensin homolog deleted 
on cromosome 10), both associated with increased excitotoxicity (Ning et al. 2004; Tu et 
al. 2010), stimulation of synaptic NMDA receptors drives protective activity. Synaptic 
NMDA receptors activate several downstream pathways including the serine/threonine Akt 
(Hardingham 2006) and the transcription factor CREB (cyclic AMP response element 
binding protein). CREB is induced by nuclear Ca2+ signaling and, in turn, induces activity- 
regulated inhibitors of apoptosis (AID), brain-derived neurotrophic factor (BDNF) and 
other molecules that inhibit pro-apoptotic factors (Hardingham 2006; Hardingham and 
Bading 2010; Zhang et al. 2009). A scheme of the opposing effects of synaptic or 
extrasynaptic NMDA receptors is drawn in figure 1.4.
Metabotropic glutamate (mGlu) receptors also contribute to excitotoxicity. MGlu receptors 
are G-protein coupled receptors that modulate excitatory synaptic transmission. There are 8 
subtypes divided into 3 groups. The group I mGlu receptors (mGlul and mGlu5) are 
predominantly found at the postsynaptic membrane of glutamatergic synapses where they 
increase neuronal excitability by modulating NMDA and AMPA receptors. Evidence that 
these receptors enhance the induction and progression of excitotoxic neuronal death is 
provided by the finding that pharmacologic blockade of group I mGlu receptors provides 
neuroprotection in in vitro and in vivo models of ischemia (Bruno et al. 2001). Group II 
(mGlu2 and mGlu3) and group III (mGlu4, mGlu6, mGlu7, mGlu8) mGlu receptors are 
predominantly found at presynaptic terminals where they inhibit the release of glutamate. 
Group II receptors are also widely expressed on astrocytes. Both group II and group III 
receptor agonists have been found to be neuroprotective by limiting the induction of 
excitotoxicty, however, group II receptor agonists also confer neuroprotection by
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increasing production of neurotrophic factors such as nerve growth factor and TGF-p in 
astrocytes (Bruno et al. 2001).
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Figure 1.4 Opposite effects o f  synaptic and extrasynaptic NMDA receptors.
A: Activation o f CREB by synaptic NMDA receptors is a multi-step process and needs the recrutiment o f the 
co-activatory molecule CBP (CREB binding protein) via CREB phosphorylation. CREB phosphorylation is 
mediated by the activation o f CaMKIV (Ca2^  calmodulin-dependent protein kinase IV) and ERK 
(extracellular signal regulated kinase) 1/2 pathway (Aa, Ab respectively) upon synaptic NMDA receptor 
signalling. CBP is subject to Ca2+-mediated transactivation by CaMKIV which phosphorylates CBP on 
serine 301 (Ac). Synaptic NMDA receptor signalling promote the nuclear import o f TORC (transducer o f 
regulated CREB activity) by TORC dephosphorylation mediated by calcineurin (Ad). TORC assists to CBP 
recruitment to favour CREB activation. Once activated, CREB promotes anti-apoptotic factors and 
neutrophic molecules. Extrasynaptic NMDA receptors are instead responsible for toxic effects via the 
inhibition o f ERK 1/2 (Ae) and the nuclear translocation o f Jacob (juxtasynaptic attractor o f caldenrin on 
dendritic boutons protein) which dephosphorylates CBP (Af).
B: Synaptic NMDA receptors are also able to induce Akt production. Akt mediates phosphorylation and 
nuclear export o f FOXO (forkhead box protein O) proteins (Ba). FOXOs are transcriptional factors for a 
number o f pro-apoptotic genes. Akt-mediated phosphorylation is thus associated with anti-aptoptotic features 
via nuclear export o f FOXOs. On the contrary, extrasynaptic NMDA receptors favour the nuclear import o f 
FOXOs (Bb) and thus promote apoptosis. In some extent, the activity o f extrasynaptic NMDA receptors can 
be blocked by synaptic receptors (Be) even though this mechanism is largely unclear (Hardingham and 
Bading 2010).
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More recent data suggest that glutamate receptors may be joined by several other 
mechanisms that are able to affect the deleterious consequences of ischemia and do not 
depend on glutamate signalling (Tymianski 2011). Among those are transient receptor 
potential (TRP) channels, and in particular the melastatin family (TRPM), a superfamily of 
nonselective Ca2+ permeable cation channels (Venkatachalam and Montell 2007). One 
element of this familiy, TRPM2, is strongly associated with toxic effects. TRPM2 is 
activated by excess of H2O2 , arachidonic acid, ROS and nitrogen species (RNS), TNF and 
intracellular Ca2+ concentrations. The gene trpm2 is upregulated in activated microglia and 
may confer to microglia toxic features (Fonfria et al. 2006).
The acid-sensing ion channels (ASICs) are activated by extracellular acidosis which 
accompanies brain ischemia. The final effect of ASICs is to increase Ca2+ intracellular 
influx, thus contributing to excitotoxicity in a glutamate-independent way (Allen and 
Attwell 2002; Giffard et al. 1990; Immke and McCleskey 2001; Yermolaieva et al. 2004).
Lastly, another mechanism that do not rely on glutamate metabolism is associated with 
activation of PANX protein (pannexin family). These proteins, although similar to the gap- 
junction forming proteins (innexins) are involved in the formation of large pores and may 
have a physiological function as well (MacVicar and Thompson 2010; Yen and Saier
2007). PANX1 is activated after oxygen glucose deprivation in cultured hippocampal and 
cortical pyramidal neurons, but their exact mechanism is unknown and their activation 
after ischemia is yet to be demonstrated in the in vivo setting (MacVicar and Thompson 
2010; Thompson et al. 2006; Tymianski 2011).
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1.2.3.2 Peri-infarct depolarisation
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Cortical spreading depression (CSD) is a self-propagating wave of electrochemical activity 
that progresses through cortical tissue in intact brain. CSD causes sustained (1-5 min) 
cellular depolarization, depressed neuro-electrical activity, increased glutamate release and 
loss of membrane ionic gradients (Gonzalez et al. 1992). Peri-infarct depolarizations 
(PIDs) are spontaneous waves of depolarization with all of the characteristic features of 
CSD that propagate through the penumbra following focal stroke. PIDs may be caused by 
the release of potassium and excitatory amino acids from the ischemic core. Although CSD 
in the normally perfused brain does not lead to cell death, recurrent PIDs in the ischemic 
brain are associated with increased ischemic injury. Repeated depolarization in the 
penumbra may mediate tissue damage by allowing calcium to accumulate within neurons. 
A critical threshold of calcium could be reached in the case of PID due to the compromised 
energy supply of the tissue, thus causing damage in the case of PID but without evidence 
of lasting damage in the case of CSD. PIDs are known to occur in animal stroke models, 
where the incidence and duration of spreading depression correlates with infarct 
maturation (Strong et al. 2000). Recently Fabricius and colleagues demonstrated the 
existence of PIDs in the acutely injured human brain, which suggests that inhibition of 
spreading depression using a therapeutic approach such as hypothermia or glutamate 
receptor antagonism could be an important strategy to limit development of ischemic 
injury within the penumbra (Fabricius et al. 2006).
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1.2.3.3 Inflammation
Inflammation rapidly establishes after ischemic injury and contributes to lesion evolution 
with long lasting effects. Many inflammatory events arise, including activation of resident 
immune populations (microglia and perivascular macrophages), recruitment of blood- 
borne cells (macrophages, lymphocytes, neutrophils and dendritic cells), activation of the 
complement system and development of cytokine/chemokine cascades. In patients with 
ischemic stroke chemokines such as monocyte chemoattractant protein-1 (MCP-1), and 
chemokine C-X-C motif ligand-1 are rapidly upregulated after stroke (Worthmann et al. 
2010), suggesting that immune cells are quickly attracted to the ischemic area. The 
inflammatory response evolves over time and is characterized by an immediate reaction to 
acute injury, followed by acute and delayed phases, each involving specific cell types and 
effector molecules (see figure 1.5). The effect of individual components of the 
inflammatory cascade can be either detrimental or beneficial, depending on the stage of 
tissue injury, the magnitude of the response and whether the inflammatory component also 
activates neuroprotective pathways (Iadecola and Anrather 2011; Magnus et al. 2012). The 
inflammatory response is thus a composite process that involves many different cell types, 
inflammatory mediators and extracellular receptors, each with a specific function and 
timing of activation. As the main topic of this thesis is the study of the inflammatoy 
populations activated/recruited in the ischemic brain, I will provide thorough description of 
inflammation after stroke in section number 1.4.
37
introduction
DelayedAcuteImmediate
A ntig en -sp ec ific  CD4 T  cella /p  T  cell v /R T
P latele t
Dying n eu ron  I - >  IL-17
I TCR
k Q1L-1P
IL-12
IL-6
IL-23
TNF
MCP1 CX C L1.R A N TES
P2X7
C aspase-1CD38
NLRP3
TLR4
— >■ IL-10TLR2
B ce ll
A ctivated  m icroglia/ 
m acro p h ag e IL-10
Figure 1.5 Cascades o f  immune activation after stroke.
Neurons die rapidly soon after initial acute injury. Danger signals (ATP, high-mobility group box 1 protein, 
HMGB1) are released and bind to P2X7 or Toll-like receptors (TLRs) on resident/early recruited immune 
cells. Microglia/Macrophages become activated upon sensing o f  danger signals and begin a downstream 
propagation o f  inflammatory molecules. The delayed response is characterized by the recruitment and 
activation o f other immune cells (such as T-cells, here represented) that can drive either a detrimental or a 
protective inflammatory activity. In this phase microglia/macrophages continue to be important actors o f  the 
inflammatory cascade by changing their polarized state (see section 1.4.2.1, Magnus et al. 2012).
1.2.3.4 Apoptosis
Mild ischemic injury preferentially induces cell death via an apoptotic-like mechanism
rather than necrosis. Because the ischemic penumbra sustains milder injury and preserves
ATP, apoptosis predominates in this region (Kerr et al. 1972). Triggers of apoptosis
include oxygen free radicals, death receptor ligation, DNA damage, protease activation and
ionic imbalance. The release of cytochrome c from the outer mitochondrial membrane
plays a central role in mediating apoptosis in response to ischemia (Fig. 1.6). Release of
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cytochrome c is caused by ionic imbalance and mitochondrial swelling or by formation of 
a pore in the outer mitochondrial membrane. The complex interplay of the Bcl-2 family of 
proteins either promotes (Bax, Bak, Bad, Bim, Bid) or prevents (Bcl-2, Bcl-XL, Bcl-w) 
pore formation. The pore is formed by oligomerization of Bax and/or Bak in the outer 
membrane, which in turn is activated by DNA damage. The anti-apoptotic Bcl-2 proteins, 
Bcl-2 and Bcl-XL, can form heterodimers with Bax, thereby preventing pore formation 
(Adams and Cory 2001; Edwards and Dean 1977; Hengartner 2000). Bad, Bim and Bid 
also influence pore formation, although the exact manner by which these molecules do so 
is unclear. Unlike Bax and Bak, Bid, Bad and Bim do not have the ability to directly 
mediate cytochrome c release by forming a pore. Instead they appear to function as sensors 
of cell stress that may promote apoptosis by heterodimerizing and antagonizing the 
function of anti-apoptotic Bcl-2/Bcl-XL and/or activating the function of Bax and Bak 
(Adams and Cory 2001; Edwards and Dean 1977; Hengartner 2000). Cytochrome c release 
activates downstream caspases of the intrinsic pathway through formation of the 
apoptosome, a complex of dATP, cytochrome c, procaspase 9 and Apafl (Fig. 1.6). 
Effector caspases 3 and 7 then target substrates that dismantle the cell by cleaving 
homeostatic, cytoskeletal, repair, metabolic, and cell signaling proteins. These caspases 
also cause further DNA fragmentation by activating capase-activated deoxyribonuclease 
(CAD) by cleaving the inhibitor protein ICAD. Caspase activation can be modulated by 
protein inhibitors of apoptosis (IAP) and indirectly by secondaiy mitochondria derived 
activator of caspase (Smac/Diablo). Activation of the extrinsic pathway of death receptors 
can induce caspase activation independent of the release of cytochrome c. Death receptor 
ligation results in activation of caspase-8 and caspase-10, which in turn can activate 
effector caspase 3 (Namura et al. 1998). Activation of death receptors such as Fas/CD95, 
TNFR1, and the TRAIL receptor is promoted by the TNF family of ligands, including
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FASL, TNF, LT-alpha, LT-beta, CD40L, LIGHT, RANKL, and TRAIL, which are 
released as part of the inflammatory response to ischemia (Del Zoppo et al. 2000).
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Figure 1.6 Apoptosis in stroke.
Cell death pathways relevant to apoptosis in cerebral ischemia. The release o f cytochrome c (cyt c) from the 
mitochondria is mediated by the proapoptotic proteins Bax and/or Bak forming a pore in the mitochondrial 
membrane. Pore formation is facilitated by Bad and Bid. Calcium influx causes the dephosphorylation o f Bad 
by calcineurin (CaN), which releases Bad from 14-3-3 and allows its translocation to the mitochondria. 
Calcium can also activate calpains, which can activate cathepsins that mediate the limited proteolysis o f  Bid, 
allowing truncated Bid (t-Bid) to translocate to the mitochondria. Caspase 8, which is activated by TNF 
receptor ligation, also mediates the limited proteolysis o f Bid, allowing truncated Bid (t-Bid) to translocate to 
the mitochondria. Once present in the cytosol, cyt c forms the apoptosome complex by binding to Apaf-1 and 
procaspase 9. The apoptosome complex cleaves and activates caspase 3, which causes actin fragmentation, 
and endonuclease activation. Caspase 3 can also be activated by caspase 8. Apoptosis-inducing factor (A1F) 
can also be released from the pore created in the mitochondria, causing DNA degradation. DNA damage 
activates p53, which further increases Bax expression. The antiapoptotic proteins Bcl-XL and Bcl-2 prevent 
Bax-mediated pore formation and cyt c release. Various survival factors also prevent pore formation and 
cytochrome C release by activation o f Akt and ERK pathways (Doyle et al. 2008).
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1.3 Pharmacological treatment of stroke
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Although more than three centuries elapsed from the first stroke description by Johan 
Jacob Wepfer (1620-1695), stroke is still an unmet medical need. The only therapy 
presently approved for clinical stroke is the administration of the thrombolytic agent tissue- 
type plasminogen activator (tPA), whose usage is however limited due to short time 
window of efficacy and to potential harmful side effects. The original 3h time window of 
tPA administration has been extended in 2008 to 4.5h as the European Cooperative Acute 
Stroke Study (ECASS) III trial (Hacke et al. 2008) provided evidence that a time window 
of 4.5h was both safe and effective. However, a further meta-analysis of all existing trials 
on intravenous tPA administration, showed that the proportion of patients achieving an 
excellent outcome of the modified Rankin Scale score declined significantly from an odds 
ratio of 2.4 when tPA was administered within 90 min, to 1.4 for tPA administered within 
3h-4.5h time frame (Lees et al. 2010). Moreover, the beneficial effects of tPA 
administration at 6h after ischemic onset declined almost to zero.
Most trials of therapy indicate that tPA use was associated with risk of intracerebral 
hemorrhage with an odds ratio of 3.49 (Lees et al. 2010; Wardlaw et al. 2009). This rate 
did not increase significantly with time, even though at 6h the blood brain barrier (BBB) is 
potentially more porous (Lees et al. 2010). The recent meta-analysis (Lees et al. 2010) 
provides evidence of a little but significant increase of mortality over the 6h time window, 
possibly suggesting that nonhemorrhagic factors are also involved during this period. 
Predictors of risk and hemorrhage may include increasing age, early ischemic change on 
CT scan, high blood pressure, high blood glucose, high NIH Stroke Scale score, atrial 
fibrillation, weight (Wahlgren et al. 2008) and protocol violations (Katzan et al. 2000). 
There are other unwanted effects of tPA that contribute to the ischemic damage in different
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ways: enhancing the excitotoxicity cleaving the NR1 or interacting with NR2 subunit of 
NMDA receptor; favouring the brain oedema formation; upregulating matrix 
metalloproteinases (MMPs); exacerbating the accumulation and the infiltration of 
inflammatory cells (such as lymphocytes, polymorphonucleates, leukocytes ecc.) from the 
periphery to the brain parenchyma (Kaur et al. 2004, Fig. 1.7).
Moreover, the use of thrombolysis for acute ischemic stroke is hampered by other reasons 
that are associated with low level of public awareness, poor recognition of symptoms, 
delays in emergency transport and a low level of expertise in tPA administration in many 
centres (Barber et al. 2001; Hoffman 2003; Hoffman and Schriger 2009; Kleindorfer et al. 
2008; Kleindorfer et al. 2004; Kwan et al. 2004; Reeves et al. 2005). Overall, only 2-5% of 
eligible patients are effectively treated with thombolytic therapy in most centres, although 
this percentage increases in centres with a higher level of expertise (Kleindorfer et al. 
2008; Nadeau et al. 2005). Thus major challenges for an effective use of the thrombolytic 
therapy remain, including further enhancement of its efficacy, extending the time window 
of administration, reducing its side effects and treating more patients within the 4.5h time
window.
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Figure 1.7 Beneficial and detrimental effect o f  tPA following cerebral ischemia (Kaur et al. 2004).
To enhance further the efficacy of the thrombolytic therapy, recent trials explored the use 
of bridging protocols, sonothrombosis or alternative thrombolytic agents. Bridging
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protocols consist on a combined approach: after the initial intravenous injection of tPA, if 
recanalization is not demonstrated within a certain time frame, intra-arterial administration 
of tPA is also performed (International Mangement of Stroke, IMS, series of trials). IMS I 
and IMS II trials proved safety and feasibility of this approach in the early phase II (IMS 
Study Investigators 2007; IMS Study Investigators 2006; IMS Study Investigators 2004) 
and phase III is currently underway (Khatri et al. 2008). Sonothrombosis is based on the 
idea that ultrasound may enhance the effects of a thrombolytic agents, possibly by 
increasing drug transport to the clot (Alexandrov et al. 2004). At present, a phase II dose- 
ranging study indicated that a 1.4mL dose of ultrasound-activated perflutren lipid 
microspheres was safe and feasible, while increasing the dose was associated with 
increased incidence of intracerebral hemorrhage (Alexandrov et al. 2008; Molina et al. 
2009). New thrombolytic agents are presently investigated. In particular, desmoteplase and 
tenecteplase have a longer half-life and are less associated with hemorrhagic risk 
(Liberatore et al. 2003; Reddrop et al. 2005; Tanswell et al. 2002). Whilst proven to be 
effective in phase II trials on MRI-based outcome measures, desmoteplase failed in phase 
III trial (Furlan et al. 2006; Hacke et al. 2009; Hacke et al. 2005). The rationale has been 
recently redesigned and a new phase III trial is still on course. Tenecteplase yielded 
encouraging results in a small pilot study (Parsons et al. 2009), being at least as effective as 
tPA and with no hemorrhagic effects when dosed at 0.1 mg/Kg. Bigger phase III trails are 
needed to substantiate these results but, unfortunately, a phase III trail in the USA 
terminated due to insufficient patient recruitment (Haley et al. 2010).
Many efforts have been done to extend the time window of efficacy of the thrombolytic
therapy. However, to date, as previously discussed, 4.5h represents the time by which tPA
must be administered to be effective. The recent IST-3 trial (Sandercock et al. 2012)
provided evidence that patients treated up to 6h with tPA survived with less disability at 6
months, whilst no difference was observed in 6 month mortality. This study confirmed the
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policy of treating patients as soon as possible, and supported the need of randomised trials 
of thrombolysis in patients more than 4.5h after stroke onset. Besides, IST-3 succeeded in 
extending the number of patients eligible for tPA treatment, including patients older than 
80 years of age and excluding restriction of treatment on the basis of stroke severity or 
early ischemic changes in CT scans (Sandercock et al. 2012).
Another approach that could be useful to treat stroke patients consists in neuroprotective 
therapies. Differently from thrombolytic agents, neuroprotection refers to the use of 
therapies that reduce brain injury during acute stroke, generally through actions on the 
brain itself rather than by directly improving blood flow and perfusion through occluded 
cerebral vessels. Included in this group of therapies are a large number of medications, as 
well as strategies such as hypothermia designed to interfere more generally with adverse 
metabolic consequences of stroke (Sacco et al. 2007). Agents with several different 
mechanisms of action have been tested. For instance, minocycline have been demonstrated 
to reduce hemorrhagic effects of tPA treatment in experimental models acting via MMP9 
(Machado et al. 2009; Machado et al. 2006; Murata et al. 2008) and to have broad anti­
inflammatory proprieties (Fagan et al. 2010). Recently clinical trials using minocycline and 
tPA have been initiated (Fagan et al. 2010; Lampl et al. 2007). Other clinical trials have 
been performed using strategies aimed at interfering with the inflammatory response. A 
phase II placebo-controlled trial explored treatment with IL-1 receptor antagonist and 
found that blockade of IL-1 receptor reverses suppression of innate immune cytokine 
responses and attenuates the maintained elevation of plasma cortisol in stroke patients 
(Smith et al. 2012). The study is not yet completed and further and wider studies are 
needed to substantiate encouraging results.
Blocking antibodies against the adhesion molecule ICAM-1 or recombinant neutrophil
inhibitory factors (Del Zoppo 2004) were unfortunately ineffective in the clinical setting,
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while an indirect modulation of the immune activity via remote preconditioning has 
recently entered in an ongoing trial (Koch et al. 2011). Thus, although in many pre-clinical 
studies specific receptors and pathways related to the inflammatory response have been 
manipulated yielding promising results, none of the therapeutic interventions aimed at 
modifying the inflammatory response after stroke have been successful in humans 
(Iadecola and Anrather 2011). The possible reasons for these failures might be due to 
shortcomings in trial design rather than absence of efficacy of the agents tested (O’Collins 
et al. 2006), or to the fact that several aspects of brain immunity still need to be revealed. 
At present, however, acute stroke treatment guidelines do not advocate treatment with any 
neuroprotectant agent (Adams et al. 2005; Donnan et al. 2011; Sacco et al. 2007).
1.4 Inflammation in the Central Nervous System
In the late 19th century, Paul Ehrlich observed that a water-soluble viable dye injected into 
the peripheral circulation would stain all organs except the CNS, providing the first 
indication that the CNS was anatomically separated from the rest of the body. The idea that 
the brain was an unique anatomical compartment was further confirmed by Edwing 
Goldman that showed that a dye injected into the spinal fluid did not stain peripheral 
tissues. It is now well known that this is due to the presence of the blood brain barrier 
(BBB), that restricts acces to the brain to soluble factors, including 98% of antibodies, and 
immune cells (Ge et al. 2008; Hawkins and Davis 2005; Mrass and Weninger 2006). This 
feature along with the lack of lymphatic system, low constitutive levels of MHC class I and 
II molecules, local production of suppressive factors and limited number of professional 
antigen presenting cells, reinforces the concept of the CNS as an immuno-privileged site 
(Wilson et al. 2010). Thus in normal conditions presence and trafficking of immune cells
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in the brain are negligible. Physiological homeostasis of the brain is ensured by microglia 
which are generally defined as the resident immune cells of the CNS (Kim and De Vellis
2005). These resident cells act mainly to stabilize the CNS by counteracting microdamages 
that possibly occur in the brain, such as small ischemic events, localized opening of the 
BBB, decline of neurons that must be removed (Hanisch and Kettenmann 2007).
In more severe diseased states, microglia as well as peripheral immune cells are recruited
and activated to lesion sites. Microglia are well positioned throughout the brain to rapidly
sense any disturbances (Denes et al. 2007), while peripheral immune cell recruitment is
facilitated by the activation of endothelial cells and BBB associated cells {i.e. astrocytes)
leading to reduced tight junction integrity and formation of transendothelial cell channels
(Lossinsky and Shivers 2004; Raine et al. 1990; Wolburg et al. 2005). Several
neurodegenerative disorders and infectious diseases are characterized by activation of
inflammatory pathways whose effects could be of opposite nature. Although the ability to
recognize infections and establish an inflammatory response in the CNS is required to limit
pathogen replication, this response is not always beneficial. The classical features of
inflammation, such as swelling and expansion, could be harmful given the presence of the
rigid skull bone. Furthermore, although the immune system can contribute to the successful
resolution of the tissutal damage associated with many CNS disorders (Byram et al. 2004;
Simard et al. 2006), inflammation itself can drive multiple neurodegenerative conditions
including Parkinson disease, Alzheimer disease and lysosomal storage diseases (Brochard
et al. 2009). After brain ischemia, inflammation can have either protective or detrimental
effects depending on timing of activation, populations involved, molecular signals released
and location in respect to the lesion site. A clear understanding of the rules that govern
brain immunity may inform the design of strategies aimed at augmenting the protective
immune repsonses while minimizing collateral damage. The past two decades have seen
remarkable advances in the comprehension of immune cell trafficking, activation and
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functions within the CNS, but many aspects of brain immunity still remain to be fully 
elucidated.
1.4.1 Inflammation after stroke
1.4.1.1 Time dependent recruitment o f immune cells to ischemic lesion site
After the ischemic insult immune populations are rapidly activated. These populations 
belong to both innate and adaptive responses and are recruited to the site of injury, where 
they further promote inflammatory signalling (Iadecola and Anrather 2011) with either 
detrimental or beneficial effects (Nawashiro et al. 2000; Zhang et al. 2000). 
Recruitment/activation of immune cells takes place in a time-dependent manner. As 
mentioned above, the inflammatory response is a composite process that involves many 
inflammatory cell types. The primary source of granulocytes and monocytes which are 
recruited to the ischemic brain is the bone marrow (D’Mello et al. 2009; McColl et al.
2008). Experimental evidence indicate that myeloid cells in the bone marrow respond very 
rapidly to ischemia, as suggested by the mobilization of Gr-1 (marker of myeloid cells) 
positive cells within 4h after MCAo (Denes et al. 2011). Within the first hours after 
ischemia, resident microglia are activated, undergo a morphological switch and begin 
producing inflammatory cytokines, including tumor necrosis factor a (TNFa) and 
interleukin (IL)-1(3. After the early activation of microglia response, immune cell types 
coming from the peripheral immune system, such as neutrophils, macrophages, dendritic 
cells (DCs) and T-Lymphocytes, are recruited to the site of injury (Garcia et al. 1994) 
according to a well define time course (Gelderblom et al. 2009). Macrophages, DCs and T- 
lymphocytes accumulate soon after microglia activation, reaching their peak of presence
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by the first 3-4 days after injury. The early accumulation of these immune cells favours the 
subsequent influx of neutrophils by the upregulation of cell adhesion molecules including 
intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin, 
thereby promoting neutrophil accumulation and migration into the brain parenchyma 
(Gelderblom et al. 2009; Huang et al. 2006). The transmigration of neutrophils through 
activated cerebral endothelium is capable to confer a neurotoxic phenotype to these cells 
(Allen et al. 2012). Neutrophil neurotoxicity develops rapidly after IL-1-induced 
transmigration and is characterized by the release of toxic proteases associated with de­
condensed DNA (Allen et al. 2012). Neurotoxic neutrophils are endowed with the ability 
to kill neurons immediately after recruitment and to induce further cerebrovascular 
activation and leukocyte recruitment since they contain high levels of pro-inflammatory 
cytokines, such as KC, MCP-1 and RANTES (Allen et al. 2012).
Over the last years, growing attention has been payed to inflammatory mechanisms driven 
by microglia/macrophages and T-cells after ischemia, aimed at depicting the exact 
behavior of both resident and recruited immune cells in the ischemic context. These 
populations, altough participating in the pro-inflammatory cascades, are also capable of 
protective and regenerative functions (Iadecola and Anrather 2011; Magnus et al. 2012). 
However, many aspects of the behavior of these populations remain elusive, and further 
studies are needed to understand the complex inflammatory response induced by brain 
ischemia, in the view of developing strategies resulting in promotion of a protective 
inflammatory phenotype.
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1.4.1.2 The cytokine inflammatory response
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Cytokines and chemokines contribute to stroke-related brain injury (Gong et al. 1998). 
During ischemia, cytokines, such as IL-1, IL-6, TNF-a, TGF-p and chemokines such as 
CINC and MCP-1 are produced by a variety of activated cell types, including endothelial 
cells, microglia, neurons, platelets, leukocytes, and fibroblasts (Huang et al. 2006, Fig. 
1.8). Production of IL-1 is increased after permanent or transient cerebral ischemia in 
microglia, astrocytes, and neurons. The exact role of IL-1 in propagating tissue damage is 
unclear, although possible deleterious effects of IL-1 include fever arachidonic acid 
release, enhancement of NMDA mediated excitotoxicity, and stimulation of nitric oxide 
synthesis (Huang et al. 2006). An additional role of IL-1 may be recruitment and adhesion 
of neutrophils. IL-1 has been shown to cause up-regulation of E-selectin, ICAM-1, ICAM- 
2, and VCAM-1 on cerebral endothelial cells and the induction of such adhesion molecules 
may explain why elevated IL-1 levels after ischemia increases neutrophil infiltration 
(Huang et al. 2006; Yamasaki et al. 1997). That the effects of IL-1 are deleterious was 
demonstrated by Garcia and Relton who showed that administration of recombinant IL-1 
receptor antagonist reduces the severity of neurologic deficits and tissue necrosis in rats 
subjected to permanent MCAo (Garcia et al. 1995; Relton et al. 1996).
In rats subjected to permanent MCAo, IL-6 mRNA expression is up-regulated as early as 
3h after occlusion, peaks at 12h, and continues for at least 24h (Wang et al. 1995). The 
biological activity of IL-6 overlaps with those of IL-1, and data from human studies 
suggest a pro-inflammatory role for IL-6 in stroke. Peripheral blood levels of IL-6 are 
higher in stroke patients and detectable within a few hours of stroke onset and higher CSF 
and serum levels of IL-6 correlate with larger infarct size and poorer clinical out come 
(Huang et al. 2006). However, in experimental models, IL-6 has been associated with anti-
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apoptotic and anti-inflammatory properties due to its ability to induce IL-1 receptor 
antagonist synthesis (Relton et al. 1996). Thus, it is unclear whether the overall effect of 
IL-6 is beneficial or detrimental in the context of stroke.
Up-regulation of TNF-a mRNA parallels that of IL-1 and IL-6 mRNA within the first 
hours after ischemia (Huang et al. 2006). Both experimental and human data indicate a 
positive correlation between TNF-a and the extent of ischemic injury. For example, a study 
of 24 patients with ischemic stroke found that CSF levels of TNF-a were markedly 
increased within 24 h of ischemic stroke and that the levels of CSF and serum TNF-a were 
positively correlated with infarct volume (Zaremba et al. 2001). Like IL-1, TNF-a induces 
adhesion molecule expression in cerebral endothelial cells and promotes neutrophil 
accumulation and transmigration. In addition TNF-a stimulates acute-phase protein 
production, disrupts the blood-brain barrier and stimulates the induction of other 
inflammatory mediators. However, recent findings on animal models of brain diseases, 
including ischemia, indicate that TNF-a may be involved in protective mechanisms as well 
(Balosso et al. 2005; Fontaine et al. 2002; Genovese et al. 2008; Lambertsen et al. 2009; 
Quintana et al. 2005). This may be due to the ability of TNF-a to bind two different surface 
receptors, TNFR1 (p55) and TNFR2 (p75, MacEwan 2002; Wajant et al. 2003) which may 
result in opposite outcome. These receptors specifically bind TNF-a, but have different 
expression profile, ligand affinity, cytoplasmic tail structure and downstream signalling 
pathway activation. TNF-associated neuroprotection following cerebral ischemia has been 
shown to occur via the p55 receptor (Taoufik et al. 2008; Taoufik et al. 2007). A further 
work indicated that microglia are able to induce neuronal protection by TNF-a synthesis 
and release (Lambertsen et al. 2009). The molecular basis of the different role of TNF-a 
action in brain ischemia needs to be fully elucidated and could involve several aspects, 
including specific timing of activation, different binding affinities of TNF-a to each 
receptor, different expression of the two receptors in brain areas and/or selected cell
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populations, and different ligand concentration. A further degree of complexity is 
represented by the existence of cross-talk between two receptor pathways.
Growing evidence suggests that TGF-p plays a neuroprotective role in the pathogenesis of 
stroke. In rodent models of cerebral ischemia, increased expression of TGF-p mRNA is 
demonstrated in ischemic tissues as early as 1-6 h after the ischemic event and remains 
elevated for up to 15-21 days (Wiessner et al. 1993). The effects of TGF-p upon stroke 
volume have been studied with intracarotid and icv administration and TGF-P has been 
found to be neuroprotective if administered before or after the ischemic insult (Huang et al.
2006). It is likely that the neuroprotective effect of TGF-p is the concerted result of the 
activation of several neuroprotective pathways. TGF-p 1 has a concentration-dependent 
protective effect against neuronal injury caused by glutamate excitotoxicity in vitro, and 
recent evidence indicates that administration of a TGF-p 1-blocking agent increases the 
extent of excitotoxic lesions after focal cerebral ischemia (Huang et al. 2006). Data also 
exist to supporting a role for TGF-p in diminishing ischemia-induced endothelial 
dysfunction (Lefer et al. 1993).
Increased expression of CINC and MCP-1 mRNA are detected in the brain of rats as early 
as 6 h after permanent MCAO, reach a maximal level at 12 h and are decreased by 24 h 
(Minami and Satoh 2003). CINC and MCP-1 expression attracts neutrophils to ischemic 
tissue, evidence for which comes from rodent experiments using transient ischemia, where 
CINC and MCP-1 are detectable in cerebral tissue before neutrophil infiltration (Huang et 
al. 2006). In rats, administration of anti-CINC antibody decreases cerebral edema and 
infarction, which further supports a role for CINC in mediating neutrophil infiltration and 
demonstrates another therapeutic opportunity (Yamasaki et al. 1997).
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Figure 1.8 Inflammatory cascades following vessel occlusion.
Occlusion by a proximal thrombus leads to inflammatory cascades in the capillaries o f distal ischemic tissue. 
P-selectin is released from preformed storage sites and, together with E-selectin, binds to sialyl-Lewis X 
moieties to promote rolling adhesion o f neutrophils (1). Ischemia induces expression o f IL-1 on endothelial 
cells that then induce expression o f ICAM-1 on surface o f endothelial cells. Integrins macrophage-1 antigen 
(Mac-1) and lymphocyte function-associated-1 antigen (LFA-1) on neutrophil surfaces binds intercellular 
adhesion molecule-1 and -2 (ICAM-1, ICAM-2), and vascular cell adhesion molecule-1 (VCAM-1) causing 
tight binding (2). Astrocytes, macrophages, and microglia in ischemic brain tissue release cytokine induced 
neutrophil chemoattractant (CINC) and MCP-1 in response to ischemically-driven cytokines. These 
chemokines signal neutrophil diapedesis and migration into the brain parenchyma, leading to tissue 
destruction (3 and 4, Huang et al. 2006).
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1.4.2 Microglia/Macrophages and Lymphocytes: double-edged swords in ischemic 
damage evolution
1.4.2.1 Microglia/Macrophages
1.4.2.1.1 Ontogeny and activation
Microglial cells are considered the immune cells of the CNS (Kim and De Vellis 2005). It 
is now generally acknowledged that all CNS disorders are characterized by activation of 
microglia and that the progression and resolution of many diseases is contingent in part on 
the activity of microglia (Ransohoff and Cardona 2010). In the early 20th century, Cajal 
identified three cell populations composing the brain: neurons (which he called the first 
element), astrocytes (second element) and a third element characterized by small, round 
nuclei. Between 1919 and 1921, del Rio-Hortega proposed that the third element 
comprised two distinct cell populations: oligodendrocytes (Gill and Binder 2007), more 
related to astrocytes and therefore belonged to the second element, and authentic third 
element cells, for which he firstly coined the term ‘microglia’. He also suggested that these 
cells could transform themselves into migratory phagocytic cells.
Ontogeny of microglia has beeen a matter of debate for years and neuroscientists and 
neuroimmunologists have been working to understand how microglia fit in the overall 
scheme of mononuclear phagocytes, the category which microglia belong to. Current data 
indicate that they are of mesenchymal origin and invade the brain in two waves: the first 
during fetal development and the second in the early post-natal days, in both rodents and 
humans (Chan et al. 2007). Microglia have proprieties of monocytes and probably derive 
from myeloid-lineage progenitors (Fig. 1.9). As they set into the brain, microglia cells 
differentiate acquiring their typical phenotype characterized by small soma and highly
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branched processes. At the end of development, microglia have populated all regions of the 
CNS, including the retina (Hanisch and Kettenmann 2007) representing the 20% of total 
glial populations within the brain. The rate of microglia turnover in the healthy adult brain 
is expected to be low, as a study on mouse retina reported a complete turnover in 6 months 
(Xu et al. 2007a). However this study was conducted using an experimental approach that 
included irradiation for depleting the intrinsic monocyte population prior to transplantation 
of bone marrow cells. Criticism of this approach regards the possible effects of irradiation 
itself on BBB integrity that may augment cell infiltration.
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Figure 1.9 Hematopoietic origin o f  microglia/macrophages.
Arrows indicate lineage relatedness. Microglia and macrophages derive from common myeloid progenitors. 
Microglia settle within the CNS where they become the resident immune population o f healthy CNS 
(Ransohoff and Cardona 2010).
There is also a population of perivascular cells that shares some features with immature 
microglia. These cells turn over more rapidly than parenchymal microglia (in 14 weeks) 
and probably turn over equally across different brain areas (Bechmann et al. 2001b;
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Bechmann et al. 2001a). Surprisingly, little is known about heterogenity of microglia cells 
within different brain regions under physiological conditions. As mentioned above, 
parenchymal microglia are different from perivascular monocytes, nevertheless 
specifically adapted microglia cells may exist in specific CNS regions. White or gray 
matter location, proximity to vasculature, BBB features, biochemical microenvironment 
and substances released from neurons could impose specific adjustements of microglia 
phenotype (Binstadt et al. 2006; Galea et al. 2007). However subsets of microglia might 
exert different functions without being clearly distinguishable on the basis of morphology 
or single marker expression. There are few studies that indicate that hippocampal microglia 
express high levels of messenger RNA for TNFa which is associated with exacerbated 
hippocampal damage in TNFR knock-out mice in a model of Parkinson disease (Sriram et 
al. 2006). Evidence also exists for microglia subsets that can be distinguished on the basis 
of morphology and LPS response (Kuwabara et al. 2003). Some diversity in microglia 
basal activities could also be related to developmental adjustements as proliferative or 
phagocytic behavior changes with transition from embryonic to neonatal or postnatal 
stages until adulthood (Ladeby et al. 2005).
On the contrary, in response to a CNS disease, microglia activation shows a plethora of 
functional states, characterized by a specific pattern of receptor expression, released 
molecules and morphological features. The transition between resting and activated state 
should be considered a change in functional phenotype rather than an awakening. 
Microglia in resting state are not dormant, but do perform active surveillance of 
surrounding microenvironment (Davalos et al. 2005). Cells depart from surveillance mode 
and acquire a reactive profile to cope with altered homeostasis (Fig. 1.10). Reactive 
microglia have different functional states that reflect the complexity of these cells and their 
ability to differentiate towards a multitude of phenotypes that can result either in protective 
or detrimental effects.
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Figure 1.10 States o f  microglia activation.
Left: in the healthy tissue, microglia do perform microenvironmental sampling by continuos rebuilding o f 
their processes (1). Microglia are equipped with receptors for a plethora o f molecules to immediately sense 
signs o f  disturbed structural and functional integrity. Neurons may deliver signals keeping microglia in this 
surveillance mode (2). Besides the parenchymal microglia, there are also perivascular macrophages in closer 
association with blood vessels (3). Subsets o f circulating monocytes may replenish perivascular cells, and to 
a much lesser extent also replenish the parenchymal microglia.
Middle: microglia rapidly re-organize their processes in response to a vascular or tissutal damage (4). 
Astrocytes do also participate in supporting the rapid microglial response (5). Microglia can produce 
neurotrophic factors to support endangered neurons (6). Disruption o f ongoing communication through 
calming signals would allow an endangered neuron to call for microglial assistance (7). Such neurons can 
also emit signals indicating disturbed functions using molecules that are not usually released (at all or at 
critical concentrations (8). Microglial cells may be able to limit further damage and restore normal 
homeostasis.
Right: stronger challenges to the CNS cause a more drastic activation o f microglia. Depending on the nature 
o f the stimuli and their context, microglial cells acquire and adapt reactive behavior. Excessive acute, 
sustained (chronic) or maladaptive responses o f microglia may lead to substantial impairment o f neurons and 
glia (9). Failure o f protection and an active contribution to damaging cascades have been attributed to 
activated microglia in many pathologic scenarios (Hanisch and Kettenmann 2007).
Macrophages are recruited to the brain as an injury occurs. They share with microglia a 
common myeloid progenitor and are defined as mononuclear phagocytes. Starting at the 
later stages of gestation, in which they are involved in the formation o f blood vessels 
(Fantin et al. 2010), mononuclear phagocytes are continually renewed from the bone
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marrow hematopoietic stem cells throughout life. They derive from a granulocyte- 
monocyte progenitor which is able to generate macrophages, monocytes and dendritic 
cells. Tissutal macrophages can be derived from blood monocytes or from circulating 
mononuclear phagocyte progenitors that settle in the brain originating perivascular, 
choroid plexus and meningeal macrophages (Ransohoff and Cardona 2010, Fig. 1.9). Their 
maintainance is due to either local self-renewal or influx of cells from the circulation. As 
an injury occurs, a further influx of macrophages into the brain is allowed by the increase 
of adhesion molecule expression on endothelial walls and by the leakage of the BBB. Once 
recruited to the brain, macrophages undergo activation leading to non-specific defense 
(innate immunity) as well as initiation of adaptive immunity. Similarly to what observed 
for microglia, macrophages exhibit a plastic nature, being able to exert either detrimental 
or protective functions upon activation (Porta et al. 2011; Porta et al. 2009).
Activated microglia and blood-born macrophages recruited to the injured ischemic brain 
are barely antigenically distinguishable and will be henceforth referred to as 
microglia/macrophages (M/M). After an insult to the CNS, including ischemia, M/M are 
able to switch their phenotype in a wide range of polarization activation states whose 
extremes are Ml detrimental phenotype and M2 protective phenotype.
1.4.2.1.2 Ml -M2 extremes of M/M polarization
Among the inflammatory cells, M/M are major cellular contributors to post-injury 
inflammation (Graeber 2010; Ransohoff and Cardona 2010). After acute brain injury, a 
rapid activation with dramatic morphological and phenotypic changes of the resident 
microglial cells has been described. Within minutes after the insult, these cells migrate to 
and start surrounding the lesion site. This initial intrinsic response is followed by massive
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expansion of activated microglia and by the recruitment of bloodbom macrophages which 
also migrate after a delay of several days into the injured brain parenchyma (Schilling et al. 
2005). Typical morphological changes associated with activation of resident microglia 
include thickening of ramifications and of cell bodies followed by acquisition of a rounded 
amoeboid shape. This process is accompanied by expression of novel surface antigens and 
production of mediators that build up and maintain the inflammatory response of the brain 
tissue. Through the release of several harmful components such as IL-1 p, TNF-a, proteases 
and ROS species (Hanisch 2002), microglia can affect neuronal function and promote 
neurotoxicity (Block et al. 2007). On the other hand, there is also growing evidence 
showing that under certain circumstances, these cells can be neuroprotective (Lalancette- 
Hebert et al. 2007; Neumann et al. 2006) and can also promote adult neurogenesis and 
lesion repair. Indeed, microglia has been proposed to be neurosupportive by several 
mechanisms including glutamate uptake (Nakajima et al. 2008), removal of cell debris 
(Stoll and Jander 1999) and production of neurotrophic factors such as IGF-1 (Thored et al.
2009), GDNF (Lu et al. 2005) and BDNF (Batchelor et al. 1999). Regarding macrophages, 
studies addressing their phenotypic changes in peripheral inflammation and immunity have 
shown that these cells can undergo two different forms of polarized activation. The first is 
the classic (or Ml) activation, characterized by high capacity to present antigen, high 
production of NO and ROS and of proinflammatory cytokines. Ml cells act as potent 
effectors that kill micro-organisms and tumor cells and drive the inflammatory response 
and may mediate detrimental effects on neural cells. The second phenotype (M2) is an 
alternative apparently beneficial activation state more related to a fine tuning of 
inflammation, scavenging of debris, promotion of angiogenesis, tissue remodeling and 
repair. Specific environmental signals are able to induce these different polarization states 
(Porta et al. 2009). In particular, stimulation via TLR ligands and INF-y induces classical 
Ml activation, while IL-4/IL-13 stimulation is able to favour the alternative M2 activation
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(Sica and Mantovani 2012). A similar possibility has been also recently raised for 
microglia, by showing that these cells, under certain conditions, can indeed be pushed to 
both extremes of the Ml and M2 differentiation spectrum (Michelucci et al. 2009).
The revelation that macrophages, depending on the disease context, can become polarized 
to pro- and anti-inflammatory states that exhibit either harmful or protective/reparative 
proprieties, has been firstly obtained by research in non-CNS fields (bacterial and parasitic 
infections, non-neural tumors, David and Kroner 2011). Ml and M2 canonical definitions 
represent the extreme of macrophage polarized states as they have been documented by in 
vitro experiments (David and Kroner 2011). These states, under certain pathological 
conditions (parasite infections, allergy, cancer) are well mirrored in vivo (Sica and 
Mantovani 2012). However in neurodegenerative disorders M/M cells with mixed 
phenotypes have been also identified (Sica and Mantovani 2012), indicating the plastic 
nature of M/M, which have the ability of acquiring multiple phenotypes in response to 
signals received and time-dependent variations in the inflammatory melieu. A generally 
accepted classification of the M/M repertoire of polarized states indicates one Ml toxic 
polarization and three M2 polarization subtypes, namely M2a, M2b and M2c, each of 
which characterized by a specific pattern of marker expression and functionality (David 
and Kroner 2011), Table 1.1. Ml is associated with phagocytosis, ability to kill 
intracellular pathogens by iron restriction, acidification of phagosome and release of 
reactive oxygen species (Mantovani et al. 2004; Mantovani et al. 2002; Martinez et al. 
2008; Martinez et al. 2006). Ml markers of phenotype include CD16, CD32, CD86, MHC 
II and iNOS. M2a polarized state is associated with immunity against parasites, 
recruitment of Th2 cells, tissue repair and growth stimulation. This state is characterized 
mainly by the expression of Arginase-1, Yml and Fizz (Gordon 2003; Gratchev et al. 
2001; Hesse et al. 2001; Mantovani et al. 2004; Mantovani et al. 2002; Martinez et al. 
2008; Martinez et al. 2006; Raes et al. 2005; Scotton et al. 2005; Stein et al. 1992; Villalta
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et al. 2009). M2b has either pro- and anti-inflammatory functions and is associated with 
memory immune response (B cell class switch and recruitment of regulatory T cells). High 
levels of IL-10 expression, MHC II and costimulatory CD86 stand as M2b pattern of 
phenotype markers (Anderson and Mosser 2002a; Anderson and Mosser 2002b; Filardy et 
al. 2010; Gea-Sorli et al. 2011; Goerdt and Orfanos 1999; Mantovani et al. 2004; 
Mantovani et al. 2002; Martinez et al. 2008). M2c is involved mainly in scavenging of cell 
debris, has pro-healing functions and is characterized by the expression of the markers 
Arginase-1, CD163 and CD206 (Bogdan et al. 1992; Goerdt and Orfanos 1999; Gordon 
2003; Gratchev et al. 2001; Mantovani et al. 2004; Mantovani et al. 2002; Martinez et al. 
2008; Valledor and Ricote 2004; Villalta et al. 2009).
The definition of M/M polarized states in CNS diseased states needs further studies using 
in vivo models of pathology. Events such as infiltration of leukocytes play an important 
role in orchestrating the polarization of M/M, making the in vivo studies far more 
instructive than in vitro models, in which the complete network of recruited/activated cells 
can not be reproduced (Sica and Mantovani 2012).
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a n t i - i n f l a m m a t o r y  
f u n c t i o n ,  B c e l l  c l a s s  
s w i t c h  a n d  a n t i b o d y  
p r o d u c t i o n ,  r e c r u i t m e n t  
o f  r e g u l a t o r y  T  c e l l s  (TR< 
c e l ls ) .  P h e n o t y p e  c a n  b e  
i n d u c e d  b y  c l e a r a n c e  o f  
a p o p t o t i c  n e u t r o p h i l s .
1 3 9 ,1 4 8 ,
1 4 9 ,
1 5 7 - 1 6 2
M 2 c I L - 1 0 ,T G F p o r  
g l u c o c o r t i c o i d s
N o n e  k n o w n C C L 1 6 , 
C C L 1 8  a n d  
C X C L 1 3
A r g in a s e  1, 
C D 1 6 3 ,  
C D 2 0 4 a n d  
C D 2 0 6
• T L R 8 .T L R 2 , IL -2 1 R
•  P o la r i z a t i o n  w i t h  IL -10 : 
d o w n r e g u l a t i o n  o f  T N F a ,  IL -6 , 
IL -12  a n d  M H C II
•  P o la r i z a t i o n  w i t h  TGF(3: 
d o w n r e g u l a t i o n  o f  T N F a , IL -1 a ,  
I L - 1 8 .C D 1 6 3
•  P o la r iz a t io n  w i t h  g lu c o c o r t i c o i d s :  
d o w n r e g u l a t i o n  o f  T N F a ,
I L -4 ,IL -5 , IL -1 ,IL -6 . IL -8 ,IL -1 2 ,  
iN O S ,C O X 2  a n d  C X 3 C R l , a n d  
i n c r e a s e  o f  C D 1 6 3
D e b r i s  s c a v e n g i n g ,  
p r o - h e a l i n g  f u n c t i o n  
a n d  i r o n  s e q u e s t r a t i o n
1 0 5 ,1 3 9 .
1 4 0 ,1 4 8 ,
1 4 9 ,1 5 6 ,
1 5 7 ,
1 6 3 - 1 6 5
Table 1.1 M l and M2 classes ofpolarized states fo r  microglia/ macrophages.
The repertoire o f M/M polarized states includes Ml and M2 subsets with a specific pattern o f phenotype 
markers and cyto-, chemo- kines produced. Each subset has a peculiar function able to impact on acute 
damage evolution (David and Kroner 2011).
1.4.2.1.3 CX3CL1:CX3CR1 signalling pathway
CX3CR1 is the receptor for the chemokine Fractalkine (CX3CL1). In the CNS the 
CX3CL1 :CX3CR1 pathway is involved in the communicaton between neurons and 
microglia, since neurons are the primary source of Fractalkine and CX3CR1 is almost 
exclusively expressed on microglia (Cardona et al. 2006). Under physiological conditions, 
CX3CL1 is released by neurons in a soluble form, probably by the activity o f disintegrin- 
like metalloproteinases such as ADAM 10 (Hundhausen et al. 2003). Upon binding with 
CX3CR1 on microglia, CX3CL1 determines the control of microglia activation, with 
suppressive functions (Zujovic et al. 2000). Following an acute insult, neurons
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significantly decrease the release of fractalkine allowing the activation of microglia 
(Hundhausen et al. 2003; Lauro et al. 2006).
CX3CR1 is also present on a subset of CNS resident monocyes, characterized by a Ly- 
6CIow/CCR2-/CX3CRl+ phenotype. These cells patrol blood vessels to rapidly sense 
vascular damages. They become activated and cause early transient inflammatory bursts 
helping subsequent recruitment of effector cells prior to switch towards an M2-like 
phenotype (Geissmann et al. 2010; Prinz and Priller 2010).
In the periphery, CX3CL1 is present on endothelial cells and functions as an adhesion 
molecule and chemoattractant for leukocytes (Imai et al. 1997). Peripheral immune cells 
have been indeed shown to express CX3CR1 in an inducible way, even though their 
recruitment to the brain seems to rely mainly on CCR or CXC families of receptors 
(Ingersoll et al. 2011; Prinz and Priller 2010; Saederup et al. 2008). Circulating monocytes 
manifest a Ly6Chlgh/CCR2+/CX3CRl- phenotype and enter the brain via signalling by 
CCL2, a chemokine produced by reactive astrocytes (Ransohoff 2011). Once infiltrated, 
Ly6Chlgh monocytes are induced to transform into macrophages by local cytokine and 
tissutal signals.
Resident microglia exhibit high levels of CX3CR1. Their turnover is due to the balance 
between apoptosis of senescent CX3CR1+ microglia and generation of new cells from 
CX3CR1+ local microglia progenitors (Ajami et al. 2011). In the inflamed CNS, microglia 
are activated and undergo morphological and phenotypical changes (Fig. 1.11).
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Figure 1.11 Steady-state maintenance o f  monocytes and microglia.
In adult life, monocytes (top) are generated in the bone marrow from HSCs that differentiate to GMPs and 
then to monocyte-dendritic cell progenitors. Mature Ly6Chi, CCR2+ ‘inflammatory’ monocytes are released 
into circulation, from which they are destined to enter inflamed tissues or lymph nodes. Ly6Clow, CC R2- 
‘resident’ monocytes derive from the same progenitors, and patrol blood vessel walls and also replace tissue 
macrophages. Microglia (bottom) may senesce and undergo apoptosis at a low rate and then be replaced by 
cell division from CNS-resident CX3CR1 + progenitors. In the inflamed CNS, both monocytes and microglia 
can give rise to active macrophage/microglial cells during neuroinflammation. Reactive astrocytes produce 
the chemokine CCL2, which signals to receptor CCR2 on Ly6Chi monocytes, aiding their entry into the CNS 
parenchyma. Local cytokine and tissue signals can then induce transformation o f monocytes to macrophages. 
Concurrently, inflammation can disrupt the blood-brain barrier, allowing plasma proteins to enter and 
activate microglia to adopt a macrophage activated phenotype; (modified from Ransohoff 2011).
The inhibition of the CX3CL1 :CX3CR1 pathway has been demonstrated to determine 
different effects on chronic or acute diseases of the CNS. In models of chronic diseases 
such as lateral amyotrophic sclerosis (ALS, Cardona et al. 2006), Parkinson’s disease 
(Pabon et al. 2011) and Alzheimer’s disease (Cho et al. 2011b), the inhibition of the 
pathway has been associated with a worst outcome possibly be due to the lack of
63
Enter inflamed
tissu es and 
iymph n od es
Environmental 
s ign a ls  |
CCR2
GMP MDP ^  Ly6C'" m onocyte
Bone marrow L.V6C10 m onocyte CX3CR1*
Patrol v esse ls  
and replace tissue  
m acrophages
Inflamed C N S
Microglial hom eostasis  
Replace via cell division
CX3CR1+ 
microglial progenitor
Plasm a
proteins CX3CR1* microglia
J>enescenc<^
CX3CR1+ microglia
M acrophage
CCL2
Astrocyte
activated microglia
introduction
fractalkine control of microglia activation leading to chronic pro-inflammatory function 
(Iadecola and Anrather 2011; Zujovic et al. 2000). Surprisingly enough, however, the 
inhibition of the CX3CL1:CX3CR1 pathway in acute injury models (transient and 
permanent ischemia, spinal cord injury) has been instead associated with a favourable 
outcome (Cipriani et al. 2011; Denes et al. 2008; Donnelly et al. 2011; Soriano et al. 2002). 
Thus available data do not allow to draw a coherent picture of the role of fractalkine in 
brain injury and disease. Specifically, little information is available on CX3CL1:CX3CR1 
pathway in the context of microglia activation following brain ischemia.
1.4.2.2 Lymphocytes
1.4.2.2.1 T-cell origin, recruitment and functions
T-lymphocytes originate from a common lymphoid progenitor derived from a 
hematopoietic stem cell (Fig. 1.09). They can be distinguished from other lymphocytes, i.e. 
B cells and NK cells, by the presence of a specific T-cell receptor (TCR) on cell surface. 
Their maturation takes place in the thymus and give origin to several subtypes (helper, 
cytotoxic, regulatory, memory and natural killer T-cells), each with a specific function.
T lymphocytes have been suggested to actively participate in the ischemic injury 
progression (Barone and Feuerstein 1999; Schroeter et al. 1994; Stoll et al. 1998). Recently 
a role for T lymphocytes has been highlighted, although the functional influence of these 
cells remains controversial. Some studies propose a deleterious role for lymphocytes (Hum 
et al. 2007; Yilmaz et al. 2006) whereas others suggest that lymphocytes, and especially T 
cells, could exert a protective role promoting neuroprotection and repair (Becker et al. 
2003; Becker et al. 1997). Number of infiltrating T-cells is supposed to be smaller if 
compared to other immune cell types recruited after ischemia (Gelderblom et al. 2009).
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Nevertheless, T-cells may have multiple targets which direct their stimulatory function on, 
being thus able to amplify downstream the effects of their activity.
A number of data supports the idea that lymphocytes mediate an antigen non-specific 
inflammatory response after stroke. However whether an adaptive immune response occurs 
and its contribution to the progression of the lesion are not clear. The adaptive immune 
response is antigen-specific and requires an education of the immune response to a certain 
antigen. T lymphocytes become activated when an antigen in the context of the major 
histocompatibility complex and an additional costimulatory signal are provided. In general 
this activation leads to a Thl immune response on subsequent encounters with the antigen. 
A Thl response is characterized by the secretion of proinflammatory cytokines as IL-2, 
TNF-a and INF-y that promote cellular immune response. A Th2/Th3 immune activation 
may also occur. This kind of response is characterized by the release of IL-4, IL-10 and 
TGF-p 1, factors that may modulate the immune response in a protective fashion.
Under normal conditions CNS antigens are compartmentalized from the systemic immune 
system by the BBB and thus they are hidden to lymphocytes. When the BBB is disrupted 
like after stroke, the immune system comes into contact with CNS antigens that may 
induce T lymphocyte priming in the lymph nodes and subsequent recruitment to the lesion 
site. T-cell priming could lead to an autoimmune response which could switch towards 
tolerance if it does not receive an appropriate costimulatory signal. Several recent reports 
show that animals tolerized to CNS antigens show a decrease in infarct size after ischemia 
in comparision with non-tolerized animals (Becker et al. 1997). Another mechanisms by 
which T-cells may have protective impact on ischemic lesion progression is associated 
with Th2 cell subtype. Protective M/M belonging to the M2a polarization have been found 
to stimulate recruitment of Th2, which in turn, can further promote M/M protective 
features by the release of IL-4 (Butovsky et al. 2007; David and Kroner 2011). This 
cytokine has been demonstrated to lead microglia cells to express neural or dendritic-like
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markers (Butovsky et al. 2007) and secrete neurotrophic factors in an event defined as 
protective autoimmunity (Hallenbeck et al. 2006).
1.5 Two-Photon Microscopy
1.5.1 Principles of two-photon excitation microscopy
The brain has a complex and dynamic structure. The spatial scales of interest to 
neurobiologists range from individual synapses (~ lpm) to neural circuits (centimeters) 
whilst timescales range from less than a millisecond (flickering of channels) to years (long 
term memory). Fluorescence microscopy offered a powerful tool to perform research 
within these spatial and temporal scales. Fluorescent objects can be selectively excited and 
visualized exploiting the properties of their specific light spectrum. Chemists have 
developed a wide range of fluorescent molecules that allow the labelling of multiple 
cellular structures of interest. Other fluorophores are sensitive to variation of Ca2+ and 
Na+ concentrations and membrane potential. Furthermore, the advent of genetically 
encoded fluorescent proteins (XFPs) allows the tagging of most cellular proteins (Tsien 
1998). XFPs have been used to the study of intracellular signalling, i.e. kinase activation 
(Miyawaki 2005) and of specific subpopulations of cells (Feng et al. 2000; Gong et al. 
2003; Lendvai et al. 2000).
A first advance of fluorescence microscopy was the introduction of confocal microscopy. 
This technique allowed to overcome the strong light scattering that causes signal 
degradation in wide-field fluorescence microscopy. Confocal microscopy uses a detector 
pinhole that serves to cut fluorescence from off-focus locations as well as photons 
scattered on their way out of the tissue (Svoboda and Yasuda 2006). Confocal microscopy
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allows three-dimensional images at high-resolution. Image acquisition along the xyz 
dimensions introduced a fundamental step forward in the analysis of subcellular locations 
and co-localizations of proteins. Confocal microscopy, however, fails to detect fluorescent 
signals deep in tissue where it becomes wasteful in terms of signal photons (Centonze and 
White 1998; Conchello and Lichtman 2005). Compensating for signal loss increasing 
fluorescence excitation would cause massive photobleaching and phototoxicity (Svoboda 
and Yasuda 2006). For these reasons, confocal fluorescence microscopy is best applied to 
thin tissue specimens (~ 20pm).
Two-photon microscopy (2-PM) represents a recent major advancement in the 
fluorescence microscopy techniques, providing high-resolution and high-sensivity 
fluorescence microscopy into intact tissues. This technique relies on the excitation of a 
fluorescent molecule by the cooperation of two low energy photons, able to generate an 
higher electronic transition in the target fluorophore. The first advantage of this kind of 
laser excitation is that fluorophores are excited almost exclusively in a tiny diffraction- 
limited focal volume. Indeed, in a focused laser, the intensity is highest in the vicinity of 
the focus and drops quadratically with above and below distance. Focusing the beam by a 
high numerical aperture (NA) objective makes the majority of fluorescence excitation to 
occur in a very small focal volume (Christensen and Nedergaard 2011). The very efficient 
localization of excitation allows to capture only useful fluorescence photons and to reach 
three-dimensional contrast and resolution without any spatial filters in the detection path 
{i.e. the pinhole in the confocal set up, Fig. 1.12).
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Figure 1.12 Fluorescence microscopies compared.
In a confocal microscope the excitation light (blue) is focused into the specimen (a), and the fluorescence 
(green) from that focal spot is captured by the objective lens, passes cleanly through the pinhole, and reaches 
the detector (b). This fluorescence light is the desired signal, but some o f it can lost because scattered (c), 
absorbed (d) or scattered before it reaches the focus (e). Background signal can be also generated if the out- 
of-focus light is scattered into the pinhole, thus reducing image contrast. In the two-photon excitation method 
the excitation photons (red) can be scattered (g) as in the confocal system. However, the probability o f two 
photons being scattered simultaneously to the same specimen location is essentially zero. In addition, a 
greater proportion o f the excitation light reaches the focal plane (h and i) due the reduced out-of-focus 
absorption and the decreased scattering o f the longer-wavelength two-photon excitation light (infrared). 
Importantly, the generated fluorescence (green), even if scattered, has an increased likelihood o f being 
detected by the photomultiplier tube (j) because no pinhole is present to block it (k). This insensitivity to 
scattering effects and absence o f out-of-focus absorption allow for the preservation o f the full image contrast 
from considerable depth within specimens.
http://www.microscopyu.com/articles/fluorescence/multiphoton/multiphotonintro.html
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2-PM provides several advantages compared to conventional fluorescence microscopy 
systems. Firstly, differently from conventional fluorescence microscopy that uses 
wavelenghts in the visible light spectrum, 2-PM uses excitation wavelengths near the 
infrared that penetrate efficiently in thick tissues due to reduced scattering and absorption 
by endogenous chromophores (Oheim et al. 2001; Svoboda and Block 1994; Yaroslavsky 
et al. 2002). Secondly, the non-linear nature of excitation determines non-appreciable 
fluorescence by scattered excitation photons. Thus, even deep into the tissue, under 
conditions in which most of the incidence photons are scattered, excitation still occurs in a 
narrow focal volume. Thirdly, as previously mentioned, all fluorescence photons constitute 
useful light signal when detected (in contrast, in wide-field and confocal microscopy 
scattered photons are either lost or cause increased background, (Centonze and White 
1998). Finally, phototoxic events are reduced in 2-PM, allowing prolonged fluorophore 
excitation with limited signal loss.
Overall, due to its features, 2-PM has been successfully applied to time-lapse three- 
dimensional imaging in living animals, at the resolution of individual cells. In the next 
section I will provide a summary of the main applications of 2-PM to CNS studies, with a 
particular attention to the studies on brain ischemia.
1.5.2 Two-photon microscopy in CNS: study of vascular and cellular dynamism
2-PM has demonstrated its potential and suitability in the study of the CNS in different 
pathological states. Many events occurring in the diseased CNS, such as cerebrovascular 
modifications and immune cell trafficking, have a highly dynamic nature and require 
adequate systems of analysis. For years, the analysis of vascular and immune responses in 
the diseased brain has been mainly based on post mortem techniques, i.e.
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immunohistochemistry and flow cytometry (Gelderblom et al. 2009), whose interpretation 
is limited by disruption and processing of tissue at defined time points. To get a reliable 
and effective picture of the dynamic processes involved in vascular and immune events in 
the CNS, real-time information in vivo is required. 2-PM represents a major qualitative 
advancement for in vivo imaging. This technique, indeed, allows high-resolution 
visualization of individual blood vessels and immune cells within a three-dimensional 
space over time (Ortolano et al. 2010; Svoboda and Yasuda 2006), overwhelming the 
major limitations in spatial resolution and three-dimensional acquisition that are associated 
with other in vivo imaging approaches (i.e. MRI, intravital microscopy). The 2-PM 
approach has been successfully used to dissect specific aspects of vascular and immune 
cell dynamism in the context of neurological diseases (Cordiglieri et al. 2010; Schaffer et 
al. 2006; Shih et al. 2012), yielding novel results that would have not been obtained with 
standard methods.
1.5.2.1 Dynamics o f blood vessels
Blood flow distribution in the brain has been studied and measured in vivo for years using 
instruments such as laser Doppler (Nakase et al. 1997) and MRI (Nagaraja et al. 2008). 
These instruments focus over an area of interest sized hundreds of microns, yielding a 
measure that represents a mean value from the blood vessels pertinent to that area. MRI in 
vivo imaging is also limited by the long time delays between sequential images, thus 
hampering the acquisition of very fast dynamic events (Cho et al. 2011a). With the 
introduction of 2-PM, the possibility to image at sufficient spatial resolution and 
acquisition rate allowed to visualize single vessels and get parameters associated with 
vessel architecture (diameter, length, number of branching, topology of vessels), blood 
flow velocity, variations of O2 concentrations, and to repeat same measures on same
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individual vessel over time. Thus, 2-PM introduced the analysis of local and temporal 
variations of CNS vasculature, where ‘local* means specific vessels and ‘temporal’ means 
in a before-after time scale.
Being brain ischemia a vascular pathology, most of these studies focus on the 
hemodynamic variations observed in different conditions modelling stroke. Stroke indeed 
induces a variety of vascular changes, including blood flow redistribution and blood brain 
barrier (BBB) leakage. These events trigger several pathophysiological cascades that 
evolve over time and space, leading to expansion of brain injury and standing as potential 
targets for therapy (Dimagl et al. 1999). For its suitability to the study of dynamic events in 
the brain, 2-PM represented a fundamental tool to investigate previously unexplored 
aspects of cerebrovascular dynamics and functions (Denk et al. 1990; Svoboda and Yasuda 
2006).
1.5.2.1.1 Parameters of blood flow dynamics, 2-PM quantitative analysis after localized 
occlusion of single vessels
Most of 2-PM studies on hemodynamics rely on the possibility to label blood vessels with 
a fluorescent dye {i.e. Rhodamine-Dextran, Q-dots) and measure blood flow velocity and 
direction in individual vessels, as firstly described by Chaigneau and colleagues 
(Chaigneau et al. 2003). Blood flow velocity in 2-PM experiments is measured on the basis 
of the time needed by a red blood cell (RBC) to travel over a certain distance within a 
blood vessel (RBC velocity, see methods for details). Being 2-PM capable to provide 
three-dimensional images of intact tissues (typically 250-600pm thick tissue stacks), it also 
allows to measure some parameters of the vascular architecture, such as diameter, length 
and branching of vessels (Cho et al. 2011a) and average blood volume flux (Shih et al. 
2012). These measures have been applied to the study of vascular rearrangements in
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models of stroke in rodents. The above listed output data from 2-PM experiments are 
important to draw a complete picture of vascular response after stroke, as the reliance on a 
single indicator of blood flow provides insufficient description (Pinard et al. 2002; Shih et 
al. 2009; Tasdemiroglu et al. 1992).
In most of the 2-PM studies on stroke, brain ischemia has been induced by a localized 
occlusion of one of the vessels pertinent to the visualized area. Being 2-PM easy to focus 
at tissue portions sized few microns, its laser beam can be directed exclusively to specific 
vessels and cause a laser induced cortical thrombosis (Nimmagadda et al. 2008). This 
model of thrombosis has been often used to occlude specific vessels and to study the 
induced changes in selected vessels downstream or upstream to the occlusion 
(Nimmagadda et al. 2008; Park et al. 2008; Schaffer et al. 2006). Due to the limitation of 
laser penetration into intact tissues (~ 600 pm), these studies focused on the response of 
cortical microvessels, nevertheless revealing intriguing aspects of vascular dynamism after 
ischemia.
1.5.2.1.2 Hierarchical structure of the cerebrovascular network, mechanisms for blood flow 
maintainance in penetrating arterioles
The complex and often redundant network of cerebral vessels showed an active role in 
confering protection from an ischemic event, given the rapid re-organization of blood flow 
supply occurring after an occlusion. Schaffer and colleagues (Schaffer et al. 2006) 
demonstrated that the surface network of communicating arterioles appears to be well 
protected against single-point occlusions of surface arterioles by virtue of its architecture 
alone. Indeed blood flow downstream a targeted occlusion, as well as in MCAo ischemic 
models, does not stop, but is rather reestablished by a reversal in the direction of flow in 
one of the downstream branches (Schaffer et al. 2006). Occlusion of a single vessel is also
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associated with a change in blood flow magnitude which is dependent on the topological 
relationship of a vessel to the clotted vessel, being reduced by less than half in the first 
downstream branch, whereas remaining close to baseline values in parallel and far 
downstream vessels (Schaffer et al. 2006). The rapid re-establishment of the new pattern of 
flow, about 1 second after clot formation, guarantees no major change in vessel diameter 
(Schaffer et al. 2006). Thus, cortical surface arterioles show persistent perfusion along with 
stability in vessel diameter without reaching the deficit in blood flow capable to cause 
irreversible neuropathology (Baron 2001; Hossmann 1994; Zhao et al. 1997). Indeed no 
downstream pathology has been observed after surface arteriole occlusion. On the 
contrary, occlusion of a penetrating arteriole has been associated with subsequent 
downstream neuropathology. Indeed penetrating arterioles can contribute significantly to 
blood flow supply over a cortical area extending up to 350pm radius and, in addition, 
collateral flow from neighboring penetrating arterioles is limited (Nishimura et al. 2007). 
After occlusion of a penetrating arteriole, RBC velocity is dramatically reduced as far as 
10 branches distal to target vessel, being dropped to approximately 0.1-0.3 times baseline 
values (Nishimura et al. 2007).
Similar topological differences in blood flow redistribution have been observed for 
venules. While the occlusion of surface venules does not cause permanent drop of RBC, 
due to the redundancy of surface vessels, occlusion of cortical ascending venules causes a 
20% blood flow decrease, potentially able to cause cognitive dysfunctions when protracted 
in time (Cho et al. 201 la). In particular, when a cortical ascending venule is occluded and 
a collateral venule is not present, capillaries one to four branches upstream to the target 
venule show dramatic decrease of RBC velocity, reversal of flow direction and diameter 
increase (Cho et al. 2011a). Venules present in the brain outnumber arterioles and, even 
sharing a similar pattern of capillary branching, their density is higher. For this reason the
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occlusion of a venule affects RBC velocity up to a distance of 4 branchings, far shorter 
than the occlusion of an arteriole (up to 10 downstream branchings).
Overall, 2-PM studies on brain cortical vasculature clearly show the hierarchycal 
organization of the cerebral blood vessel network, based mainly on vascular geometry. 
Occlusions at different levels of vascular hierarchy yield different severity of ischemic 
damage, since vascular geometry has a fundamental role in redistributing blood flow. 
Surface vessels communicate by frequent connections and form a highly redundant 
network. In case of an occlusion, blood flow is rapidly re-established to pre-occlusion 
values by virtue of vessel geometry itself, with subsequent prevention of neuropathology. 
The network formed by penetrating vessels, on the contrary, is less redundant and, as a 
consequence of their architecture, penetrating vessels individually feed wide areas. After 
occlusion, alternative blood flow supply is limited in penetrating arterioles, resulting in 
tissutal damage. Thus, the redundancy of collateral networks observed for the surface 
blood vessels stands as a protective mechanism to assure sufficient perfusion of 
downstream penetrating arterioles, even during occlusions. Flow reversal indeed occurs in 
surface arterioles, but does not take place in penetrating arterioles (Shih et al. 2009), 
suggesting that the hierarchycal network is organized so to avoid eccessive variations in 
penetrating arteriole blood flow, whose occlusion would in turn cause pathology.
1.5.2.1.3 Blood flow regulation of neuronal activity
2-PM reaches sufficient spatial resolution to visualize finer structures than cerebral 
vasculature, such as neuronal dendrites and dendritic spines. In vivo imaging of these fine 
structures is limited by the intrinsic ability of infrared light to penetrate intact tissues and 
by the slight movements of the fluorescently labelled structures, due to heart/breathing rate 
and vasomotion, that may determine decreased resolution (Sigler and Murphy 2010). Most
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of the 2-PM studies on dendritic plasticity have been thus conducted near to the pial 
surface, where dendrites of layer 5, 2 and 3 neurons curve and run almost parallel to pial 
vessels (Sigler and Murphy 2010). The main advantage of using 2-PM in the field of 
dendritic activity is the ability to image neurons in a before-after time frame. Investigators 
have altered sensory experience of animals under 2-PM imaging by whisker trimming or 
odorous stimuli, and recorded the elicited effects on the structural neuronal wiring. Data 
revealed that dendritic spines undergo a rapid turnover associated with enduring motor 
memories (Xu et al. 2009; Yang et al. 2009).
Dendritic plasticity has been also evaluated in relation with microcirculation during acute 
stroke (Sigler and Murphy 2010). 2-PM provided simultaneous visualization of cerebral 
vasculature and dendrites, thus revealing the effects of a vessel occlusion on the turnover 
of dendritic spines and to define the relationship between perfusion and dendritic structure 
(Fig. 1.13). Under normal conditions, the neuronal network is hard wired with minimum 
variations observed over time. Severe ischemia induced by the vasoconstrictor endothelin, 
dropping blood supply to 10% of normoperfused vessels, was able to cause a rapid loss of 
dendritic spines as early as 10 minutes from occlusion (Tsai et al. 2009; Zhang and 
Murphy 2007). If perfusion was re-established within 50 minutes, the dendritic and spine 
structures could be largely restored (Zhang et al. 2005). Dendritic spines are normally 
located at 13pm from blood vessels. During ischemia, as expected, many non perfused 
areas develop. In areas without flowing vessels, the dendritic structures could be 
maintained if distanced less than 80pm from the nearest perfused vessel (Zhang and 
Murphy 2007). In general, the differences in perfusion of vessels draw a sharp transition 
between intact and damaged dendritic structures, being vessels able to provide support for 
dendritic viability at a maximum distance of 80pm. In peri-infarct areas, where blood flow 
supply is maintaned over the critical values and redundant vascular architecture helps 
preserving perfusion, dendritic structures showed the highest plasticity, expecially at the
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later stages of stroke pathogenesis. At 1-2 weeks after ischemia, the dendritic structures 
located within peri-infarct areas reached their maximal plasticity, as indicated by a 4-fold 
increase in spinogenesis, still detectable at 6 weeks (Brown et al. 2009; Brown et al. 2007). 
These changes were selectively associated with the neurons at the peri-infarct areas, since 
the spine turnover rates were not affected at the distal locations from the lesion (> 1.5mm).
M C A O
Figure 1.13 View o f  local changes in dendritic structures before, during and after MCAo by 2-PM.
A: 2-PM images taken from transgenic mice expressing GFP in neurons show the dendritic structure before 
ischemia (upper panel), during ischemia (middle panel) and after reperfusion (bottom panel). The dashed line 
in the left part o f  middle panel indicates the border o f  the structural damage, whitin which the dendritic 
damage is more evident. The dashed line in the centre o f middle panel indicates a vessel with partial a 
perfusion that helped neurons to keep intact dendrites. A significant recovery o f  neuronal dendritic structures 
is observable after reperfiision.
B: Closer magnification o f the rectangle indicated in A, upper panel. MCAo drives dendritic structure loss, 
while reperfusion induces significant recovery (Li and Murphy 2008).
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1.5.2.1.4 Imaging of O2 and blood flow
For a complete understanding of brain metabolism, the measure of the previously reported 
vascular parameters should be paralleled by the quantification of the amounts of oxygen 
that can be diffused to surrounding tissue (Raichle and Mintun 2006). Classical PO2 
measurements with electrodes (Lecoq et al. 2009; Ndubuizu and LaManna 2007) are 
limited by their invasivity and lack intravascular PO2 sensivity (Lecoq et al. 2011). 2-PM 
offered a solution to these limitations. Recently the use of a phosphorescent probe, PtP- 
C343 (Finikova et al. 2007) was combined with 2-PM to get a simultaneous measure of 
PO2 and blood flow in cerebral vessels up to 300pm of depth in rat brain (Lecoq et al. 
2011). This probe proved enough sensivity to PO2 , decreasing its phosphorescence lifetime 
as PO2 increased. This technique allows a very high resolution mapping of oxygen levels 
in the brain, enabling to measure vascular PO2 inbetween two flowing RBC. Intriguingly, 
authors reported local increase of PO2 associated with erythrocytes, as probe 
phosphorescence liftime was significantly shorter in the immediate vicinity of RBC than in 
the bulk plasma (Lecoq et al. 2011). Furthermore, they were able to generate local PO2 
variations by evoking odor stimulation. In particular odor triggers an increase of vascular 
PO2 preceded by a dip in tissutal PO2 (Lecoq et al. 2011).
1.5.2.2 Regulation o f bloodflow by cells o f the neurovascular unit
1.5.2.2.1 Imaging of astrocytes enveloping the endothelium
As mentioned above, modifications to blood flow supply, BBB damage or 
microhemorrages are all capable to regulate the activity of both resident and recruited CNS 
cells. Neurons, astrocytes, pericytes and, in some extents, lymphocytes are in turn able to
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affect blood flow, thus drawing a complex dynamic picture of cellular-vascular interplay. 
Local blood flow increases are needed for sustaining neuronal activity, in an event defined 
as neurovascular coupling. Evidence exists that local dilatation of capillaries takes place in 
response to whisker stimulation, allowing the needed metabolic support for neuronal 
activity (Stefanovic et al. 2008). Alteration to the vascular tone have been also observed in 
pathological conditions, such as ischemia or Alzheimer disease (Zlokovic 2005). The local 
control of blood flow supply is exerted by glial and neuronal cells proximal to vasculature 
and rely on different control mechanisms in respect to vascular autoregulation, the latter 
needed for ensuring constant blood flow in the brain. Local constriction or dilation of 
blood vessels depend on the activity of the smooth muscle cells associated with the 
endothelium. Smooth muscle cells are solely effector cells that regulate blood vessel 
diameter in response to signals received from astrocytic endfeet. Astrocytes are indeed 
located in an ideal situation to sense neuronal stimulation and transfer signal to smooth 
muscle cells, since astrocytes surround synapses and envelop blood vessels with their 
endfeet (Attwell et al. 2010). When astrocytes are activated upon sensing of neuron- 
released glutamate, they in turn release metabolites of arachidonic acid (prostaglandins and 
epoxyeicosatrienoic acids) causing relaxation of smooth muscle cells (Gordon et al. 2008; 
Metea and Newman 2006; Peng et al. 2004; Peng et al. 2002; Zonta et al. 2003). 
Interestingly, in contrast with these studies, a 2-PM study on brain slices from both rats 
and mice, provided evidence of vasoconstriction by astrocytes (Mulligan and MacVicar
2“b2004). The authors investigated the effects of selective waves of increased Ca 
concentrations at the astrocytic endfeet that were stimulated by localized flash photolysis 
of caged Ca2+ with 2-PM (Brown et al. 1999; Soeller and Cannell 1999). Upon increased 
[Ca2+] with propagation to the endfeet, astrocytes were able to cause vasoconstriction. The
t
peak of [Ca ] increase preceded vasoconstriction by 2.7±0.5 s, time enough for the 
syntesis and release of second messengers diffusing from astrocytic endfeet to smooth
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muscle cells at the vascular walls. The authors identified the Ca2+-sensitive photolipase A2 
to be responsible of the induced vasoconstrictions (Mulligan and MacVicar 2004).
Studies on brain slices provided contrasting results on the vascular control by astrocytes, 
having Zonta and colleagues proposed a role in vasorelaxation (Zonta et al. 2003) whilst 
Mulligan and MacVicar a role in vasoconstriction (Mulligan and MacVicar 2004). These 
studies are limited by the lack of blood perfusion in organotypic slice cultures, thus relying 
on potentially altered models in respect to intact animals. Takano and colleagues applied in 
vivo 2-PM to transgenic mice expressing GFP under the control of GFAP and 
demonstrated that photolysis of caged Ca2+ in astrocytic endfeet caused vasodilatation 
(Takano et al. 2007). They also showed that, at the early stages of Alzheimer disease, 
astrocytes have an abnormal activity characterized by spontanous increases of Ca 
signalling that, in turn, causes repetitive cycles of vascular relaxation/constrictions. This 
astrocytic dysfunction and the subsequent abnormal microcirculation precede amyloid 
deposition and neuronal loss. Brain ischemia is also capable to induce variation in [Ca ] in 
astrocytes. In a model of photothrombosis, repetitive and transient Ca2+ signals were 
detected starting from 20 minutes after clot formation (Ding et al. 2009). Photothrombosis 
caused increased amplitude and frequency of Ca2+ transients lasting up to 3h after 
occlusion onset. Antagonists for mGluR5 and GABAbR attenuated astrocytic Ca2+ 
signalling, suggesting a role of the two receptors in the elevation of Ca2+ stores (Ding et al. 
2009).
1.5.2.2.2 Imaging of pericyte actions on brain capillaries
The studies on the control of vascular tone by astrocytes, in most cases conducted by post 
mortem analysis or in in vitro settings (Attwell et al. 2010), have suggested for years that 
the neurovascular coupling was mediated exclusively by smooth muscle cell activation.
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Recently, a similar ability has been proposed for pericytes, whose presence and distribution 
along capillaries suggested their ability to regulate blood flow at the capillary level 
(Hamilton et al. 2010; Puro 2007; Shepro and Morel 1993). A number of studies 
demonstrated the ability of cultured pericytes to contract in response to arachidonic acid 
and neurotransmitters, further corroborating their role in blood flow regulation (Peppiatt et 
al. 2006; Puro 2007; Shepro and Morel 1993). Direct evidence of pericyte control of blood 
flow has been provided by a 2-PM study using GFP fluorescent mice (Femandez-Klett et 
al. 2010), as shown in figure 1.14. Under conditions of tissutal hypoperfusion caused by 
the topical administration of an agonist of TBXA2 , a mediator of vasoconstriction, local 
capillary constrictions were evident and more pronounced at pericyte bodies (Femandez- 
Klett et al. 2010). On the contrary, pericytes were not involved in capillary diameter 
increase after administration of bicucullin, a GABAa receptor antagonist able to induce 
recurring bursts of neuronal spike activity. Thus, in neurovascular coupling, capillaries 
dilate passively in response to increased pressure in upstream arterioles, and this process 
does not require pericyte functionality (Femandez-Klett et al. 2010). Pericyte contractile 
features are needed for vasoconstriction in response to an altered perfusion state, i.e. 
ischemia. During ischemia, pericytes constrict capillaries below a 5pm diameter, and the 
effects of the provoked vasoconstriction may be enhanced by blood cell trafficking. Red 
and white cells, indeed, have to deform considerably to flow through a 5pm diameter 
(Attwell et al. 2010) and, since ischemia significantly increases the number of circulating 
blood cells, collateral capillary clots may occur (no-reflow phenomenon, del Zoppo 1997) 
originating new, small non-perfused areas.
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Figure 1.14. Organisation o f  the capillary neurovascular unit and 2-PM  vasualization o f  contractile 
pericytes.
A: Pericytes send processes along and around capillaries, partially enveloping the vessels.
B: Using organotypic slice cultures from transgenic p-actin-GFP mice, pericytes (p) are clearly visible under 
2-PM. C: The topical administration o f an agonist o f  TBXA2 (U46619, 100 nM) induces vasoconstriction, 
which is particularly evident at the pericyte bodies (arrowheads, modified from Femandez-Klett et al. 2010; 
Hamilton et al. 2010).
1.5.2.3 Dynamics o f immune populations recruited and activated in the CNS
2-PM has been extensively used to study dynamics of immune cells behavior within CNS 
and revealed the ability of BBB components to instruct circulating immune cells prior to 
infiltration and the mechanisms of vascular alterations capable of activating resident 
microglia. All togheter these results depicted a new scenario on vascular-immune cell 
interaction within the CNS.
1.5.2.3.1 Two-photon imaging of T-Lymphocytes in CNS pathologies
As reported above, cells belonging to the immune system are recruited to brain in a time- 
dependent manner (Gelderblom et al. 2009). T-cells raised a particular interest as they play
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a pivotal role in the progression of many autoimmune and inflammatory brain conditions, 
thus representing a potential therapeutical target.
Many CNS pathological conditions are often associated with a loss of BBB integrity, thus 
allowing passive T-cell infiltration. However, due to the complex cellular structure of the 
BBB, it is also conceivable that the BBB does not allow only a passive transfer of immune 
cells from blood stream to the brain once opened, but rather participate to their recruitment 
in an active manner. Owens and colleagues (Owens et al. 2008) elegantly described that 
extravasated T cells are likely to move in the perivascular space rather than in the brain 
parenchyma, and they possibly come into contact with the different cell types that compose 
the BBB to receive specific signals. Direct demonstration of this become only recently 
available, as, in different models of brain diseases, 2-PM observations clearly showed T- 
cells patrolling the perivascular space of CNS blood vessels prior to tissutal invasion.
Early 2-PM studies on T-cells behavior within CNS were conducted in rodent models of 
experimental autoimmune encephalitomyelitis (EAE, Bartholomaus et al. 2009; Fliigel et 
al. 2007), and meningitis (Kim et al. 2009), both conditions characterized by a massive 
reactive T-cell recruitment. After collection of lymphocytes from donor animals, T-cells 
were fluorescently labelled and injected into recipient animals with pathology to be 
followed by 2-PM. In EAE, T-cell migratory behavior was investigated soon after transfer 
into recipient, where T-cells remained traceable for days. About 80% of injected T-cells 
were found to be crawling along blood vessel intraluminal side, with a crawling half-life of 
15 minutes before extravasation (Bartholomaus et al. 2009). It is likely that T-cells move 
along blood vessel inner surface searching for a suitable place for completing tissutal entry. 
As the right spot to enter is found, the extravasation process takes approximately 10-20 
minutes (Bartholomaus et al. 2009), during which integrins and G-coupled proteins on 
endothelial cells participate to allow either para- or trans-cellular migration (Bauer et al. 
2009; Engelhardt 2006; Engelhardt and Wolburg 2004). Once passed through endothelium,
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T-cells spend 80% of their time crawling on the abluminal space of vessels, a fundamental 
location for contacting various components of the BBB (Fig. 1.15). The encounter with 
perivascular resident cells stands as a crucial checkpoint prior to T-cell tissutal invasion. 
Motility of injected T-cells was affected by their ability to recognize a specific antigen. 
When immunized for ovalbumin, T-cells decreased their velocity upon administration of 
ovalbumin (from average 8.01±0.47 pm min'1 to 2.76±0.19 pm min’1), and many arrested 
when in close contact with tetramethylrhodamine-dextran positive cells (meningeal and 
perivascular phagocytes (Odoardi et al. 2007).
A perivascular location was described also for T-cells in the model of meningitis (Kim et 
al. 2009). Naive GFP+ CD8+T-cells expressing a receptor able to recognize the 
lymphocytic-choriomeningitis virus (LCMV) were visualized in the brain after craniotomy. 
The number of T-cells increased significantly in 6 day symptomatic mice. The authors 
reported T-cell ability to recruit myelomonocytic cells which in turn caused vascular injury 
with subsequent BBB leakage (Kim et al. 2009). T-cell velocity was affected by their 
interaction with LCMV specific antigen. When this interaction was prevented, indeed, T- 
cells moved at an average speed of 5.16±0.46 pm min'1, faster than their average 3.41 ±0.27 
pm min'1 in the context of antigen presentation (Kim et al. 2009). Similarly, other works 
describe the ability of CD4+ T cells to slow down upon specific antigen encounter (Miller 
et al. 2002; Zinselmeyer et al. 2005). When primed and tolerized, CD4+ T-cells decreased 
their speed from 10 pm min’1 approximately to 4-5 pm min'1. 2-PM thus well demonstrated 
that T-cells decrease their velocity when the immune synapse is formed and they receive 
priming/tolerization.
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Figure 1.15. Invasion steps o f  T-cells in brain parenchyma in EAE revealed by 2-PM.
A: T-cells arrive at CNS leptomeningeal vessels and roll on endothelial cells (1). This is followed by 
intraluminal crawling directed both upstream and downstream o f blood flow (2). After the extravasation (3), 
T- cells continue to crawl to the abluminal surface o f vessels (4a). A part o f T cells dive to the Robin 
Virchow space (RV; 4b). T cells meet local antigen-presenting cells at the perivascular space o f 
leptomeningeal vessels (5a) or parenchyma (5b) and are activated. Activated T cells are allowed to penetrate 
within the CNS parenchyma (6). Finally, T cells can be further activated by antigen-presenting cells in the 
CNS parenchyma (7).
B: 2-PM images showing the migratory paths o f moving T-cells over 30min o f  imaging either at day2 or 
day3 after EAE induction. Blood vessels are in red, T-cells in green. Arrows indicate the direction o f blood 
flow, blue lines indicate paths o f intravascular cells, while yellow lines indicate paths o f extravascular cells 
(modified from Bartholomaus et al. 2009; Kawakami and Flugel 2010).
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Over the last years, microglia has been widely studied by in vivo 2-PM and time-lapse 
confocal microscopy using a transgenic mouse model expressing GFP under the control of 
fractalkine receptor (cx3crl), which is costitutively expressed by resident microglia 
(Davalos et al. 2005; Liang et al. 2009; Masuda et al. 2011; Ohsawa and Kohsaka 2011). 
These studies revealed the high dynamic nature of microglia within CNS (Fig. 1.16). In 
physiological conditions, microglia extend and retrieve their processes to sample the 
surrounding microenvironment (Davalos et al. 2005) and make direct contact with other 
cell types present in the CNS, such as neurons (Wake et al. 2009) and perivascular 
astrocytes (Mathiisen et al. 2010). As an injury occurs, microglia become hypertrophic and 
retract their processes to acquire an ameboid active status. This event is triggered by the 
sensing of ATP (Davalos et al. 2005) through the adenosine receptor A2A whose expression 
is increased in microglia cells soon after injury and is counterbalanced by decrease of 
P2Yn receptor expression (Haynes et al. 2006; Orr et al. 2009). This pathway is also 
responsible for increased microglia displacement after LPS stimulation (Ohsawa and 
Kohsaka 2011). However, the ability of microglia to travel over brain tissue seems to be 
dependent on the kind of danger signal received. In a model of spreading depression that 
causes loss of synaptic activity, microglia showed displacement by Levy flight-like 
movements in response to decreased synaptic activity (Grinberg et al. 2011). On the 
contrary, in models of brain injury such as traumatic brain injury, photothrombotic stroke 
model and global ischemia, microglia did not show any body movement in response to 
damage (Davalos et al. 2005; Masuda et al. 2011). The observed lack of microglia 
displacement after ischemia could be related to the rapid decline of ATP levels due to 
vessel occlusion, being, as reported above, ATP needed for the cytoscheletal modifications 
exploited by microglia to migrate within the tissue (Davalos et al. 2005; Grinberg et al.
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2011). The ability of microglia to rapidly modify their shape upon ischemic insult may 
need a lesser income of ATP, but it is dramatically affected by the residual capillary blood 
flow around their soma (Masuda et al. 2011). After complete loss of blood flow in their 
territory, microglia enter in a stalled status, unable to withdraw ramifications. Acquisition 
of the ameboid morphology requires a minimum level of blood flow and ATP supply by 
surrounding capillaries (Masuda et al. 2011). Resiliency of microglia is a key feature of 
this population, as they recover process activity once blood flow is re-established, even in 
the areas severely affected by transient occlusions (Masuda et al. 2011).
Cerebral vessels can determine activation of microglia also because of their bleeding, as a 
recent 2-PM study revealed (Rosidi et al. 2011). Cortical microhemorrages, while not 
producing acute stroke symptoms in aging brains (Cullen et al. 2005; Farrall and Wardlaw 
2009), do cause activation of microglia cells up to 200pm from the origin of the bleeding 
(Rosidi et al. 2011). The area of microglia activation after microhemorrages (400 pm 
diameter) correlates to the extent of extravasated blood plasma, suggesting that blood 
plasma components trigger microglia activity (Rosidi et al. 2011). Since BBB leakage 
occurs soon after ischemia (Strbian et al. 2008), plasma components may be among the 
first activatory signals that elicit microglia response.
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Figure 1.16. M icroglia sensing o f  a laser-induced injury.
Microglia are normally present as ramified cells that explore their surrounding microenvironment (a). A 
laser-induced injury (white spot in b) causes rapid microglia activation. At 15min after injury microglia 
extend branches towards the site o f injury (c), and at subsequent time points this event is paralled by 
retraction o f  branches that lay in direction opposite to the lesion site (arrows in d, e). At 2h 45min microglia 
processes almost completely surrounds the lesion (f, Davalos et al. 2005).
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2. AIM OF THE STUDY
The main aim of this project has been to explore, in the ischemic brain: 1) the dynamics of 
vascular rearrangements; 2) the morphological and phenotypical changes associated with 
microglia/macrophage activation and 3) the dynamic behavior of T-cell recruited to the 
lesioned area. To these purposes, I used a model of transient and of permanent ischemia in 
mice and applied in vivo two-photon microscopy and post mortem quantitative histology.
To date, analysis of the pathogenetic mechanisms associated with brain ischemia has been 
mainly based on post mortem techniques, whose interpretation is limited by disruption and 
processing of tissue at defined time points. For a reliable and effective picture of the 
dynamic processes occurring in the central nervous system after an acute injury, such as 
vascular rearrangements and immune cell behavior, real-time information in vivo is 
required. There are currently a few in vivo imaging systems, among which 2-PM is a truly 
innovative tool for studying the brain. The 2-PM, indeed, introduced a new perspective to 
look at brain dynamism, given its ability to provide three-dimensional, high resoluted 
images over time. In this study, I applied 2-PM to visualize blood vessels, microglia and 
lymphocytes and to collect quantitative parameters associated with their dynamism after 
brain ischemia. To get insight into the phenotypical nature of the investigated immune 
populations, I also performed quantitative analysis of marker expression and evaluation of 
their co-expression, exploiting post mortem immunohistology and immunofluorescence 
followed by bright field or confocal microscopy.
I divided the study into four sections, whose rationale and specific aims are presented 
below.
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1. Microvascular modifications after brain ischemia revealed by 2PM
A peculiar application of 2-PM is high-resolution angiography since both major vessels 
and microvasculature can be visualized and numerical data {i.e. vascular diameter, blood 
flow speed and flux volume) can be obtained as well. Studies using this approach have 
been focused on the vascular rearrangements occurring after permanent middle cerebral 
artery occlusion (pMCAo) or within 2 h after transient MCA occlusion (tMCAo), however, 
no studies are available describing blood flow dynamics at longer time points which are 
more applicable to intervention.
Specific aims of this part of the project included: 1) set up of a reliable method for 
repetitive in vivo imaging on the same animals (longitudinal study) up to 24h after injury;
2) identification of an area accessible to imaging and affected by MCAo; 3) obtaining 
information on the degree of blood flow velocity variations during MCAo and up to Id 
after reperfusion; 4) measurement of the extent of extravasation (BBB damage).
2. In vivo imaging of microglia and protective features of CX3CRl-deficent microglia
Microglia/macrophages (M/M) are rapidly activated after brain ischemia and have a 
prominent role in ischemic damage progression. CX3CR1 is a receptor expressed by M/M 
cells, binds to neuron-secreted fractalkine and serves for control of M/M activation. 
Although widely studied in models of chronic diseases, the role CX3CR1 .-fractalkine 
pathway following brain ischemia has been scarcely addressed. Furthermore, available data 
on this pathway do not allow to draw a coherent picture of its function and the role of 
CX3CR1 after brain ischemia remains elusive.
The main aim of this part of the study has been to identify the consequences of CX3CR1 
absence after brain ischemic injury, specifically addressing whether CX3CRl-deficent
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M/M exhibited, compared with wt microglia: 1) different motility; 2) different 
morphological switch in response to injury; 3) alternative pattern of M/M marker 
expression (namely CDllb, CD68, CD45, Yml, CD206 and iNOS); 4) lower 
susceptibility to ischemic brain injury.
In this part of the study, I used transgenic mice carrying GFP expression under the control 
of the promoter of the receptor of fractalkine (cx3crl) to specifically image microglia by in 
vivo 2-PM. I have subjected transgenic mice to tMCAo and visualized GFP+ microglia by 
in vivo 2-PM before and up to 24h after ischemic injury, to measure motility and 
morphological parameters. At 24h after tMCAo, animals were sacrified and tissue 
collected for quantitative histology.
3. Temporal pattern of expression and colocalization of M/M
As previously mentioned, activated microglia and recruited macrophages can affect 
neuronal function and promote neurotoxicity through the release of several harmful 
components such as IL-lp, TNF-a, proteases and reactive oxygen and nitrogen species. On 
the other hand they also possess protective qualities and promote neurogenesis and lesion 
repair. Indeed, microglia have been proposed to be beneficial by several mechanisms 
including glutamate uptake, removal of cell debris and production of neurotrophic factors 
such as IGF-1, GDNF and BDNF. These functions are associated to specific patterns of 
phenotype markers, that confer M/M a given polarization state ranging from the toxic (Ml) 
to the protective (M2) extremes. In spite of the large literature on inflammation after 
ischemia, information on M/M phenotype marker expression, their colocalization and 
temporal evolution in the injured brain is lacking.
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Specific aims of this section included: 1) identification of the time course of expression of 
the selected M/M markers, with particular regard to the time of Ml and M2 polarization 
arousal; 2) understanding the tissutal location of M/M makers in relation to the ischemic 
site at distinct phases after injury; 3) definition of the pattern of co-expression of the 
selected M/M markers.
In this part of the study, I subjected mice to pMCAo and applied post mortem 
immunohistochemistry for selected M/M markers (CDllb, CD68, CD45, Yml, CD206 
and iNOS) followed by quantitative bright field microscopy. I then assessed the pattern of 
co-expression of the selected markers by using immunofluorescence followed by three- 
dimensional confocal analysis.
4. In vivo imaging of T-celi in the ischemic brain
T-cells play a pivotal role in the progression of many autoimmune and inflammatory brain 
conditions, thus representing a potential therapeutical target. Their gate to access the brain 
is vasculature, which is normally strictly closed to immune cell passage by the BBB, but 
may be permissive to cell infiltration after an injury, as BBB opens. The behavior of T- 
cells has been widely investigated by 2-PM in disease models that are associated with a 
huge recruitment of T-cells, such as experimental autoimmune encephalitomyelitis (EAE), 
toxoplasmic encephalitis and meningitis. The 2-PM approach allowed to describe T-cell 
behavior on the basis of motility parameters and route of trafficking. Despite stroke causes 
BBB leakage along with an increased expression of adhesion molecules, on the whole 
facilitating T-cell infiltration, there are far fewer T-cells in the brain after stroke compared 
with EAE, toxoplasmic encephalitis and meningitis. For this reason, time lapse in vivo 
imaging of T-cell dynamics in a model of stroke represents a major technical challenge.
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Specific aims of this part of the project have been: 1) definition of the motility features of 
extravasated T-cells; 2) identification of the routes of T-cell trafficking within the ischemic 
area; 3) obtaining information on their crawling behavior on perivascular space.
In this part of the study I used adult male CBA/CaXC57F7BL/10 hCD2-GFP transgenic 
mice that express GFP specifically in T-cells under control of the hCD2 promoter. 
Transgenic mice have been subjected to pMCAo and T-cells have been visualized by in 
vivo 2-PM 3d after injury to obtain a quantitative description of T-cell motility.
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3. MATERIALS AND METHODS
materials and methods
3.1 Animals
Procedures involving animals and their care were conducted in conformity with 
institutional guidelines that are in compliance with national (D.L. n.l 16, G.U. suppl. 40, 18 
February 1992) and international laws and policies (EEC Council Directive 86/609, OJ L 
358,1; Dec. 12,1987; NIH Guide for the Care and Use of Laboratory Animals, U.S. 
National Research Council 1996). Animals (11 week old) at Mario Negri Institute were 
housed in an Specific Pathogen Free (SPF) vivarium, 5 per cage and kept at constant 
temperature (21 ± 1 °C) and relative humidity (60 %) with regular light/dark schedule (7 
am-7 pm). Food (Altromin pellets for mice) and water were available ad libitum. Before 
beginning any procedure, mice were housed for at least 1 week in their home cages at the 
conditions described above.
All mice used at the Biological Procedures Unit, University of Strathclyde were 
maintained on a 12/12 h light/dark cycle with free access to food and water, and all the 
procedures performed in accordance with local ethical and UK Home Office regulations.
Strains used in the project were:
- Male 11 week old C57BL/6J mice (Harlan, Italy);
- Male 11 week old CBA/CaxC57F7BL/10 that expressed GFP under control of the 
hCD2 promoter (kindly gifted by Dr. Dimitris Kioussis, NIMR, London, UK). GFP 
is expressed almost exclusively in thymocytes, and virtually all mature thymocytes 
express it (irrespective of CD4 or CD8 expression), peripheral B cells show about 
1% of the GFP fluorescence of T cells (De Boer et al. 2003);
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- Male 11 week old cx3crlGFP/+ and cx3crlGFP/GFP mice (Jackson laboratories, CA, 
USA). These mice express the GFP under the control of the promoter of cx3crl, 
which is costitutively expressed by microglia cells in the brain. To generate 
transgenic mice, the gene for GFP has been put on a substitution cassette, thus 
cx3crlGFP/GFP do not express CX3CR1 and will be indicated in the text such as 
cx3crl'/\  Haplotype (cx3crlGFP/+) do express CR3CR1 and will be refereed to as 
cx3crl~/+ mice.
3.2 Experimental design and blinding
Mice were assigned to surgery and experimental groups with surgery distributed equally 
across cages and days. To minimize the variability, all surgeries were performed by the 
same investigator, blinded to the experimental groups. All subsequent evaluations were 
also done by blinded investigators.
3.3 Surgery protocols
3.3.1 Craniotomy for two-photon imaging
To image living mice under the 2-PM, animals were subjected to a craniotomy to expose 
the cortical area of interest at AP: -1 mm and L: -2.5 mm from bregma. Cranial window 
craniotomy was used for imaging blood vessels in chapter 4 (see details in section 4.2.2), 
whilst skull thinning craniotomy was used for imaging microglia (chapter 5) and T-cells 
(chapter 7) as detailed in section 5.2.2 and 7.2.2, respectively.
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3.3.2 Transient middle cerebral artery occlusion (tMCAo)
materials and methods
Anesthesia was induced by 3% isoflurane inhalation in an N2O/O2 (70/30%) mixture and 
maintained by 1% to 1.5% isoflurane inhalation in an N2O/O2 (70/30%) mixture. Twenty- 
four hours after craniotomy and 45 min after the first imaging session, transient ischemia 
was induced by tMCAO (Gesuete et al. 2009). The right common carotid artery was 
exposed and the external carotid artery and its branches, including the occipital artery and 
the superior thyroid artery was isolated and cauterized. A silicone coated monofilament 
nylon suture (7-0, Doccol Corp, Redlands, CA), was introduced into the common carotid 
artery and advanced to the internal carotid artery so as to block its bifurcation into the 
MCA. At the end of the ischemic period, blood flow was restored by carefully removing 
the nylon filament. Mortality rate was 4%. Sham operated mice received a midline neck 
incision, and the subsequent exposure of the carotid sheath. The external carotid artery and 
its branches were isolated without being ligated or cauterized.
To confirm hypoperfusion and reperfusion in our model, blood flow was measured (n=3) 
during the entire tMCAo surgery and at the same post-reperfusion times of two-photon 
imaging (post and post24h) by laser doppler flowmetry (Perimed PF5010). We used a 
flexible 0.5 mm probe (Perimed, 407-1) positioned on the brain surface and secured with 
glue on the skull at the same coordinates of the cranial window: AP: -1 mm; L: -2.5 mm 
from bregma.
3.3.3 Permanent middle cerebral artery occlusion (pMCAo)
Permanent ischemia was obtained by pMCAO (Perego et al. 2011). Briefly, mice were 
anesthetized with Equitensin (pentobarbital 39 mM, chloral hydrate 256 mM, MgS04 86 
mM, ethanol 10% v/v, propyleneglycol 39.6% v/v) 100 pl/mouse administered by
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intraperitoneal (i.p.) injection. A vertical midline incision was made between the right orbit 
and tragus. The temporal muscle was excised, and the right MCA was exposed through a 
small burr hole in the left temporal bone. The dura mater was cut with a fine needle, and 
the MCA permanently occluded by electrocoagulation just proximal to the origin of the 
olfactory branch. Intraoperative rectal temperature was kept at 37.0 ± 0.5°C using a heating 
pad (LSI Letica). Mortality rate was 8.5%. Sham-operated mice received identical 
anesthesia and surgical procedure without artery occlusion.
3.4 Two-photon microscope set up
3.4.1 Microscope used at Mario Negri Institute:
BX51WI microscope coupled to an FV300 scanner head (Olympus Corporation, Tokyo, 
Japan) and equipped with a multiphoton laser, Chamaleon ultra II (Coherent, Santa Clara, 
USA). A 20x magnification water immersion objective (XLUMPFL20X W/IR Objective 
with NA 0.95 WD 2.0 mm, Olympus, Tokyo) was used for multiphoton microscopy.
3.4.2 Microscope used at Strathclyde University:
A Ti-sapphire femtosecond laser (Chameleon, Coherent) provided pulsed infra-red light 
via a Radiance 2000 scanhead (BioRad) to an upright microscope (Eclipse, Nikon) with a 
large micrometer-driven stage. A Nikon Fluor 40x, NA 0.80 water immersion objective 
was used.
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materials and methods
To check that the point on the skull with coordinates 2.5 mm lateral and 1 mm posterior to 
bregma was within the damaged area, we labeled the brain of one pMCAO wild type mice 
with Evans blue. A 29G needle was inserted at these surface coordinates to a depth of 1.5 
mm through a craniotomy and 1 pL of Evans blue solution was injected. The mouse was 
then injected i.p. with equitensin to induce a deep anesthesia and transcardially perfused. 
Twenty-micron coronal brain sections were cut and stained with cresyl violet (Sigma 
Aldrich, MO, USA) to detect ischemic lesion as previously described (Capone et al. 2007; 
Perego et al. 2011). Images were acquired by an BX61 microscope managed by AnalySIS 
software (Olympus, Tokyo, Japan).
3.6 In vivo tracking of the ischemic region
The sites of imaging were identified by their relation to blood vessels and the stereotaxic 
coordinates (Fumagalli et al. 2011). The green autofluorescence of the skull bone was used 
to determine the underside of the skull, which we defined as z=0. To characterize the 
imaged brain area, 100 pL of a solution of propidium iodide (PI, Sigma-Aldrich; 1 
mg/mL), which labels dead cells, was injected intravenously in cx3crl'/+ mice or wild-type 
mice 20 hours after tMCAO, or pMCAo, or sham surgery. The mice were imaged through 
the thinned skull 4 hours after the propidium iodide injection and 24h after tMCAo or 72h 
after pMCAo, along with respective sham animals. Excitation wavelength used for PI 
detection was: 767 nm, while GFP was excited at 844nm. Superimposed 350x350x50 pm 
thick volumes were obtained combining the two channels.
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3.7 Brain transcardial perfusion
At selected time points, namely 24h after tMCAo and 6h, 12h, 24h, 48h, 3d and 7d after 
pMCAo, mice were deeply anesthetized with Equitensin (120 pl/mouse i.p.) and 
transcardially perfused with 20 ml of PBS, 0.1 mol/liter, pH 7.4, followed by 50 ml of 
chilled paraformaldehyde (4%) in PBS. After carefully removing the brains from the skull, 
they were transferred to 30% sucrose in PBS at 4°C overnight for cryoprotection. The 
brains were then rapidly frozen by immersion in isopentane at - 45°C for 3 min before 
being sealed into vials and stored at -70°C until use.
Animals returned to cages and had access ad libitum to food and water. No major deficits 
impairing autonomous feeding and water intake was observed after surgery at any time 
points (from 6h to 7d), so animals did not receive any further treatments.
3.8 Histology
3.8.1 Ischemic volume assessment
For lesion size determination, 20pm coronal brain cryosections were cut serially at 320pm 
intervals and stained with Cresyl Violet (Capone et al. 2007). Seven coronal brain slices 
were assessed, starting from AP=2.5mm and finishing at AP=4.5mm from bregma. On 
each slice, the infarcted area was assessed blindly and delineated by the relative paleness 
of histological staining tracing the area on a video screen. The infarcted area and the 
percentage of brain swelling for edema correction were determined by subtracting the area 
of the healthy tissue in the ipsilateral hemisphere from the area of the contralateral 
hemisphere on each section (De Simoni et al. 2003; Swanson et al. 1990). Infarct volumes
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were calculated by the integration of infarcted areas on each brain slice as quantified with 
computer-assisted image analyzer and calculated by Analytical Image System (Imaging 
Research Inc., Brock University, St. Catharines, Ontario, Canada).
3.8.2 Immunohistochemistry
Immunohistochemistry was performed on 20pm brain coronal sections using anti-mouse 
antibodies as listed in Table 3.1. Positive cells were stained by secondary antibody 
coupling (see below, paragraph 3.12.7) and reaction with 3,3 diaminobenzidine 
tetrahydrochloride (DAB, Vector laboratories, CA, USA). For negative control staining, 
the primary antibodies were omitted and no staining was observed.
3.8.3 Immunofluorescence
Immunofluorescence was performed on 20pm coronal sections according to the previously 
described method (Gesuete et al. 2009). Primary and secondary antibodies used are listed 
in Table 3.1 and in paragraph 3.8.4. Appropriate negative controls without the primary 
antibodies were performed. None of the immunofluorescence reactions revealed unspecific 
fluorescent signal in the negative controls.
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Specificity Immunized
species
Isotype Dilution Company
a-C D llb Rat IgG 1:800 
1:30 000
Kindly provided by Dr. A. Doni
a-CD45 Rat IgG 1:800 BD Biosciences Pharmingen, San Jose, 
CA, USA
a-CD3 Rat IgG 1:200 BD Biosciences Pharmingen, San Jose, 
CA, USA
a-CD206 Rat IgG 1:100 AbD Serotec, Kidlington, UK
a-CD68 Rat IgG 1:200 AbD Serotec, Kidlington, UK
a-Ym l Rabbit IgG 1:400 Stem Cell Technologies, Vancouver, 
Canada
a-GFP Rabbit IgG 1:500 Molecular Probes, Life Technologies, 
Paisley, UK
a-GFAP Mouse IgG 1:2 000 Chemicon, Millipore, Billerica, MA, 
USA
a-iNOS
/NOSII
Rabbit IgG 1:50 BD Biosciences Pharmingen, San Jose, 
CA, USA
Table 3.1 List o f  the prim ary antibodies used.
3.8.4 Secondary antibody used for positive cell staining
For DAB staining, I used biotinylated a-rat or a-rabbit IgG antibodies, at 1:200 dilution 
(Vector Laboratories, Burlingame, CA, USA).
For fluorescent staining, I used fluorconjugated Alexa488 a-mouse, Alexa546 a-rat and 
Alexa594 a-rabbit (all 1:500, Invitrogen, Carlsbad, CA, USA). I also used biotinylated a- 
rat and a-mouse (1:200, Vector Laboratories, Burlingame, CA, USA) followed by 
flourescent signal coupling with streptavidine Alexa647 fluorconjugated (1:100,
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Invitrogen, Carlsbad, CA, USA) or TSA amplification system kit (Cy5 1:300, Perkin 
Elmer, MA, USA).
Alexa488 fluoroconjugated Griffonia simplicifolia isolectin IB4 (marker of endothelium, 
microglia and perivascular macrophages, Invitrogen, Carlsbad, CA, USA) was used to 
identify cerebral vessels and perivascular macrophages or microglia.
3.9 Confocal analysis
Immunofluorescence was acquired using a scanning sequential mode to avoid bleed- 
through effects by an 1X81 microscope equipped with a confocal scan unit FV500 with 3 
laser lines: Ar-Kr (488nm), He-Ne red (646nm), and He-Ne green (532nm, Olympus, 
Tokyo, Japan) and a UV diode. Three-dimensional images were acquired over a 10pm z- 
axis with a 0.23pm step size and processed using Imaris software (Bitplane, Zurich, 
Switzerland) and Photoshop cs2 (Adobe Systems Europe Ltd).
3.10 Statistical analysis
Group comparisons have been done by appropriate analysis of variance and post hoc test, 
as indicated in each figure legend. Choice of parametric or non-parametric test has been 
done after normality Kolmorgov-Smimov test to assess whether groups met normal 
distribution. Group size has been defined by the formula: n=2o2f(a,(3)/A2 (sd in groups=a, 
type 1 error a=0.05, type II error [3=0.2, percentage difference between groups A=20). 
Standard deviation for ischemic volume assessment has been calculated on a previous 
experiment in which o=18, thus yielding n=12.79. Standard deviation for histological
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evaluation of M/M markers between groups has been calculated on the bases of a previous 
experiment for CD llb marker expression quantification, where g=14, thus yielding 
n=7.74. Statistical analysis was performed using standard software packages GraphPad 
Prism (GraphPad Software Inc., San Diego, CA, USA, version 4.0). All data are presented 
as mean and standard deviation (sd). p-values lower than 0.05 were considered statistically 
significant.
3.11 Experimental design
I performed in vivo 2-PM imaging to visualize blood vessels, microglia or T-cells in the 
ischemic tissue. I obtained different quantitative parameters relative to vascular or cellular 
dynamics, including blood flow velocity, extravasation, morphological complexity and 
parameters of cell motility.
I then combined 2-PM output data with histological analysis to confirm in vivo imaging 
data, to visualize the physical relationship between lymphocytes and the neurovascular unit 
and to define the phenotypical nature of the M/M population in respect to lesion 
progression.
The general experimental design included:
1) the opening of a craniotomy to uncover a cortical brain area to imaging;
2) in vivo 2-PM imaging at basal conditions (i.e. before ischemia) of a selected region of 
interest;
3) induction of transient or permanent ischemia;
102
materials and methods
4) in vivo 2-PM imaging of the selected region of interest during and at different time 
points after ischemia;
5) quantitative analysis of the three-dimensional time-lapse acquisitions obtained at the 2- 
PM (measurements of blood flow velocity, extravasation and parameters of motility and 
morphology).
6) Sacrifice of animals at selected time points to perform histological analysis (assessment 
of ischemic volume, quantification of apoptotic cells, viable neurons and marker 
expression, analysis of marker co-expression).
In the sections number 4, 5, 6 and 7 I will provide a more accurate description of the 
experimental plan for each part of the study.
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4. MICROVASCULAR MODIFICATIONS AFTER BRAIN ISCHEMIA 
REVEALED BY 2-PM
4.1 Background
Ischemia determines major vascular effects (Morita et al. 1997; Watson et al. 2002; Wei et 
al. 1998), including blood flow redistribution and BBB leakage. These events trigger 
several pathophysiological cascades that evolve over time and space, leading to expansion 
of brain injury (Dimagl et al. 1999). The initial onset and temporal evolution of vascular 
modifications following ischemia are still largely unknown. In this part of the project, I 
propose to study microvascular rearrangements in a model of tMCAo, by applying 2-PM at 
different time points from ischemic injury, namely before, during and lh and 24h after 
occlusion onset. This part of my project also served for the set up of reliable protocols for 
preparing animals to 2-PM imaging, for visualizing vessels pertinent to an area affected by 
ischemia and for performing repeated imaging of the same ischemic area.
A peculiar application of two-photon microscopy is high-resolution angiography since both 
major vessels and microvasculature can be visualized and numerical data {i.e. vascular 
diameter, blood flow speed and flux volume, Helmchen and Kleinfeld 2008) can be 
obtained as well. This approach has been successfully applied to evaluate the effects of 
local vascular thrombosis and MCA occlusion (MCAo) in rats (Murphy et al. 2008; 
Nimmagadda et al. 2008; Park et al. 2008; Schaffer et al. 2006; Shih et al. 2009). These 
studies have been focused on the vascular rearrangements occurring after permanent MCA 
occlusion (pMCAo) or within 2 h after transient MCA occlusion (tMCAo), however, no 
studies are available describing blood flow dynamics at longer time points which are more
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applicable to intervention. In my work I used 2-PM approach to assess in vivo blood flow 
redistribution in a clinically relevant model of tMCAo (Capone et al. 2007). Reperfusion, 
although ultimately contributing to brain tissue recovery, may also, in the early phases 
after injury, significantly participate in the pathogenesis by conveying inflammatory cells 
to the injured area and oxygen to cells unable to use it leading to increased oxygen radical 
formation (Lo et al. 2003). I examined and analyzed vascular dynamics during ischemia 
and over time in the same vessels up to 24 h after reperfusion. Furthermore, I provided 
information on the extent of extravasation in the exact same vessels, as an index of BBB 
damage, in ischemic conditions starting from very early time points from MCAo onset.
4.2 Specific methods in this chapter
4.2.1 Experimental plan
Experiments were conducted according to the plan detailed in Figure 4.1 A.
4.2.2 Cranial window for two-photon imaging (Mostany and Portera-Cailliau 2008)
During craniotomy, anesthesia of C57BL/6J mice was induced by 3% isoflurane in a 
N2O/O2 (70/30%) mixture and maintained by 1-1.5% isoflurane in N2 O/O2 (70/30%) 
mixture. A cranial window was opened at AP: -1 mm and L: -2.5 mm from bregma to 
expose vessels lying in the region fed by the middle cerebral artery (MCA, Fig. 4.1 B,C). 
To this purpose, after a midline scalp incision, periostium was gently removed and a 
cranial window (circular, 1.8 mm in diameter, wide enough to uncover distal branches of 
the MCA) was created using an electric drill leaving the dura mater intact (drill tip by
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Meisinger, Germany). A coverglass was placed on the craniotomy and the space between 
the glass and the brain was filled with agarose at 1.5% in sterile saline. Coverglass and a 
small nut were glued on the skull to permit animal immobilization under the microscope 
and a small well was created using epoxy glue to allow objective lens immersion in water 
during imaging. Craniotomized mice were given an overnight recovery before first 
imaging session.
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Figure 4.1 Experimental plan and cranial window fo r  imaging.
Imaging was performed according to the plan showed in A. Cranial window was opened at day 0, while 
imaging was performed at day 1 and 2. RBC indicates the assessment o f RBC speed, while extrav indicates 
the quantification o f  extravasated fluorescent signal. At pre, RBC and extrav were collected 30min and 20min 
before ischemia respectively. At during RBC and extrav were collected lOmin and 20min after MCAo onset 
respectively. At post RBC and extrav were collected 40min and 50min after MCAo onset respectively. At 
post24h, only RBC was assessed. B) A distal branch o f  the MCA was exposed under the cranial window 
(image modified from: The Anatomy o f  the Laboratory Mouse, by Margaret J. Cook:
http://www.informatics.jax.org/cookbook). C) Two-photon high-resolution angiography o f  the region lying 
under the cranial window and used for analysis. A mean o f 6 vessels per brain were used to assess RBC 
speed and extravasation. After the first imaging session (pre) the analyzed vessels were labelled with a 
number on the angiography image obtained (Fig. 1C). This allowed to perform subsequent analysis on 
exactly the same vessels at each experimental time point. Scale bar= 25pm.
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4.2.3 High-resolution angiography and extravasation measurement
A 20x magnification water immersion objective (XLUMPFL20X W/IR Objective with NA 
0.95 WD 2.0 mm, Olympus, Tokyo) was used for high-resolution angiography. 
Tridimensional reconstructions over the z-axis were obtained at each time point of the 
observation and were used to measure extravasation. Image resolution was 800x600 pixels 
and distance between subsequent focal levels was 2 pm. Extravasation analysis was 
performed on each vessel used for RBC speed evaluation. It was identified by parenchymal 
accumulation of the fluorescent marker whose transendothelial transport is negligible 
under physiological conditions due to its molecular weight (70 kDa, Deli). All the images 
lying on the same focal stack of a vessel were collected and included into the analysis. 
Integrated pixel density over the selected stack was calculated inside (intra-vascular) and 
nearby (extra-vascular) a vessel. ImageJ software (http://rsbweb.nih.gov/ij/) was used for 
the analysis and extravasation was expressed as ratio between intra-vascular and extra- 
vascular mean pixel density over the z axis.
4.2.4 Blood flow speed measurement
Blood flow speed was calculated as red blood cell (RBC) speed according to the line-scan 
method (Fig. 4.2, Nimmagadda et al. 2008; Schaffer et al. 2006). Imaging was performed 
over a 250 pm thick cortical region, where most vessels lie horizontal to the cortical 
surface. Line-scan acquisition was performed at a rate of 830 Hz, positioning the 
acquisition line at the centre of the vessel where blood flow speed is supposed to reach its 
maximum value (Schaffer et al. 2006). The determination of RBC speed from the streaks 
in the space-time line-scan data was performed over 6 second epochs, divided into short 
subset epochs of 300ms each. Three 300ms epochs per image were then rotated to yield
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horizontal RBC streaks and speed was calculated by assessing the mean Ax/At slope value 
for each vessel (Nimmagadda et al. 2008). A negative value for speed accounts for 
inversion in blood flow direction in comparison to the baseline condition.
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Figure 4.2 M ethod fo r  RBC speed calculation.
RBC can be visualized as round-shaped black objects in the blood stream as they do not take up the 
fluorescent dye. Five-thousands linescans over 6 seconds are acquired and piled up to yield an image whose 
side lengths corresponds to distance (mm) and time (sec). RBC, by flowing within the vessel according to 
blood flow direction, form diagonal streaks. Slopes o f  streaks are calculated to obtain RBC speed as mm/sec.
4.2.5 Histological assessment of extravasation
To verify our in vivo extravasation method, we additionally assessed extravasation via well
established post-mortem histological technique (Marcon et al. 2009). Extravasation was
evaluated at post experimental time point. Briefly, after skin incision, mice were
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transcardiacally perfused with a fluorescent dye solution (FITC-albumin, 10 mg/ml in 
buffered saline, Sigma-Aldrich) at 1 ml/min (10 ml/kg, Marcon et al. 2009). Five minutes 
after injection, mice were killed by decapitation and their brains were immersion-fixed for 
48h in 4% paraformaldehyde in 0.1 M PBS, pH 7.4, cryoprotected overnight in 30% 
sucrose in PBS, frozen at -45 °C in isopentane and stored at -20 °C. Coronal sections (20 
pm) were cut on cryostat and collected on gelatin-coated slides and coverslipped using 
Fluorsave to preserve fluorescent signal (Calbiochem, Germany).
Z-stacked images from cortical regions at -0.58 and -1.22 mm from bregma were collected 
with the confocal microscope Olympus 1X81 equipped with an Olympus confocal scan unit 
FV500 and managed by Fluoview software (Olympus Tokyo, Japan).
4.2.6 Blood gas analysis
Craniotomized ischemic mice were prepared for blood gas analysis in order to establish 
whether the anesthesia and surgery protocol affected physiological parameters. After 
anesthesia induction and at the experimental time points shown in Fig. 4.1 A, mice were 
subjected to right carotid artery exposure and 100 pL of blood was withdrawn and loaded 
on cartridges. Blood gas analysis was then performed by the i-STAT 1 analyzer (i-STAT 
Corporation, East Windsor, NJ).
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4.3.1 RBC speed
Assessment of pH and pCC>2 values revealed that anesthesia and surgery procedures did 
not significantly affect physiological parameters (Table 4.1).
Table 4.1 Physiological parameter analysis
parameter pre during post post24h
pH 7.3±0.03 7.3±0.08 7.2±0.02 7.4±0.08
pCO2 39.4±4.41 37.4±8.13 35.2±2.17 36.4±8.95
Data for pH and pCO2 (mm Hg) are showed for each experimental time point, n=4.
A total of 24 vessels visualized in 4 different ischemic mice were analyzed and pre- 
ischemic baseline RBC speed for each vessel ranged from 0.438 to 8.000 mm/s (Table 
4.2), with a mean value of 3.130±2.121 (mm/s, mean±sd). Each vessel represented an 
independent biological unit for statistical analysis in this result section.
During MCAo mean RBC speed dropped to 0.287±0.411 mm/s. Blood flow was 
completely blocked in 4/24 (0 mm/s) while the remaining vessels were still perfused, albeit 
to different extents. Perfusion in 11/24 vessels was largely inadequate ranging from 0.025 
to 0.069 mm/s (during, Table 4.2). Blood flow was found to be slightly preserved only in 
6/24 vessels ranging from 0.258 to 0.982 mm/s, which represents a percentage drop of 
85% in comparison to pre values. Notably, in 3/24 vessels blood flow was inverted, 
reaching a mean speed of -1.170±0.207 mm/s. The temporal profile of RBC speed for each 
vessel is illustrated in figure 4.3 A,C.
When reperfusion was allowed, 10 min after reperfusion, RBC speed showed a mean value
of 0.403±0.523 mm/s. 2/24 vessels exhibited zero flow and 7/24 showed a poor perfusion
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ranging from 0.025 to 0.055 mm/s (Table 4.2). In 11/24 vessels blood flow was restored
ranging from 0.147 to 0.778 mm/s corresponding to a reduction of 80% in RBC baseline
speed. Blood flow was restored to higher levels (1.487 to 1.767 mm/s, representing a 64%
drop) only in three vessels belonging to the same mouse, while reverted flow was
preserved in only 1 vessel (-0.162 mm/s).
Twenty-four hours after ischemia RBC speed averaged 0.471±0.751 mm/s. The total 
number of blocked or inadequately perfused vessels did not vary in comparison with post. 
Interestingly, as illustrated in Table 4.2, these vessels were not necessarily the same which 
were blocked or poorly perfused at the previous time point and, vice versa, some vessels 
that showed a flow soon after reperfusion were not able to preserve it 24 h later.
Notably, in one mouse, 24 h after reperfusion, blood flow was completely prevented in 
three vessels, although these vessels were not blocked either during ischemia or 10 min 
after reperfusion. RBC speed in the vessels in which blood flow was re-established at 
post24h showed a reduction of 70% compared to pre values. No vessel exhibited a reverted 
blood flow 24 h after reperfusion, indicating that the endogenous flow reversal in response 
to an occlusion is a transient event.
I did not observe any significant variation in RBC speed of the four sham-operated mice 
(22 vessels were analyzed) during the whole experiment (Fig. 4.3 B,D).
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mouse 1
mouse 2
mouse 3
mouse 4
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Red Blood Cell speed values
pre during % post % post24h %
2.608 0.982 37.653 0.147 5.637 0.000 0.000
3.355 -1.232 -36.721 -0.162 -4.829 0.000 0.000
3.046 0.325 10.670 0.043 1412 0.009 0.295
5.078 0.025 0.492 0.000 0.000 ;0.057 1122
2.078 0.064 3.080 0.037 1.781 0.011 0.529
3.043 0.039 1.282 0.021 0.690 0.031 1019
3.241 0.058 1.790 0.325 10.028 0.178 5.492
2.656 0.052 1.958 0.161 6.062 0.076 2.861
4.799 0.032 0.667 0.055 1146 0.036 0.750
4.478 0.000 0.000 0.190 4.243 0.053 1184
6.731 0.386 5.735 0.769 11.425 0.219 3.254
2.714 0.000 0.000 0.570 21.002 0.702 25.866
7.218 -1.339 -18.551 1.767 24.480 2.798 38.764
3.030 0.470 15.512 1487 49.076 2.367 78.119
4.799 0.368 7.668 1.608 33.507 1.177 24.526
0.871 0.064 7.348 0.373 42.824 0.217 24.914
2.134 0.258 12.090 0.778 36.457 0.684 32.052
0.736 0.068 9.239 0.288 39.130 0.158 21.467
1157 0.061 5.272 0.392 33.881 0.066 5.704
1.086 0.068 6.262 0.037 3.407 0.714 65.746
0.911 0.069 7.574 0.046 5.049 0.285 31.284
0.438 0.000 0.000 0.000 0.000 0.000 0.000
8.000 -0.939 -11.738 0.402 5.025 1.306 16.325
0.914 0.000 0.000 0.025 2735 0.151 16.521
Absolute RBC speed values expressed as mm/s and their % compared to pre 
are reported for each analyzed vessel.
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Figure 4.3 RBC speed measurements.
A) Representative ischemic mouse: RBC streaks (white lines) obtained from the line-scan acquisition over a 
135 ms period, change their slope revealing blood flow slowing down during ischemia and at post. RBC 
speed remains slow at post24h, indicating an inadequate reperfusion. Scale bar= 14pm. B) Representative 
sham-operated mouse: the slopes o f  RBC streaks (white lines) do not vary over the four experimental time 
points. C) RBC speed fold-change compared with pre in 4 ischemic mice showing a significant reduction in 
RBC speed during tMCAo. At post and post24h blood flow appears to be only weakly restored. Calculated 
fold-change values for speed in sham-operated animals are plotted in D. Each line corresponds to an 
individual vessel. One-way ANOVA for repeated measures; post-hoc Tukey’s test; *p<0.05, **p<0.05,
***p<0.001.
4.3.2 Laser Doppler measurements
To exclude the possibility that poor blood flow re-establishment was due to an 
experimental artifact (e.g. lack of reperfusion of MCA or increased blood density after 
dextran injection), we performed a laser Doppler analysis at the same stereotactic 
coordinates of the cranial window (AP: -1 mm; L; -2.5 mm from bregma). Mice were
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subjected to the same anesthesia regimen of imaging sessions and injected with 
fluorescent-dextran prior to ischemia. Laser Doppler measurement revealed blood flow 
restoration, although incomplete, both 10 min and 24 h after ischemia (n=3, Fig. 4.4 
showing a representative mouse).
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Figure 4.4 Laser Doppler tracking o f  a mouse subjected to tMCAo.
Blood flow (blue track) dropped significantly (over 70%) after MCAo compared with baseline values in the 
area measured by the laser Doppler (2.5 mm lateral and 1 mm posterior to bregma). When reperfusion was 
allowed, blood flow re-established to levels that were kept at 24h after MCAo. PU = perfusion units; time 
scale indicates hours:minutes.
4.3.3 Extravasation
Extravasation was assessed by parenchymal accumulation of the fluorescent marker which 
normally does not cross the barrier due to its molecular dimension (70 kDa). Extravasation 
was measured 20 min after the ischemic onset and 20 min after reperfusion. Since imaging 
at post24h was obtained following a new fluorescent dextran administration, comparable 
extravasation data at this time point could not be provided.
Fluorescent dextran presence in the parenchyma was significantly increased 20 min after 
MCA occlusion onset (Fig. 4.5 A-C, G) suggesting a rapid appearance of extravasation. In 
contrast to ischemic mice, sham-operated mice did not show any significant extravasation, 
indicating that imaging in normal conditions did not affect vessel viability (Fig. 4.5 D-F). 
A mild, not statistically significant, increase of integrated density ratio between extra- and
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intra-vascular pixels was also apparent in the sham animals (Fig. 4.5 G). This was probably 
due to either a progressive loss of performance of the laser during imaging or to the 
physiological clearance of the dextran over time, which leads to a gradual decrease of 
intravascular concentration of the fluorescent dye. It is important to note that this technical 
bias did not hamper the visualization of vessels, therefore fluorescent signal was not 
enhanced by laser intensity or photomultiplier adjustment over time.
To further validate the in vivo method to detect extravasation and exclude any false 
positive results due to the technical bias, we performed a post-mortem analysis through a 
well established histological method (Marcon et al. 2009). By transcardiac injection of 
FITC-albumin, we were able to confirm that extravasation was present at post in the 
ischemic region and that surrounding cortical areas did not reperfuse (Fig. 4.5 H,I). Contra­
lateral side was used as control and showed a uniform perfusion in the cortex with no signs 
of extravasation (Fig. 4.5 L,M).
Extravasation was found to be associated with morphological changes in the vessel 
profiles, possibly due to the incipient BBB damage. The alterations were evident during 
ischemia and lasted at every time point considered (Fig. 4.6 A-D). In the sham-operated 
mice vessel edges preserved their straight and regular shape (Fig. 4.6 E-H).
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Figure 4.5 Extravasation assessment at the different experimental time points.
Extravasation became evident as early as 20 minutes after the occlusion onset. At baseline (A) the fluorescent 
marker signal was confined into the vessels, with a minimum background noise widespread in the 
parenchyma. During tMCAo (B) the fluorescent signal was also clearly visible outside the vessels indicating 
that extravasation occurred. A differential image o f the red insert was obtained by subtracting image A to 
image B. The resulting image (C) shows the parenchymal accumulation o f dextran. In sham-operated mice 
(D, E and F) no extravasated fluorescent signal was detectable, and the apparent signal in the differential 
image in F is due to a slight misalignment o f the vessels. Bars= 100 pm.
G) Integrated density ratio between extra- and intra- vascular dextran. In the ischemic mice extravasation is 
significantly increased as early as 20 minutes after the occlusion onset. Data from the same mice that were 
calculated for RBC speed and expressed as mean+sd, n=24 vessels for ischemic mice and n=22 vessles for
117
microvascular modifications after brain ischemia revealed by 2-PM  
sham-operated animals. Two-way ANOVA (pO.OOOl) followed by post-hoc Bonferroni test: ***p<0.001 vs 
sham. H) Post-mortem histological analysis o f  extravasation (FITC-Albumin) at post reaveals vast cortical 
areas with no-reperfusion in the ischemic mice (dashed areas) and some extravasation (white arrow); scale 
bar= 200pm. At higher magnification (I) extravasation is clearly visibile; scale bar= 50pm. Contra-lateral 
side appears entirely perfused and does not show any visible extravasated fluorescent dye (L, M).
pre during post post24h
Figure 4.6 Morphological changes in the vessel edges accompanies extravasation.
At baseline (A) vessel borders appear to be straight and regular, while during tMCAo (B) they became 
markedly irregular possibly due to the incipient BBB damage (white arrows). During the first minutes o f  
reperfusion (C) and at longer times (D), BBB damage is still present, being the irregular shape always visible. 
In a sham-operated mouse, no alteration in the vessel morphology is apparent at any time point analyzed (E, 
F, G and H). Scale bar= 25 pm.
4.4 Discussion
In this part of the project, I have: 1) set up and applied an in vivo 2-PM protocol for 
investigating temporal vascular and hemodynamic events in individual cerebral vessels 
after ischemia/reperfusion; 2 ) used the protocol to obtain data on blood flow speed, 
extravasation and vascular morphology.
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During occlusion we consistently observed a massive blood flow decrease in the cortical 
region fed by MCA. Notably, in a few branches, blood flow reversion occurred. This 
phenomenon that had been previously described following permanent ischemia could be 
the result of redundancy in the cortical vascular architecture that acts as endogenous 
protective response to occlusions (Schaffer et al. 2006). We found that extravasation 
appeared within the first 20 min after tMCAo onset, rapidly contributing to edema 
formation. This data is consistent with the observations by Strbian et al. (Strbian et al. 
2008) who studied gadolinium extravasation in a rat model of transient ischemia by means 
of MRI and found that extravasation is present at 25 min after ischemia (Strbian et al. 
2008). Compared with MRI, 2-PM provides a higher level of resolution, allowing 
monitoring of morphology and blood flow changes over time in each individual vessel. 
Notably, analyzing vascular morphology, we could observe that the vessel edges became 
markedly irregular during ischemia indicating that the microvascular structure was rapidly 
affected by ischemia. In sham-operated mice vascular borders kept their regular and 
straight shape during the whole session of imaging and this was regarded as an index of a 
healthy state. These results in the sham-operated mice show that 2-PM is a suitable 
technique to study intact tissues over time. Indeed, the fluorescent signal was clearly 
detectable at each time point analyzed and, moreover, exposure to the laser beam did not 
impair vessel viability.
We could observe that reperfusion did not result in an adequate re-establishment of blood 
flow at post, in line with what observed by Shih et al. (Shih et al. 2009). We could also 
show that this lack of reperfusion persisted up to 24 h after the occlusion removal, although 
the laser Doppler analysis showed that reperfusion was there at both time points. The 
apparent inconsistency between laser Doppler and two-photon analysis can be explained as 
while laser Doppler measures the general blood flow in an area beneath the probe
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including large vessels, 2-PM allows the study of small individual vessel contribution to
perfusion with an higher anatomical resolution.
The existence of an incomplete re-establishment of blood flow following reperfusion in 
small vessels had been previously proposed on the basis of post-mortem analysis and 
defined as ‘focal no-reflow’ (Del Zoppo and Mabuchi 2003). It suggests the existence of 
further pathogenetic mechanism, induced by the occlusion, affecting vascular viability. It is 
possible that rapidly established edema causes an increased parenchymal pressure leading 
to a relevant vascular compression able to affect flow recovery in the microvasculature. 
Furthermore, even if the number of inadequately perfused vessels did not vary either 10 
min or 24 h after ischemia, the analysis of each individual vessel showed that not every 
perfused vessel at post was able to maintain perfusion later on, and vice versa. This 
observation corroborates the idea that mechanisms driven by edema prompted the 
vasculature to a further rearrangement during reperfusion, impairing, thereby, a complete 
and effective blood flow re-establishment.
Massive rearrangements in blood flow and morphological changes of vessels along with 
early extravasation following tMCAo confirm that cerebral vasculature responds to an 
altered CNS state with high dynamism (Del Zoppo and Mabuchi 2003). CNS vascular 
architecture forms a highly interconnected network which has been hypothesized to assure 
a source of collateral flow in the event of a vessel occlusion (Brozici et al. 2003; Vander 
Eecken and Adams 1953; Wei et al. 1995). In this respect 2-PM represents a unique tool to 
study rapid vascular rearrangements and to follow them for several hours after ischemic 
injury.
In this study we have analyzed, for the first time, the effects of reperfusion on vascular 
dynamics following ischemia up to 24 h after injury. This is relevant since reperfusion 
leads to massive recruitment of immune cells that significantly contribute to the ischemic 
damage pathogenesis. At this time point I could show that blood flow is not fully restored,
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possibly as a consequence of extravasation effects, and that flow reversal is not present any 
longer.
It has been recently reported that anesthesia regimen may influence blood flow analysis 
with 2-PM (Tetrault et al. 2008). Our data clearly show that haemogas parameters were not 
significantly affected by the chosen anesthetic regimen across groups, excluding the 
hypothesis that anesthesia per se could be responsible for RBC speed changes through 
mechanisms that are independent from MCA occlusion. Fluorescent-dextran clearance may 
represent an additional bias that affects extravasation measurements possibly originating 
false positive data. We confirmed the occurrence of extravasation by a conventional 
confocal analysis on frozen sections from FITC-Albumin perfused brains. The histological 
analysis also revealed that vast not-perfused areas were present in the cortical regions 
affected by ischemia. This data is in line with the lack of reperfusion that we observed by 
in vivo imaging. Interestingly, since not-perfused areas on the sections were spread all over 
the injured cortex and were present also beyond the imaged area, we can further rule out 
the possibility of any local artefact in the area assessed in vivo due to either the cranial 
window or the laser irradiation.
4.5 Conclusions
We established a reliable model to study the effects of ischemic/reperfusion injury at 
different time points and up to 1 day after the ischemic onset, thus providing a detailed 
time course of the events in the same animal. We showed a massive reduction in blood 
flow measured as RBC speed during ischemia and an inadequate re-establishment of flow 
after reperfusion. This focal no-reflow in the area fed by the MCA can be explained by
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mechanisms driven by rapid extravasation which causes microvessel compression and 
impairs reperfusion. Indeed extravasation could be shown as early as 20 minutes after the 
MCA occlusion. Furthermore, we showed that reversion in blood flow is a transient event 
since it is not present 1 day after ischemia.
In humans, the degree of reperfusion after brain ischemia, if present, is highly variable 
(Caplan et al. 2011; Lo 2008b). However, in the future the number of patients undergoing 
reperfusion is likely to increase, since the time window for thrombolytic therapy has been 
recently widened from 3 to 4.5 h (Davis and Donnan 2009). Thus, the exact 
comprehension of vascular dynamics at the level of the individual vessel in vivo when 
reperfusion is allowed represents a crucial issue for stroke therapy and improved recovery.
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5. IN  VIVO IMAGING OF MICROGLIA AND PROTECTIVE FEATURES OF 
CX3CR1-DEFICIENT MICROGLIA
5.1 Background
In physiological conditions, microglia perform micro-environmental patrolling by the 
extension/withdrawal of ramifications (Davalos et al. 2005; Hanisch and Kettenmann 
2007). Activation of microglia in response to a pathological status drives a switch in 
phenotype along with change in cell morphology. Following ischemia, activated microglia 
can potentially exert either protective or detrimental effects suggesting that these cells may 
acquire different phenotypes belonging to the ‘classical’ (Ml) or to the ‘alternative’ (M2) 
active status which have been described for macrophage-driven immunity (David and 
Kroner 2011; Michelucci et al. 2009). Specific environmental signals, including effector 
molecules, timing of activation and degree of injury may induce these different 
polarization states (Porta et al. 2009; Zanier et al. 2011). As a direct consequence of their 
commitment, microglia can worsen the final outcome or promote tissue recovery.
Over the last years, a particular interest raised for fractalkine, a chemokine responsible for 
deregulating microglia activity (Lauro et al. 2006; Prinz and Priller 2010). Fractalkine 
binds to its unique receptor CX3CR1, which is expressed on resident brain 
microglia/macrophages and on peripheral immune cell populations (Prinz and Priller
2010). Binding of fractalkine to CX3CR1 is needed for neuron-microglia communication. 
In normal conditions, neurons continuosly release fractalkine keeping microglia inactive. 
Following an acute insult, neurons significantly decrease the release of fractalkine allowing 
the activation of microglia (Hundhausen et al. 2003; Lauro et al. 2006). Animals in which
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the cx3crl gene is substituted with the gene for the green fluorescent protein (GFP) on 
both alleles (cx3criGFP/GFP), thus being defective for the receptor of fractalkine (henceforth 
referred to as cx3crl'l~ mice), have been used to assess the importance of the 
fractalkine:CX3CR1 pathway in neurological disorders (Cardona et al. 2006; Corona et al. 
2010; Denes et al. 2008; Donnelly et al. 2011). In models of chronic diseases such as 
lateral amyotrophic sclerosis (ALS, Cardona et al. 2006) Parkinson’s disease (Pabon et al.
2011) and Alzheimer’s disease (Cho et al. 2011b), the absence of CX3CR1 has been 
associated with a worst outcome possibly be due to the lack of fractalkine control of 
microglia activation leading to chronic pro-inflammatory function (Iadecola and Anrather 
2011; Zujovic et al. 2000). Surprisingly enough, however, the absence of CX3CR1 in acute 
injury models (transient and permanent ischemia, spinal cord injury) has been instead 
associated with a favourable outcome (Cipriani et al. 2011; Denes et al. 2008; Donnelly et 
al. 2011; Soriano et al. 2002). Thus available data do not allow to draw a coherent picture 
of the role of fractalkine in brain injury and disease. Specifically, little information is 
available on fractalkine:CX3CRl pathway in the context of microglia activation following 
brain ischemia.
In this part of the study, using a murine model of transient focal ischemia (tMCAo), I 
explored the consequences of CX3CR1 absence on microglia phenotype. I analyzed 
microglia morphology and motion in vivo by two-photon microscopy before, lh and 24h 
after transient brain ischemia in cxScrl'1' and in cx3crl'l+ mice. In these two strains I also 
assessed the expression of the microglia/macrophage (M/M) markers CD lib , CD6 8 , 
CD45, Yml, CD206 and iNOS by quantitative immunohistochemistry. Lastly, I 
determined the susceptibility to ischemic injury.
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5.2 Specific methods in this chapter
5.2.1 Experimental plan
Experiments were conducted according to the plan shown in Fig. 5.1.
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Figure 5.1 Experimental plan.
Mice were subjected to skull thinning craniotomy. After one overnight recovery, they received iv Rhodamine 
dextran to label the vessels and underwent two-photon imaging at baseline (pre), lh  and 24h after tMCAo 
(postlh and post24h respectively). Each imaging session lasted approximately 30 min including animal 
positioning under the objective, RBC speed acquisition and 20min time-lapse recording. Mice were 
sacrificed at 24h for histological analysis.
5.2.2 Thinned skull craniotomy for two-photon imaging (Fumagalli et al. 2011)
At Mario Negri Institute, Milan, Italy: The blood was labeled by injecting a red fluorescent 
marker in a tail vein, rhodamine B isothiocyanate-dextran (RhITC-dextran, 70 kD, Sigma; 
5% in PBS, 150 pL) prior to imaging. Mice (n=5) were isoflurane-anesthetized with rectal 
temperature maintained at 37°C and positioned on a stereotactic frame (KOPF, CA, USA). 
The left parietal skull was exposed and dried; a point near 2.5 mm lateral, 1 mm posterior 
to the bregma was marked. Under a dissecting microscope, the skull was thinned using a 
dental drill with a diamond burr (Meisinger, Neuss, Germany). When the pial vasculature
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could be clearly seen, a sterile absorbable gelatin sponge with hemostatic effect was 
applied on the thinned skull for the control of the bleeding of skull microvessels 
(Curaspon, Cura Medical, Assendelft, The Netherlands). A stainless M3 nut was 
positioned on the contra-lateral side of the skull and glued with epoxidic glue. This served 
to firmly position the animal under the microscope during the whole imaging sessions. A 
small well was prepared around the thinned skull with the epoxidic glue to allow objective 
immersion in water for image acquisition. Craniotomized mice were given an overnight 
recovery before first imaging session.
5.2.3 Imaging of GFP+ microglia
5.2.3.1 GFP signal detection
We imaged cortical volumes sized 350x350x30 pm in mice receiving a previous 
intravenous injection of RhITC-dextran, 70 kDa, Sigma; 2.5% in sterile water, 150 pL. 
RhITC-dextran and GFP were simultaneously excited at 844nm, and emission wavelengths 
were separated through a 500nm dichroic mirror and conveyed to two external 
photomultipliers (Hamamatsu Photonics, Japan).
5.2.3.2 Image acquisition and processing
The location (centroid) of each GFP+ cell within each 3-dimensional image stack was 
determined manually by the operator. To quantify GFP+ cell displacement rate we 
calculated, for each cell, the straight line distance from the first location in the track to the 
last and divided by the time it was tracked (Fig. 5.2 A). Where needed, image shift over
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time was corrected in the 3-dimensional space using vessel geometry as reference points. 
Displacement rate was expressed as pm/minute (Fumagalli et al. 2011).
Sholl analysis (Gensel et al. 2010) was used for measuring cell morphology on the basis of 
frequency and length of ramifications. Each GFP+ cell was visualized in orthogonal view 
mode, selected and put into a field formed by concentric circles whose smallest had a 5pm 
radius and biggest a 40pm radius. Distance between each circle was 0.5pm. The frequency 
of each circle touching by cell ramifications was counted (Fig. 5.2 B). Mean number of cell 
touchings per cell from 5 to 10 pm, 10 to 20 pm and 20 to 30 pm from cell controid were 
plotted into graphs and used for statistical analysis.
Post-acquisition processing was performed by using Imaris software (Bitplane, 
Switzerland) and ImageJ (http://rsbweb.nih.gov/ij/). Five animals per group underwent 
imaging session and 18-20 GFP+ cells per imaged volume were detectable at each time 
point.
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displacement rate=
(t1+t2+t3)
Figure 5.2 Methods fo r  quantification o f  cell displacement and Sholl analysis.
To calculate cell displacement rate, xyz coordinates o f  cell centroid for a given cell were connected between 
subsequent time points ( t l .. .t3). Linear distance between first and last time points was calculated and divided 
by the total time in which the cell was imaged (tl+t2+t3+...+tf= 20 minutes, A). Sholl analysis was 
performed for each visible cell in the imaged field (B). Isolated cells were put into a field made by concentric 
circles with increasing radius (ranging from 5 to 40pm, 0.5pm interval). Number o f  ramification touchings 
per circle was quantified and graphed.
5.2.4 Slices selection and quantitative analysis
The coronal sections used for marker quantification in ischemic areas were: 
cortex: - 1 mm from bregma, corresponding to the cortical area beneath the craniotomy 
(Fumagalli et al. 2011). 13 frames at 40x magnification, distancing their centres 270 pm 
horizontally and 360 pm vertically;
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striatum: +0.6, 0 and -  0.6 mm from bregma, 10 frames at 40x magnification per section.
Centres of frames were distanced 450pm for horizontally aligned frames and 400pm for
vertically aligned frames.
Positioning of the frames is detailed in Fig. 5.3.
Quantifications were performed using ImageJ software (http://rsbweb.nih.gov/ij/) and 
expressed as positive pixels/total assessed pixels (staining percentage area), or cells/mm 
(cell density) for subsequent statistical analysis (Perego et al. 2011).
AP« 0 mmAP*> +0.6 mm • AP= -0.6 mm
Figure 5.3 Slice selection fo r  immunohistological measurements.
Three brain coronal slices were chosen for striatal quantification, namely AP=+0.6, 0 and -0.6mm from 
bregma; one brain coronal slice was chosen for cortical quantification at AP=-lmm from bregma, just 
beneath the craniotomy for 2-PM. Fields at 40x magnification were positioned as detailed in the figure (black 
boxes).
5.3 Results
5.3.1 Characterization of the imaged area
The cranial window through skull thinning exposed the area susceptible to MCA occlusion
(Fig. 5.4 A, Fumagalli et al. 2011). RBC speed significantly decreased in all the animals
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tested lh after tMCAo when compared to baseline values (pre, Fig. 5.4 B). In cx3crl'l+ 
mice, RBC speed dropped from 4.7±2.8 mm/s (mean±sd, n=19-23 vessels from 5 mice per 
group) at pre, to 1.2±0.9 mm/s at postlh, and in cx3crT!~ mice RBC speed dropped from 
5.4±3.5 mm/s at pre to 1 .9 ± 1 . 7  mm/s at postlh. Intravenous injection of PI in selected 
animals was used to detect the presence of dying cells (Unal Cevik and Dalkara 2003). The 
observation that no PI positive cells were present in sham-operated mice, showed that 
thinning of the skull did not cause cell death or compromise the blood- brain barrier 
integrity (Fig. 5.4 C, Hussain et al. 1985). On the contrary, a great number of PI positive 
cells appeared to be labelled after MCAo, showing that in the ischemic areas where GFP+ 
cells were imaged, PI extravasated from vessels and penetrated inside cells (Fig. 5.4 D) 
indicating leakage of the blood- brain barrier and debility of the stained cells after MCAo 
(Fumagalli et al. 2011).
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F igure 5.4 Characterization o f  the cortical area subjected to t\vo-photon imaging before and after tMCAo. 
Thinned skull allows direct inspection o f main cerebral blood vessels under light microscope (A). RBC speed 
is significantly reduced at postlh  in the vessels belonging to the imaged area across the entire experimental 
group, with no significant differences between c x 3 c r l'+ and cx3crl''' mice (B). n=19-23 vessels from 5 mice 
per group, two-way ANOVA for repeated measures followed by Bonferroni’s post hoc test: ***p<0.001 pre 
vs postlh. Propidum iodide uploaded in vivo into cell nuclei reveals the presence o f dying cells in the 
visualized region o f ischemic animals (D, red: propidium iodide positive cells; green: GFP+ cells), but not in 
sham animals (C). Tick interval = l Opm. GFP+ cells display an intense explorative activity by branch 
protruding/withdrawal at baseline point (E, 3D rendering). Microglia often take contact with blood vessels
131
in vivo imaging o f  microglia and protective features o f  CX3CR1 -deficient microglia 
(F, arrow, scale bar = 20pm), during a 10 min acquisition. During imaging before ischemia (pre), rhodamine- 
dextran (red) is confined into blood vessels and GFP+ cells (green) are clearly detectable in the brain tissue 
(G). One hour after ischemia (postlh), Rhodamine-dextran extravasates due to blood-brain barrier damage 
and GFP+ cells show a ramified shape (H). Tick interval = 50pm.
5.3.2 In vivo time-lapse imaging and immunophenotyping of GFP+ cells
When in vivo imaging was performed at pre, an intense activity of microenvironment 
exploration by ramification protruding/withdrawal was detected in microglia GFP+ cells 
(Fig. 5.4 E). As illustrated in Fig. 5.4 F, microglia cells were located close to blood vessels 
and often wrapped their ramifications around the vessel surface. A dramatic change in 
GFP+ cell shape was observed lh following ischemia when GFP+ cells presented new 
ramifications or thickened the existing ones in both cx3crl'l+ (Fig. 5.4 G, H) and cx3crl',~ 
mice (data not shown). Images in figure 5.4 document the leakage of rhodamine-dextran 
lh after tMCAo (Fig. 5.4 G, H) indicating an early damage to the blood-brain barrier.
To explore GFP+cell phenotype, we performed post mortem immunophenotyping (Fig.
5.5). cx3crl'l+ mice subjected to in vivo imaging were sacrificed at 24h after tMCAo and
immunofluorescence assays for CD1 lb, CD45, CD3 and CD206 were performed on frozen
20pm coronal brain sections. GFP+ cells were evaluated by confocal microscopy
exploiting the native protein fluorescence emission. GFP+ cells co-localized with ramified
CDllb+ cells, whilst no co-localization was detected with round-shaped CDllb+ cells,
CD45hlgh+ leukocytes (Stein et al. 2007) and CD3+ lymphocytes (Fig. 5.5 A-C). Also
perivascular macrophages (CD206+, Galea et al. 2005) appeared to express GFP
fluorescent protein (Fig. 5.5 D). We then assessed the presence of GFP in the peripheral
immune system. In spleen, immune cells expressing CD1 lb, CD45 or CD3, were found to
be partially positive for GFP (Fig. 5.5 E-G). As GFP is controlled by the promoter of the
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fractalkine receptor gene (cx3crl), the absence of GFP signal in CD45hlgh+ cells in the
brain tissue and their presence in the spleen indicates that the monocyte/macrophage subset
recruited in the inflammed brain does not express cx3crl similarly to what reported in
other organs (Ingersoll et al. 2011). Thus in vivo analysis based on GFP positivity in the
brain was referred to resident microglia. Similar findings were obtained in cx3crl''' mice
(data not shown).
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Figure 5.5 Coexpression o f  CD l ib ,  CD45, CD3 or CD206 with GFP in cerebral cortex and spleen o f  
cx3crl'/+ mice 24h after tMCAo.
Photomicrographs o f  cortical brain region ipsilateral to the lesion (A-D). GFP co-localizes exclusively with 
C D llb  ramified cells (A). Round-shaped C D llb +  (A), CD45+ (B) and CD3+ (C) cells do not express GFP, 
suggesting that infiltrating cells in the brain do not express CX3CR1. Perivascular macrophages (CD206+) 
express GFP (D). At variance with cortex, immune cells in spleen (E-G) expressing C D llb  (E), CD45 (F) or 
CD3 (G) are partially positive for GFP. Scale bars = 20pm.
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5.3.3 Quantification of microglia cell displacement
Microglia did not show any significant motility within the imaged volume at pre, postlh 
and post24h acquisitions. Cell bodies remained almost still over the 20 min time-lapse 
imaging recordings in both cx3crl'l+ and cx3crl~lm strains (Fig. 5.6 A-C, D-E). In fact, 
when a stack obtained at the beginning of postlh acquisition (green) was superimposed to 
one from the same area obtained 2 0  min later (red), a good overlay (yellow) with minor 
shift at the level of cell bodies was obtained, indicating an almost null displacement. The 
same finding was obtained from pre and post24h acquisitions (data not shown). 
Displacement rate was calculated throughout the experimental time points in both strains 
used. We found that mean displacement rates were always below the threshold for cell 
motility (lpm/min, Cordiglieri et al. 2010, Fig. 5.6 G), being 0.32±0.30, 0.47±0.49 and 
0.80±0.75 pm/min (mean±sd, n~100 cells per time point, 5 mice per group) at pre, postlh 
and post24h respectively in cx3crl'l+ mice and 0.35±0.34, 0.52±0.47 and 0.39±0.50 
pm/min at pre, postlh and post24h respectively in cx3crr'' mice. This confirmed that 
microglia was not motile. No significant difference in cell displacement rates were found 
comparing the two mouse strains.
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Figure 5.6 Analysis o f  GFP+ cell displacement by two-photon microscopy.
Superimposition o f  image stacks from time-lapse recording acquired at the beginning o f  the postlh imaging 
session (A, D) and 20 min later (B, E). In the overlay image (C, F) GFP+ cell bodies co-localize (yellow) 
with only a minor shift over the time span acquired. Scale bars = 20pm. Mean values o f  displacement rate are 
below the threshold for cell motility (1 pm/min) at every time point analyzed and in both strains (lines at the 
indicated mean values, n~100 cells per time point, 5 mice per group (G), thus confirming that GFP+ do not 
move in this time window (20 min). Two-way ANOVA for repeated measures was applied and did not yield 
any significant difference.
5.3.4 Analysis of microglia morphology
Since microglia displayed active morphological dynamism rather than variation of
motility, morphological features of microglia were analyzed in both strains at pre, postlh
and post24h time points. In cx3crl~l+ mice microglia sprouted new ramifications at postlh
and subsequently acquired a hypertrophic morphology characterized by numerous and
short ramifications at post24h (Fig. 5.7 A). In cx3crr'~ mice microglia were still able to
sprout new ramifications at postlh, but they did not acquire the hypertrophic morphology
with short branches at post24h (Fig. 5.7 B). Sholl analysis was applied to quantify cell
complexity on the basis of frequency and length of branches emerging from cell bodies
(Gensel et al. 2010, Fig. 5.2). At pre and post24h time points Sholl curves of complexity
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were unmatched when cx3crl'l+ and cx3crl'A mice curves were compared (Fig. 5.7 C, E) 
whilst they were similar at postlh (Fig. 5.7 D). Cell complexity was statistically analyzed 
by considering, for each time point the frequency of short, intermediate and long 
ramifications (see methods for Sholl analysis in section 5.2.3.1). cx3crl~,~ mice displayed a 
significant 2.0 fold increase in intermediate ramifications at pre time point (Fig. 5.7 F), 
equal length and frequency of branches at postlh (Fig. 5.7 G) and a significant 1.7 fold 
increase of intermediate ramifications and 3.1 fold increase of long distance ramifications 
at post24h (Fig. 5.7 H) when compared to cx3crl'l+ mice. It should be noted that the 
majority of long ramifications emerge directly from cell soma, thus contributing to the 
value of short ramification frequency. The fact that this value did not vary between the two 
strains indicates a similar number of total ramifications emerging from cell body at any 
time points. The different values found for intermediate and long ramifications are instead 
indicative of a different length of ramifications between the two strains. On the whole 
these results indicate that at 24h after tMCAo, in cx3crl'l+ mice microglia evolved towards 
an amoeboid shape in response to ischemia (Fig 5.7 A), while in cx3crl'l~ mice they failed 
to withdraw their longer branches and to acquire an amoeboid phenotype (Fig. 5.7 B).
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Figure 5.7 Quantification o f  morphological complexity by Sholl analysis.
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cx3crl'/+ and cx3crV'~ mice show a different evolution o f  microglia morphology over time. In cx3crl'l+ mice 
microglia increase number and length o f ramifications at postlh and subsequently acquire a hypertrophic 
morphology by shortening ramifications at post24h (A). On the contrary, microglia in cx3crl'A mice increase 
number and length o f  ramifications at postlh and leave them unaltered at post24h (B). Arrows indicate cells 
showed in the higher magnification fields, scale bars=20pm. When the two strains are compared directly, 
cx3crV'' mice reveal increased touchings at pre, equal touchings at postlh and increased touchings at post24h 
compared with cx3crl'l+ mice (C,D,E: Sholl curves; F,G,H: statistical analysis between the two strains 
comparing frequency o f  ramifications at short (5 to 10pm), intermediate (10 to 20pm) and long (20 to 30pm) 
distance from cell centroid). Mean -/+ sd, n=90-100 cells per time point, 5 mice per group, two-way ANOVA  
followed by Bonferroni’s post hoc test: *p<0.05, ***p<0.001.
Sham operated cx3crl'l+ mice (n=75 cells from 4 mice) did not show any significant 
difference in microglia morphology at the three time points assessed. The number of short
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ramifications was 17.8±10.5 (mean±sd), 18.5±9.8 and 22.1±12.5, that of intermediate was 
10.9±13.6, 9.1±12.3 and 8.8±9.6, that of long was 2.1±5.2, 0.9±3.1 and 0.6±2.5 at pre, 
postlh and post24h, respectively (Fig. 5.8).
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Figure 5.8 Quantification o f  morphological complexity by Sholl analysis in sham animals.
Analysis o f  Sholl applied to cx3crl',+ sham mice revealed that no variations in cell complexity was 
observable over the three time points considered, thus confirming that imaging procedure itself does not 
induce microglia morphological changes.
5.3.5 Quantification of immunostainings for CDllb, CD68, CD45, Yml, CD206 and 
iNOS
At post24h, coronal brain sections were stained and quantified for CD llb (marker of 
microglia/macrophages), CD6 8  (marker of active phagocytosis, (De Beer et al. 2003; 
Ramprasad et al. 1996), CD45hlgh (recruited macrophages), CD45low (resident microglia) 
(Gesuete et al. 2009; Perego et al. 2011; Stein et al. 2007), Yml and CD206 (markers of 
M2 polarization) and iNOS (Ml polarization) expression. Immunohistological analysis 
was performed both in cortex and striatum, the latter representing the ischemic core area. 
At 24h after ischemia, CDllb+ cells in cx3crl'l+ mice showed hypertrophic morphology 
upon activation in both cortex and striatum (Fig. 5.9 A, B). In cx3crl'1' mice these cells 
appeared highly ramified and did not show the same hypertrophic appearance (Fig. 5.9 A,
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B). Quantification of the stained area revealed that CD llb expression was decreased in 
cxScrl'1' ischemic mice compared to cx3crl'l+ mice at 24h after tMCAo in both cortex 
(3.54±1.76 vs 6.79±2.30 % stained area, mean±sd, n=6 , Fig. 5.9 A) and striatum 
(8.69±1.44 vs 10.88±1.61, Fig. 5.9 B). Expression of CD6 8  was induced 24h after tMCAo, 
in cx3crl’1’ and cx3crl'l+ mice (Fig. 5.9 C, D), but to a lesser extent in striatum of cx3crl~l~ 
mice compared to the same area of cx3crl'l+ mice (1.25±0.40 vs 2.00±0.53 % stained area, 
Fig. 5.9 D). CD45high+ and CD45low + cells were quantified separately. Massive recruitment 
of CD4 5 hlgh+ cells occurred at 24h after tMCAo in both cortex and striatum (Fig. 5.9 E, F). 
The number of CD45hlgh+ cells was significantly higher in cx3crl''' compared to cx3crl'/+ 
mice (cortex: 108.97±100.31 vs 25.64±21.18 cells/mm2; striatum: 65.56±12.24 vs 
41.87±23.77, Fig. 5.9 E, F). CD45low+ cells were present both in sham and ischemic 
cx3crl~l~ and cx3crl'l+ mice with no significant difference in cell density across the groups 
(Fig. 5.9 E, F). Yml expression was induced after ischemia (Fig. 5.10 A, B) in both strains. 
No significant difference could be detected in cortex (Fig. 5.10 A) whilst Yml appeared to 
be increased in striatum of cx3crl'A compared to cx3crl'l+ mice (0.31±0.11 vs 0.18±0.04 % 
stained area, Fig. 5.10 B). CD206+ cell density was increased after ischemia in both 
cx3crl'A and cx3crl'l+ mice with no significant difference between the two strains (Fig. 
5.10 C, D). iNOS expression was induced after tMCAo with no difference between the two 
strains in cortex, whilst, in striatum, it showed to be significantly upregulated in cx3crl'A 
compared to cx3crl'l+ mice (0.08±0.05 vs 0.19±0.10 % stained area, Fig. 5.10 E,F).
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Figure 5.9 Immunostainings and quantitative analysis fo r  C D llb , CD68 and CD45 expression in cortex and  
striatum at 24h after tMCAo.
C D llb +  cells (A, B) show a different morphology between the two strains, being hypertrophic and ameboid 
in cx3crl'l+ mice and highly ramified in cx3crl~'~ mice. Quantitative analysis reveals that in both cortex (A) 
and striatum (B), C D llb  stained area is significantly decreased in cx3crl''' mice after ischemia. Phagocytic 
activity (CD68+ cells) is unchanged in cortex (C), but it is significantly reduced in striatum (D) o f  cx3crr'' 
mice. Differential count for CD45hlgh+ cells (arrows in E) and CD45Iow+ cells (arrowheads in E) reveals a 
significant increase o f  round-shaped CD45hlgh+ cells in both cortex and striatum o f  cxScrl'1' mice (E, F) and 
no changes in ramified CD45low+ cells. No significant differences are detectable comparing sham animals for 
the assessed markers. Scale bars = 20pm. Mean+sd, n=6, Two-way ANOVA followed by Bonferroni’s post 
hoc test for C D llb  and CD45. Since CD68 was not detectable in sham animals, sham groups were excluded 
from statistics. Mann-Whitney test was used for CD68. *p<0.05, n.d. = not detectable.
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Figure 5.10 Immunostainings and quantitative analysis fo r  M2 polarization markers Yml and CD206 and 
M l polarization marker iNOS in cortex and striatum at 24h after tMCAo.
The expression o f  Ym l remains unchanged in cortex (A), whilst it is significantly increased in striatum o f  
cx3crl-/~ mice after ischemia (B). No Ym l positivity is detectable in sham animals. The density o f  CD206+ 
cells do not change in both cortex (C) and striatum (D) comparing sham and tMCAo cx3crl~/+ and c x ic r /’7' 
mice. iNOS expression, whilst not changing in cortex (E), is significantly decreased in striatum o f  cx icr i'7’ 
mice (F). Scale bars = 20pm. Mean+sd, n=6, Mann-Whitney test: *p<0.05, n.d. = not detectable.
5.3.6 Assessment of lesion volume at 24h after tMCAo
tMCAo induced a comparable decrease of RBC speed values in both strains (Fig. 5.4 B) 
with no significant difference in flow reduction (1.9±1.7 mm/s in cx3crl''' mice and 
1.2±0.9 mm/s in cx3crl'l+ mice). Histological evaluation of ischemic lesion revealed that at 
24h after ischemia cx3crl~,~ had a smaller ischemic volume compared to cx3crl'l+ mice
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(29.32±6.76 vs 39.33± 7.39 mm3, mean±sd) corresponding to a 25.5% reduction in lesion 
size in mice defective for cx3crl (Fig. 5.11).
C X IC rl-
Figure 5.11 Ischemic volume assessment.
Representative distribution o f  the lesion 24h after tMCAo in typical cx3crl'l+ and cx3crl''' mice (A). 
Quantification o f  the lesion shows a significant reduction (by 25.5%) in cx3crV'' compared to cx3crl'l+ mice. 
Mean+sd, n=12, Mann-Whitney test: *p<0.05.
5.4 Discussion
I used a murine model of transient brain ischemia and advanced two-photon in vivo 
imaging techniques in combination with post mortem phenotype analysis to reveal the 
early effects of CX3CR1 deficiency after ischemia. I demonstrated that CX3CR1 
deficiency leads microglia to express an early protective phenotype. In particular, 24h after 
ischemia: 1 ) microglia displayed an increased number of ramifications and lack of ameboid 
morphology; 2) the expression of M/M markers CD llb and CD6 8  was reduced in the 
ischemic area, indicating a lower level of activation and decreased phagocytic function; 3) 
the recruitment of CD45hlgh cells was enhanced; 4) the expression of Yml was increased in 
striatum, indicating a shift towards a M2 polarization within the ischemic environment. All 
these changes were associated with a 25.5% decrease of ischemic volume.
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The transgenic model based on GFP expression under the control of the promoter of 
cx3crl has been widely used to assess microglia behavior in vivo in different models of 
neurological conditions (Cardona et al. 2006; Cipriani et al. 2011; Corona et al. 2010; 
Davalos et al. 2005; Denes et al. 2008; Donnelly et al. 2011). Most of these studies refer to 
GFP+ cells as microglia although other cell types may express cx3crl (Prinz and Priller 
2010). While at baseline only resident monocytes (microglia and perivascular 
macrophages) are present in the brain (Hanisch and Kettenmann 2007), after ischemia, 
infiltration of immune cells from the periphery occurs with a specific pattern of tissutal 
invasion (Gelderblom et al. 2009). Thus to obtain information on the phenotype of GFP+ 
cells after brain ischemia, we analyzed cx3crl-expressing cells exploiting native GFP 
emission. At 24h after tMCAo, GFP was expressed exclusively by CDllb+ ramified 
(microglia) and CD206+ (perivascular macrophages) cells. None of the cells presenting the 
features of infiltrating immune cells, expressed GFP in the brain, being round-shaped 
CDllb+, CD45hlgh+ and CD3+ cells all negative for native GFP. These cell types were 
instead found to be partially GFP+ in the spleen. Constitutive expression of cx3crl is 
typical of resident monocytes (and microglia), while it is inducible in peripheral immune 
cells (Huang et al. 2001; Prinz and Priller 2010). Circulating monocytes have been divided 
into two subsets, each with a specific pattern of chemokine receptor expression and 
trafficking activity (Geissmann et al. 2003; Sunderkotter et al. 2004; Ziegler-Heitbrock 
2007). Monocytes belonging to the classical subsets express the CCR family receptors and 
are more prone to tissutal invasion upon recruitment (Ingersoll et al. 2011; Prinz and Priller 
2010; Saederup et al. 2008). On the contrary, those belonging to the nonclassical subsets 
express CX3CR1, demonstrate a patrolling behavior along blood vessel walls and 
accumulate into peripheral tissues as spleen, lung and liver (Auffray et al. 2007; 
Geissmann et al. 2003; Ingersoll et al. 2011). The nonclassical CX3CR1 subsets may be 
recruited in the brain at later stages after acute injury, and thus may not be present at the
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early time points after insult that we analyzed. Overall, these data corroborate the 
observation that infiltrated immune cells were negative for GFP, allowing us to refer to 
GFP+ cells, in the used ischemic model, at the considered time points, as microglia. 
Variations of cell morphology or cell displacement are related to the specific activity of 
microglia (Soltys et al. 2005), being specific shapes or motility rates strongly associated 
with function. Analysis of cell dynamics over time can thus provide information on 
microglia activity status. We exploited in vivo 2-PM to assess microglia dynamism and 
morphology over time. We used a thin skull craniotomy approach, which has minor effects 
on the cortical tissue beneath, leaving the density of dendritic spines unchanged and 
avoiding inflammatory response (Fumagalli et al. 2011; Xu et al. 2007b; Yang et al. 2010). 
In the cortical area selected for imaging we could confirm in vivo both the decrease in 
blood flow (RBC speed) and the presence of dying cells (PI administration) as a 
consequence of MCAo.
We assessed microglia cell body displacement within the imaged volume. The ability of 
microglia to travel over long distances seems to be dependent on the danger signal 
received. In models of brain injury such as traumatic brain injury, photothrombotic stroke 
model and global ischemia, microglia did not show any body movement in response to 
damage (Davalos et al. 2005; Masuda et al. 2011). On the contrary, in a model of spreading 
depression that causes loss of synaptic activity, microglia showed Levy flight-like 
movements in response to decreased synaptic activity (Grinberg et al. 2011). In our 
tMCAo model, microglia were almost completely stationary within the imaged volume at 
any time point considered. Indeed, during the 20min imaging sessions, for both cx3crl'l+ 
and cx3crr'' mice, mean displacement rate calculated for cell centroid was below 
1 pm/min, which is the minimum threshold for immune cell motility in the central nervous 
system (Cordiglieri et al. 2010; Fumagalli et al. 2011). The observed lack of microglia 
displacement could be related to the rapid decline of ATP levels due to tMCAo, being ATP
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needed for the modifications of the cytoskeleton exploited by microglia to migrate within 
the tissue (Davalos et al. 2005; Grinberg et al. 2011). To analyze cell morphology, we 
measured cell complexity on the basis of ramification frequency and length (Gensel et al. 
2010). At baseline, cx3crl~l+ and cxScrl'1' mice showed a distinct cell complexity having 
cxScrl'1' animals a higher number of intermediate distance ( 1 0  to 2 0  pm from centroid) 
ramifications. Thus, at baseline, the lack of fractalkine receptor prevents fractalkine, which 
is continously shed from neurons, from keeping a low number of ramifications, i.e. low 
level of microglia activity (Prinz and Priller 2010). At 24h after ischemia, in cx3crl'l+, but 
not in cx3crr'~ mice, microglia switch towards a hypertrophic morphology characterized 
by numerous, short and thick ramifications indicating that fractalkine is a key factor in 
inducing microglia ameboid, hypertrophic shape.
We then assessed if these morphological differences were associated to a different 
expression of markers of M/M phenotype, namely CDllb, CD6 8  and CD45. CD llb 
staining revealed that in both cortex and striatum ramified microglia was hypertrophic with 
numerous, short and thick branches in cx3crl’l+ mice, and highly ramified with long 
protrusions in cx3crl~,~ mice, coherently with the results obtained by in vivo imaging. The 
observed increase in ramified microglia in cx3crl~l~ mice was associated with a reduction 
of infarct size. In a recent paper, Vinet and colleagues (Vinet et al. 2012) showed a 
protective role of ramified microglia in excitotoxicity-induced neurodegeneration. Our 
observations are coherent with the suggestion made by these authors that ramified 
microglia not only survey their microenvironment but also contribute to protection of 
neurons under pathological conditions. CD llb stained area was significantly reduced in 
cx3crl~l~ mice suggesting a different/defective activation of M/M. The ameboid shape of 
M/M has been associated with their phagocytic function, which can be assessed by CD6 8  
staining (De Beer et al. 2003; Ramprasad et al. 1996). cx3crT'~ mice showed a decrease in 
CD6 8  stained area compared to cx3crl'l+ mice in striatum, in line with the different cell
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morphology described for the two strains. The phagocytic activity was thus significantly
reduced at 24h after tMCAo in the absence of the fractalkine receptor, suggesting the
involvement of the fractalkine:CX3CR1 pathway in the activation of the innate phagocytic
functions of microglia. Similar changes in microglia phenotype and CD llb and CD6 8
expression had been previously reported following other protective manipulations such as
stem cells infusion or ischemic preconditioning, where the observed protective effects were
associated to a decrease of ameboid CD1 lb/CD6 8  positive cells and to a decrease of CD6 8
expression (Longhi et al. 2011; Zanier et al. 2011).
The expression of CD45 was then assessed by a differential count of microglial CD45low+ 
cells and leukocyte-like round-shaped CD45hlgh+ cells (Gesuete et al. 2009). The frequency 
of CD45low+ cells was not different between cx3crl'l+ and cx3crl'A mice, indicating that the 
absence of CX3CR1 did not alter the number of microglia cells present in the ischemic 
areas, possibly due to the absence of displacement. Leukocyte-like CD45h,gh+ cells were 
instead significantly more numerous in cx3crl~,~ mice in line with an increased recruitment 
from blood. This picture may be different at longer time points when recruitment of 
CX3CR1-dependent pathway monocytes takes place (Nahrendorf et al. 2007). Indeed a 
reduced infiltration of immune cells in ischemic brains of cx3crT'~ mice has been reported 
3 days after injury (Denes et al. 2008). Overall these observations suggest that immune cell 
infiltration is somehow anticipated in cx3crl~l~ mice and perhaps occurs over a narrower 
time window compared to cx3crf/+ mice, the latter being also exposed to the late wave of 
CX3CR1-dependent pathway monocyte infiltration. At 24h after tMCAo, in the absence of 
CX3CR1, the increased/anticipated infiltration of CD45hlgh cells could be associated to an 
alternative M2 polarization of M/M. Indeed infiltrated leukocytes, among which are 
polarized T-cells (Thl, Th2 and Tregs) have been documented to be key orchestrators of 
M/M polarized activation (Biswas and Mantovani 2010; Sica and Mantovani 2012) with 
the ability to drive a protective phenotype (Butovsky et al. 2007). I observed an increase of
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Yml expression in cx3crl''~ mice but not that of the other M2 marker CD206 indicating
that M2 polarization in vivo may show multiple M/M phenotypes (Perego et al. 2011; Sica
and Mantovani 2012). Interestingly the upregulation of protective Yml marker is
paralleled by significant decrease of the expression of the marker of toxic Ml polarization
iNOS. This observation may indicate that CX3CR1 deficency leads to different M1/M2
balance in the ischemic territory, and, in particular, that M/M switch towards the M2
protective polarization is enhanced and favoured.
5.5 Conclusions
Overall the results obtained in the present study, together with the literature data allow to 
propose a different role for fractalkine and its receptor in the control of microglia in 
different circumstances. Under physiological conditions in mice defective for CX3CR1, 
the suppressive function of fractalkine is prevented and this determines a chronic activation 
state of microglia displaying a highly ramified morphology (present study). This state has 
been associated to decreased hippocampal neurogenesis and cognitive deficits (Bachstetter 
et al. 2011; Rogers et al. 2011; Tremblay et al. 2011). Early after acute injury, chronically 
activated microglia enhance the ramified morphology, downregulate the phagocytic 
activity and acquire protective features typical of the M2 polarization that result in 
decreased susceptibility to the ischemic injury (present study). This response may be 
transient, and, as evidenced above, at longer times other events may take place 
dramatically changing the impact of CX3CR1 deficiency. Among these, recruitment of 
macrophages belonging to the CX3CR1-dependent pathway (non classical monocyte 
subset) has been associated with beneficial effects as this population is capable of tissue 
healing (Nahrendorf et al. 2007). CX3CR1 deficiency would impair the recruitment of this
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protective population thus resulting in a detrimental phenotype, as strongly supported by 
the wide literature on cx3crl'f' mice in chronic CNS diseases (Prinz and Priller 2010).
Thus blocking the fractalkine:CX3CRl pathway inhibits the detrimental activity of 
microglia and enhances/anticipates their protective functions early after ischemia. 
Inhibition of this pathway at later times, preventing fractalkine physiological control of 
microglia activation may result in a toxic phenotype.
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6. TEMPORAL PATTERN OF EXPRESSION AND COLOCALIZATION OF 
MICROGLIA/MACROPHAGE MARKERS
6.1 Background
Microglia, the major cellular contributors to post-injury inflammation, have the potential to 
act as markers of disease onset and progression and to contribute to neurological outcome 
of acute brain injury. After acute brain injury, these resident cells are rapidly activated and 
undergo dramatic morphological and phenotypic changes (Davalos et al. 2005; Iadecola 
and Anrather 2011; Yenari et al. 2010). Microglial response is associated to recruitment of 
blood-born macrophages which migrate into the injured brain parenchyma (Jin et al. 2010; 
Schilling et al. 2005). This process is accompanied by expression of novel surface antigens 
and production of mediators that build up and maintain the inflammatory response of the 
brain tissue. Activated microglia and recruited macrophages (which are antigenically not 
distinguishable, henceforth referred to as M/M), can affect neuronal function and promote 
either neurotoxicity or neuroprotection.
Studies addressing phenotypic changes occurring in macrophages in peripheral 
inflammation and immunity have shown that these cells can undergo different forms of 
polarized activation. One is the classic or Ml activation, characterized by high capacity to 
present antigen, high production of NO and ROS and of proinflammatory cytokines. Ml 
cells act as potent effectors that kill micro-organisms and tumor cells, drive the 
inflammatory response and may mediate detrimental effects on neural cells. The second 
phenotype (M2) is an alternative apparently beneficial activation state, more related to a 
fine tuning of inflammation, scavaging of debris, promotion of angiogenesis, tissue 
remodeling and repair. Specific environmental signals are able to induce these different
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polarization states (Porta et al. 2009). A similar possibility has been also recently raised for 
microglia, by showing that these cells, under certain conditions, can indeed be pushed to 
both extremes of the Ml and M2 differentiation spectrum (David and Kroner 2011; 
Michelucci et al. 2009). More studies are needed to substantiate these observations.
In this frame, this part of study aims at getting insight on previously unexplored aspects of 
microglia phenotype changes induced by cerebral ischemia, namely, the presence of 
specific phenotype markers, their temporal expression, whether or not they are 
concomitantly expressed by the same subpopulation, whether they are expressed at distinct 
phases or locations in relation to the ischemic lesion. I focused on a few molecules that are 
known to be expressed by macrophages in peripheral inflammation and that have been 
associated to different functions. They include: CD lib , a marker of M/M 
activation/recruitment, CD45 expressed on all nucleated hematopoietic cells (Penninger et 
al. 2001), CD68 a marker of active phagocytosis, Yml a secretory protein that binds 
heparin and heparin sulphate, CD206 a C-type lectin carbohydrate binding protein, both of 
them expressed by alternatively activated macrophages and associated to recovery and 
function restoration (Bhatia et al. 2011; Raes et al. 2002) and iNOS, a cytokine-inducible 
nitric oxide synthase that has been associated with classical activated macrophages (David 
and Kroner 2011).
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6.2 Specific methods in this chapter
6.2.1 Experimental plan
Experiments were conducted according to the plan detailed in Figure 6.1 A.
6.2.2 Slice selection and quantitative analysis
The coronal sections used for marker quantification in ischemic areas were: +1.54, +0.50 
and -  0.94 mm from bregma, 24 fields at 20x or 33 fields at 40x magnification. The first 
row of fields at 40x was positioned at the lesion edge, spacing each field by 572.5pm 
(distance between centres of the fields). Further rows of fields were positioned distanced 
by 389.3pm each. 20x magnification fields were separated by 572.5pm (distance between 
centres of fields), while distance between each row was 389.3pm.
Field selection was performed using a BX61 Olympus microscope equipped with a 
motorized stage acquiring the same focal plan throughout the samples (Donnelly et al. 
2009; Perego et al. 2011). Positioning of the frames is detailed in Fig. 6.1 B.
Quantifications were performed using ImageJ software (http://rsbweb.nih.gov/ij/) and 
expressed as positive pixels/total assessed pixels (staining percentage area), or cells/mm 
(cell density) for subsequent statistical analysis (Perego et al. 2011).
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Figure 6.1 Experimental plan, selection o f  slices and tissue sampling fo r  neuronal counts, TUNEL and  
quantification o f  immunostained area.
Mice subjected to pMCAo or sham surgery were sacrified at the indicated time points for assessment o f  
ischemic volume, neuronal count, TUNEL and quantitative immunohistology (A). Fields for neuronal counts, 
TUNEL evaluation and quantification o f  stained area were positioned within the ischemic territory at defined 
distances (B, see methods for details). The regions sampled pertained to the ischemic territory (B, yellow) at 
the time points considered (6h, 12h, 24h, 48h and 7d).
6.2.3 Neuronal Count
Cresyl Violet stained brain sections were used for neuronal count. Thirty-three fields at 
40x were analyzed for each mouse. The amount of neuronal loss was calculated by pooling 
the number of stained neurons in the three ipsilateral sections and expressed as percentage
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of those in sham- operated animals. Fields were analyzed using ImageJ software 
(http://rsbweb.nih.gov/ij/) and segmentation was used to discriminate neurons from glia on 
the basis of cell size.
6.2.4 TUNEL staining
To assess the presence of injured cells showing DNA damage, terminal deoxynucleotidyl 
transferaseYmediated dUTP nick end labeling (TUNEL) staining was performed on 20-pm 
sections by in situ cell death detection kit (Roche, Mannheim, Germany) according to the 
manufacturer instructions, as previously described (Ortolano et al. 2009a). DNase-treated 
sections were used as a positive control. After staining, the sections were visualized using 
fluorescent microscopy (Olympus 1X70 Olympus Tokyo, Japan). Images of the area of 
interest were acquired using AnalySIS software (Olympus, Tokyo, Japan). For each mouse 
twenty-four fields at 20x were analyzed. TUNEL-positive cells were counted using ImageJ 
software (http://rsbweb.nih.gov/ij/) and expressed as number per mm2 for subsequent 
statistical analysis (Longhi et al. 2011).
6.2.5 Three-dimensional renderings of immunofluorescent stainings
Images from confocal microscope were managed by Imaris software (Bitplane, 
Switzerland) and processed. Briefly, image files were uploaded with the surpass mode on 
software. A color channel was selected and a color threshold applied so to specifically 
remove background noise signal. Isosurfaces were then created by using same threshold in 
the algorhitm for creating surfaces. Algorhitm was applied for each color channel. 
Resulting isosurfaces were merged and rotated on the screen so to choose the right 
orientation prior to export snapshot images.
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6.3.1 Comparison of microglia distribution after transient or permanent ischemia
The degree of reperfusion in the clinical setting is highly variable (Caplan et al. 2011; Lo 
2008b), and thus pre-clinical research should consider the use of both transient and 
permanent models of brain ischemia. In vivo imaging studies of microglia reported in the 
result section 5 refer to a transient model of ischemia (tMCAo). In this and in the following 
section (number 7), in addition to tMCAo, I will also use a model of permanent ischemia, 
achieved by the permanent occlusion of the MCA (pMCAo) through electrocoagulation 
(see methods 3.3.3).
Cx3crlGFPI+ mice were subjected to tMCAo or pMCAo and compared for distribution of 
microglial cells at 24h after injury, exploiting the native GFP emission. Interestingly, the 
presence/absence of reperfusion had a huge effect on GFP+ microglia distribution in 
relation to the lesion (Fig. 6.2). After tMCAo, microglia in the ischemic area, that include 
both striatum and cortex (dashed red line in Fig. 6.2 A), mostly survived and activated as 
suggested by their hypertrophism in both areas (Fig. 6.2 B, C) compared with the contra­
lateral side (Fig. 6.2 D). After pMCAo, instead, GFP+ microglia almost completely 
disappeared in the ischemic area, which is located in cortex (dashed red line in Fig. 6.2 E), 
where only sparse residual fluorescent signal could be detected (Fig. 6.2 F). At the borders 
of the lesion area, microglia were still present and showed the hypetrophic shape (Fig. 6.2 
G), differently from the highly ramified microglia visualized in the contra-lateral side (Fig.
6.2 H). Overall, these results confirm that microglia need residual or quickly re-established 
blood flow to become activated (Masuda et al. 2011) after sensing an injury, and indicate 
that the prolonged absence of blood supply leads to microglia cell death within 24h.
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The ischemic area of pMCAo mice is rapidly replenished by immune cells positive to 
CD lib , most of which are negative to GFP (Fig. 6.2 I) and may be recruited from the 
periphery (see section 5.3.2). Resident microglia (GFP+/CDllb+) seem to settle 
preferentially around the lesion (Fig. 6.2 J) and only few cells can survive and activate 
within the core area. To study both resident and recruited CD llb after pMCAo, I chose to 
perform post mortem imaging at different time points and analyze microglia/macrophage 
phenotype on the basis of temporal and topological distance from the injured area.
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Figure 6.2 Distribution o f  GFP+ microglia in transient (tMCAo) or permanent (pMCAo) ischemia.
A: microglia are distribuited in all ischemic areas (dashed red line, traced according to cresyl violet staining 
o f  adjacent slice) 24h after tMCAo. Microglia are hypertrophic in both cortex (B) and striatum (C), whilst 
they are high ramified with thin branches in contra-lateral side (D).
E: microglia are almost not present in the ischemic area (dashed red line, traced according to cresyl violet 
staining o f  adjacent slice and F) 24h after pMCAo. At the border o f  the lesion microglia show hypertrophic 
morphology (G), whilst they are high ramified with thin branches in contra-lateral side (H). The ischemic
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area in E is replenished by many GFP-/CDllb+ cells (I); GFP+/CDllb+ resident microglia are mainly 
located at the borders o f  the lesion (J). Scale bars in A,E=lmm, scale bar in B-D, F-H=20jim.
6.3.2 Histopathological findings at different time points from pMCAO
Histological analysis were performed according to the experimental plan shown in figure
6.1 A and by sampling the ischemic area as shown in figure 6.1 B. We specifically 
quantified lesion progression on the basis of ischemic volume assessment, viable neuronal 
count and apoptotic cell count. We measured the expression of selected M/M markers 
(CDllb, CD68, CD45, CD206 and Yml) by quantification of immunostained area or 
positive cell density. These measures have been performed at different time points after 
pMCAo, namely at 6h, 12h, 24h, 48h and 7d.
pMCAO induced an infarcted area in the ipsilateral cortex (Fig. 6.3 A) as expected 
(Gesuete et al. 2009; Storini et al. 2006). The lesion, evaluated as relative paleness of 
cresyl violet staining and corrected for edema, at 6h, 12h, 24h, 48h and 7d, had a volume 
of 12.5mm3±5.8, 12.4mm3±5.7, 23.8mm3±5.1, 22.1mms±3.3 and 9.6mm3±4.7, respectively 
(Fig. 6.3 B).
Cortex, the brain area involved in the ischemic lesion was considered for neuronal count 
(Fig. 6.3 C). Six hours after ischemia, neuronal count performed in the ipsilateral cortex 
revealed a significant cell loss when compared to the corresponding area in the sham- 
operated group (84.9%). Neuronal counts progressively but slowly decreased reaching 
64.9% at 7d. No significant difference was found between ispilateral and contralateral side 
in sham-operated animals (data not shown).
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At 6h after pMCAO rare TUNEL-positive cells were present in the injuried cortex
•  2indicating the presence of few dying cells (30.2±14.2, expressed as cell density per mm , 
Fig. 6.3 D). Number of dying cells progressively increased at 12, 24 and 48h post ischemia 
(278.6±51.1, 589.7±77.3 and 708.8±30.2, respectively). Seven days after ischemia still 
several TUNEL-positive cells were present (343.6±120.0) indicating the persistence of 
dying cells at this time point. Positive TUNEL staining was not apparent in any sham- 
operated mice at any time points.
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Figure 6.3 Histopathological findings at different time points from  pMCAO.
A: representative brain coronal sections obtained 24h after pMCAO. Pale demarcated areas depict the 
ischemic lesion. Quantification o f ischemic volume (B), neuronal counts (data obtained from the mean o f  33 
frames/mouse and expressed as % o f sham groups, C) and TUNEL-positive cells (D) in the cortex o f  sham 
and ischemic mice at different times after pMCAO. Data are reported as mean+sd, n=8. *p<0.05,**p<0.01, 
***p<0.001 versus sham; °p<0.05, oop<0.01, ooop<0.001 versus 6h, Bonferroni's Multiple Comparison Test.
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6.3.3 Time-course of expression of M/M markers: CDllb, CD45, CD68, Yml, CD206 
and iNOS
The M/M marker expression was analyzed within the ischemic area based on the tissue 
sampling represented in Fig. 6.1 B. At each time point, the sampled cortical area pertained 
to the ischemic territory, being the number of neurons in this region decreased compared to 
sham animals at every time points (Fig. 6.3 C).
CDllb, a constitutive marker of microglia and macrophages was expressed at every time 
point considered as well as in sham-operated mice (5.6±1.9, percent of stained area). 
Starting from 6h the immunoreactivity increased and remained elevated at every 
subsequent time point considered, with no major differences throughout the experimental 
groups (9.5±1.5, 11.7±1.6, 10.1±1.7, 13.1±2.8, 13.0±0.1, respectively at 6h, 12h, 24h, 48h 
and 7d, Fig. 6.4 B).
Outside the lesion, CDllb staining revealed thin ramifications and small soma (Fig. 6.4 
A/C). CD llb immunoreactivity was associated with a different morphology in relation to 
the cell localization in the lesioned area. Two main areas were identified, namely a lesion 
border showing CDllb+ highly ramified cells (Fig. 6.4 A,D) and an ischemic core 
showing both CD1 lb+ ameboid cells and cells with hypertrophic soma endowed with thick 
branches (Fig. 6.4 A,E).
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Figure 6.4 Immunohistochemical analysis and quantification o f  the microglial marker C D llb .
A: representative micrographs o f C D llb  immunostaining in the injured cortex at 24hours after pMCAo. 
CD lib-positive cells display different morphology depending on their localization in the ischemic area (C: 
outside the lesion, D: border zone, E: ischemic core). B: quantification o f  CD1 lb  immunostaining at different 
times after pMCAo. Data are expressed as mean+sd o f  33 frames/mouse, n=8. One way Anova: pO.OOOl. 
**p<0.01 vs sham; Bonferroni’s Multiple Comparison Test. Scale bars=10pm.
No CD45-positive cells (CD45hlgh cells, see methods, Fig. 6.5 A) could be observed in 
sham-operated mice and in the contralateral hemisphere of ischemic mice. Six hours after 
ischemia these cells were clearly visible in the area considered (0.4±0.2 percent of stained 
area). The immunoreactivity was further increased 12 and 24h after ischemia (0.6±0.2 and 
1.1±0.3, respectively). No further increase could be observed at 48h (1.1±0.4). CD45 
staining was still present at 7d (0.9±0.4, Fig. 6.5 A).
CD68 immunoreactivity was undetectable in sham-operated mice and appeared 6h after 
ischemia (0.3±0.2 percent of stained area). It progressively increased at every time point
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considered (0.6±0.2 at 12h; 1.7±0.2 at 24h; 3.7±0.8 at 48h). Notably, further increase in the 
CD68 stained area could be observed at 7d (7.4±1.4, Fig. 6.5 B).
Yml immunoreactivity was detectable starting from 12h (0.04±0.02 percent of stained 
area). This marker was maximally expressed at 24h (0.84±0.16) and markedly decreased at 
later time points (0.37±0.10 at 48h and 0.23±0.15 at 7d, Fig. 6.5 C).
CD206 positive cells were present in sham-operated mice (7.3±0.9 cell/mm2). They could 
be observed 6h after pMCAO (12.2±6.2) and significantly increased progressively up to 
24h (23.6±5.3 at 12h and 40.0±14.9 at 24h). A significant number of CD206 positive cells 
was still present at 48h (30.5±10.5) and 7d (32.7±8.8, Fig. 6.5 D).
iNOS positive cells were present starting from 6h after pMCAo (194.3±41.4 cells/mm2). 
At 12h their number did not change significantly (191.5±124.8), while started to increase 
at 24h 273.4± 107.1) and reached a peak at 48h (528.2± 149.1). At 7d their number was 
reduced to the lowest value measured (105.2±99.9, Fig. 6.5 E).
161
temporal pattern o f  expression and colocalization o f  M/M  markers
1.0.
s  «■o
o .o .
B
1.5.
<o£
1.0.TOC
0.0-
n 800-
10.
1 * 
f :
I
• *  '*
r 3^
X
I
D
E 60.
w
75o 40.4>
?(Oo
CM
O 20. O
« _o
£wc<ua
Figure 6.5 Immunohistochemical analysis and quantification o f  the microglial markers CD45, CD68, Yml, 
CD206 and iNOS.
Representative micrographs o f  CD45 (A), CD68 (B), Y m l (C), CD206 (D) and iNOS (E) immunoreactivity 
at 24hours after ischemia, and related quantifications at different times after pMCAO (Bar 10pm). Data are 
expressed as mean+sd o f  33 frames/mouse (24 frames/mouse for CD45, TUNEL, CD206), n=8. One way 
Anova: p<0.0001. *p<0.05, **p<0.01 vs sham; oop<0.01, ooop<0.001 vs 6h (12h for Y m l). Bonferroni’s 
Multiple Comparison Test.
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6.3.4 Localization of M/M markers with respect to the lesion
Twenty-four hours after pMCAO, the immunoreactivity for CD llb appeared to be evenly 
distributed in the ischemic area, being present both in the lesion border and in the ischemic 
core (Fig. 6.6). At the same time CD45 staining showed a similar distribution being present 
throughout the entire ischemic area (Fig. 6.6). CD45 cells visible at lOx magnification 
(Fig. 6.6) did not reveal the presence of CD45low cells (corresponding to ramified 
microglia) appearing in the CDllb staining microphotograph. Conversely CD68 appeared 
to be mainly concentrated in the border zone, with rare cells present in the ischemic core. 
Notably, at longer time points (7d) along with the great increase of its expression (Fig. 6.5 
B), CD68 appears both in the border and in the core areas (Fig. 6.10). Yml at 24h after 
pMCAO appeared exclusively expressed in the ischemic core, similarly to CD206 (Fig. 
6.6). With the exception of CD68, all the markers considered showed a similar distribution 
at every time point (data not shown).
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Figure 6.6 Distribution o f  the selected M /M  markers inside the ischemic lesion at 24h from  the injury. 
Representative immunostaining micrographs show spatial distribution o f  M/M phenotype markers (C D llb , 
CD45, CD68, Y m l, CD206 and iNOS) into the ischemic area at 24h after ischemia. Bar=250p.m. Drawings 
representing the immunostaining data. Only immunoreactivity for C D llb  could be observed outside the 
lesioned area in basal conditions (sham-operated mice). In the lesion, C D llb +  cells showing a ramified to 
globular morphology could be observed going from the border zone to the ischemic core (red). CD45 
staining was present throughout the entire ischemic area (pink). Conversely CD68 appeared to be strongly 
concentrated in the border zone. Y m l, CD206 and iNOS were exclusively expressed in the ischemic core.
6.3.5 Coexpression of M/M markers at 24h and 7d after pMCAO
Twenty-four hours after ischemia CD68 was expressed in hypertrophic ameboid CD llb 
cells present in the ischemic core and in ramified microglia in the border zone where CD68 
positive cells were mostly located (Fig. 6.6 and 6.7 A-B). A similar pattern of coexpression 
could be observed at 7d. At this time point the expression of CD68 was greatly increased 
both in globular CDllb+ cells in the ischemic core and in ramified CD llb cells laying in 
the border zone (Fig. 6.6 and Fig. 6.7 C-D).
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Figure 6.7 Coexpression o f  C D llb  (red) and CD68 (green) 24h (A-B) and 7d (C-D) after pMCAO.
In the ischemic core at 24h CDl lb  positive cells are prevalently globular and some o f  them are positive to 
CD68 (A). In the border zone (B) CDl lb  cells display rounded cell bodies and ramified processes positive to 
CD68. Globular CDl lb  cells in the lesioned area 7d after ischemia mostly express CD68 marker (C). A high 
number o f CDl lb  cells displaying different morphology colabel with CD68 in the border zone (D). Data are 
representative o f 3 independent experiments. Bars: 20pm.
At 24h after pMCAO Yml positive cells co-labeled with C D l l b  globular cells within the 
ischemic core, where they were exclusively located (Fig. 6.6 and Fig. 6.8 A-B-E-F). Seven 
days after ischemia Yml and CDl lb coexpression pattern was similar to that observed at 
24h (Fig. 6.8 C-D-G-H).
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Figure 6.8 Coexpression o f  C D llb  (red) and Yml (green) at 24h (A-B-E-F) and 7d (C-D-G-H) after 
pMCAO.
Yml positive cells co-label with globular CDl I b postive cells at both time points (A,C). High magnifications 
(E-G) and 3D rendering (F-H) show colabeling o f markers further highlighting the coexpression (blu=nuclei, 
bar: 5pm). Consistent with the observation that no Yml cells are present in the border zone (fig. 6.6), no 
immunostaining for Yml at neither time points could be observed in this area (B, D). Data are representative 
o f 3 independent experiments. Bars: 20pm.
CD206 at 24h was present exclusively in the ischemic core (Fig. 6.6) where it colocalized 
with globular C D l l b  positive cells (Fig. 6.9 A-B-E-F). The same pattern of coexpression 
was observed at 7d (Fig. 6.9 C-D-G-H).
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Figure 6.9 Coexpression o f  C D llb  (red) and CD206 (green) at 24h (A-B-E-F) and 7d (C-D-G-H) after 
pMCAO.
At 24 h after ischemia some globular C D llb  cells co-label with CD206 marker in the ischemic core (A). 
Seven days after ischemia C D llb  cells are prevalently globular in the ischemic core and are highly positive 
to CD206 (C). High magnifications (E-G) and 3D rendering (F-H) show colabeling o f  markers further 
highlighting the coexpression (blu=nuclei, bar: 5pm). Consistent with the observation that no CD206 cells 
are present in the border zone (fig. 6.6), no immunostaining for this marker at neither time points could be 
observed in this area (B, D). Data are representative o f  3 independent experiments. Bars: 20pm
At 24h after pMCAO, the few CD68+ cells found in the ischemic core did not colocalize 
with Yml+ cells that were present exclusively in this area (Fig. 6.6 and Fig. 6.10 A-B). In 
the magnification of Fig. 6.10 E-F it is possible to observe that even when these markers
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appear closely related, they actually belong to distinct cells. At longer times (7d) Yml cells
not colocalizing with CD68 are still present, however coexpression with CD68 can also be
seen (Fig. 6.10 C-D-G-H).
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Figure 6.10 Coexpression o f  CD68 (red) and Yml (green) at 24h (A-B-E-F) and 7d (C-D-G-H) after 
pMCAO.
At 24h CD68 positive cells found in the ischemic core do not co-localize with Ym l positive cells (A). In 
high magnifications panels (E-F) the two markers appear to belong to different cells although in close contact 
(blu=nuclei). Seven days after ischemia, when CD68 immunoreactivity is greately increased, Y m l appears to 
be expressed also, but not exclusively in CD68 positive cells (C). Note the presence o f  one Y m l positive 
cells (arrow) that does not co-localize with CD68. High magnifications (G) and 3D rendering (H) show 
colabeling o f  markers further highlighting the coexpression (blu=nuclei). Consistent with the observation that 
no Y m l cells are present in the border zone (fig. 6.6), no immunoreactivity for this marker could be observed 
at either time points in that area (B, D). Data are representative o f  3 independent experiments. Bars: 20pm. 
High magnifications and 3D rendering bar: 5pm.
CD68
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A small fraction of CD206 positive cells show coexpression with CD68 at 24h after
ischemia in the ischemic core (Fig. 6.11 A-E-F). Similar situation is observed at 7d after
pMCAO when a dramatic increase in CD68 positive cells is apparent in the ischemic core
(Fig. 6.11 C-G-H). CD206 marker is not present in the border zone at both time points
(Fig. 6.11 B-D).
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Figure 6.11 Coexpression o f  CD68 (red) and CD206 (green) at 24h (A-B-E-F) and 7d (C-D-G-H) after 
pMCAO.
At 24h and 7d after ischemia, a minor part o f  CD68 positive cells found in the ischemic core colocalize with 
CD206 (A, C). High magnification (E-G) and 3D rendering (F-H) show both single- and double-positive 
cells in the ischemic core (blu=nuclei, bar: 5pm). Consistent with the observation that no CD206 cells are 
present in the border zone (fig. 6.6), no immunoreactivity for this marker could be observed at neither time 
points in that area (B, D). Data are representative o f  3 independent experiments. Bars: 20pm.
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Yml and CD206 appeared to be coexpressed in the ischemic core both at 24h (Fig. 6.12 A- 
C-D) and 7d (Fig. 6.12 B-E-F) after pMCAO. None of the two markers was present in the 
border zone at both time points considered (Fig. 6.6).
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Figure 6.12 Coexpression o f  Yml (red) and CD206 (green) at 24h (A-C-D) and 7d (B-E-F) after pMCAO.
At 24h and 7d after ischemia Ym l positive cells co-label with CD206 positive cells in the ischemic core (A- 
B) Bars: 20pm. High magnification (C-E) and 3D rendering (D-F) show coexpression o f  markers with the 
same cell nucleus (blu). Bar: 5pm. Consistent with the observation that neither Ym l cells nor CD206 cells 
are present in the border zone (fig. 6.6) no immunostaining for these markers could be observed at neither 
time pointsi in this area (data not shown). Data are representative o f  3 independent experiments.
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As expected all CDl lb  globular, CD68 globular, Yml and CD206 positive cells were all 
positive for CD45hlgh in both ischemic core and border zone (data not shown), being CD45 
a common marker for immune cell populations (Sedgwick et al. 1991; Stein et al. 2007).
A summary of M/M markers coexpression 24h and 7d after the ischemic lesion is reported 
in Fig. 6.13.
CD68CD68
CD206
Figure 6.13 Summary o f  M/M markers coexpression 24h and 7d after the ischemic lesion.
At 24h after injury (A) immunoreactivity for CDl 1, which is readly increased after ischemia, is expressed in 
ramified and globular cells. CD68 is present in a percentage o f both globular and ramified C D llb +  cells. 
Yml and CD206 that are present mostly in the core o f the lesion, are expressed by a fraction o f globular 
CDl lb+  cells and can present on the same cells. A few cells coexpressing CD206 and CD68 can be found in 
the area between the core and the border zone where the two markers are mainly located respectively. At 7d 
after injury (B) Yml decreases while CD68 expression greatly increases and from the border zone where it 
was at earlier times it invades the ischemic core (see also data in Fig. 6.3). A few CD68+ cells appear now to 
express Y m l.
Lastly, to provide additional details on the functional status of M/M, we assessed their
relationship with neurons (NeuN+). We analyzed CD llb/CD68 and CDl lb /Yml  double
positive cells as these populations showed to increase at different time points, thus
suggesting distinct functional states. C D l l b  stain of M/M membranes was chosen for
documenting the morphology of M/M when contacting neurons. Neurons were found to be
often enwrapped by CDl lb positive cells in both ischemic core and border zone at both
24h and 7d (Fig. 6.14). In most cases CDl lb cells surrounding neurons were positive for
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CD68 at both zones (Fig. 6.14 A-B-C-D), suggesting an active phagocytosis. None of the 
CD1 lb/Yml double positive cells at 24h appeared to be engaging a phagocytic interaction 
,with neurons, being these cells never in contact with NeuN positive cells (Fig. 6.14 E). At 
7d, a few CD1 lb/Yml double positive cells showed a phagocytic appearance enveloping 
neurons (Fig. 6.14 G), coherently with their partially CD68 positive phenotype at this time 
point (Fig. 6.10). In the border zone, at both time points, Yml was not detectable and only 
single CD1 lb positive cells did envelop neurons (Fig. 6.14 F-H).
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Figure 6.14 Coexpression o f  C D llb  (red) and NeuN (blue) with CD68 (green) at 24h (A-A ’-B -B ) and 7d 
(C -C ’-D -D ) or with Yml at 24h (E -E ’-F -F ) and 7d (G -G ’-H -H ) after pMCAO.
In the ischemic core C D llb/C D 68 double positive cells envelop NeuN positive cells, possibly indicating 
phagocytosis o f neurons (A; 3D rendering in A’). The same interaction was observed in the border zone (B- 
B’). At 7d after ischemia, when CD68 expression is enhanced (Fig. 6.5) in both ischemic core and border 
zone, C D llb/C D 68 double positive cells enwrap neurons, suggesting active phagocytosis also at this time 
point (C-C’-D-D’). At 24h after pMCAO in the ischemic core, where Ym l positive cells are exclusively 
located, CD1 lb/Y m l double positive cells do not appear involved in a phagocytic interaction with neurons 
(NeuN positive cells, E; 3D rendering on E ’). C D llb  single positive cells in both ischemic core (E-E’) and 
border zone (where Ym l is not expressed, F-F’) surround neurons. At 7d after ischemia part o f  CD1 lb /Y m l 
double positive cells engage a phagocytic appearance by enveloping neurons in ischemic core (G-G’) 
coherently with their partially CD68 positive phenotype at this time point (Fig. 6.10). In the border zone at 7d 
(Yml is absent) C D llb  single positive cells still enwrap neurons (H-IT). Data are representative o f  3 
independent experiments. Bar: 20pm.
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This part of the project shows that the ischemic lesion is accompanied by activation of 
specific M/M phenotype that presents distinctive spatial and temporal features. I have 
demonstrated that: 1) the ischemic lesion induces the expression of the selected M/M 
markers that develop over time, each with a specific pattern; 2) the selected markers are 
associated with globular or ramified CD llb morphology, 3) each marker has a given 
localization in the lesioned area with no apparent major changes during time, with the 
exception of CD68, 4) M2 polarized cells have a peak at 24h after injury, while Ml cells 
peak at 48h.
We have firstly determined the histopathological features of the lesion induced by 
pMCAO. From the analysis of the temporal evolution of the lesion it appears that the 
percentage of neuronal loss is somehow stable from 24h up to 7d although the persistence 
of TUNEL-positive cells at this late point indicates that some cells may still be in 
degeneration at that late time. It should be noted that assessing the lesion volume by the 
paleness of the cresyl violet staining may lead to misleading conclusions since, as detailed 
below, invading inflammatory cells may contribute to the apparent reduction of the 
lesioned area at 7d. Actually the quantification of the CD llb and CD45hlgh 
immunoreactivity indicates that inflammatory cells rapidly increase in number and/or size 
early after the injury and at every time point considered.
M/M play a pivotal role in surveillance and response to altered CNS conditions (Davalos et 
al. 2005; Jin et al. 2010; Yenari et al. 2010). An emerging concept is that, similarly to what 
happens for peripheral macrophages, these cells can exert different antithetic functions 
depending on environmental signals, acting as major players in the pro-inflammatory 
cytotoxic response, but also participating in the immunosuppressive and self-repair 
processes (Block et al. 2007; Colton 2009; Lambertsen et al. 2009). The phenotype
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markers considered here include classical markers of M/M activation (CDllb and CD45) 
and markers expressed by alternatively activated macrophages (CD68, Yml and CD206). 
Although evidence of M2 activation state in the brain has been reported in M/M in AD 
models (Reed-Geaghan et al. 2010; Shin et al. 2011), following global ischemia (Ohtaki et 
al. 2008), in models of experimental autoimmune encephalomyelitis (Ponomarev et al. 
2007) or spinal cord injury (David and Kroner 2011; Kigerl et al. 2009), information on 
M2 marker expression, coexpression and temporal evolution in the injuried brain is 
lacking. We could observe that these phenotype markers are exclusively expressed by 
CD llb cells and that each of them shows distinct features in terms of time course of 
activation and localization in relation to the ischemic lesion.
CD llb is expressed on the surface of many leukocytes and is a widely used marker of 
M/M. It belongs to a family of cell surface receptors known as integrins. It is covalently 
bound to a beta 2 subunit to form integrin oiMp2 (Mac-1, CD 1 lb/CD 18) which is 
implicated in diverse responses including cell-mediated killing, phagocytosis, chemotaxis 
and cellular activation. CD1 lb has the ability to recognize a wide series of ligands such as 
fibrinogen, iC3b fragment of the third complement component, ICAM-1, denaturated 
products, blood coagulation factor X (Solovjov et al. 2005). My data show that CD llb 
staining increases at early time points after ischemia, rapidly reaching a plateau of 
activation. Notably, CDllb positive cells display a different morphology in relation to the 
lesion, namely they are ramified in the border zone and ameboid in the ischemic core. 
Similarly to CDllb, also CD45hlgh cells increase rapidly after ischemia. These cells, 
display a rounded morphology and most probably correspond to recruited macrophages, 
neutrophils and lymphocytes (Gelderblom et al. 2009; Gesuete et al. 2009; Stein et al. 
2007). This study does not specifically address the question of differentiating between 
invading macrophages and resident microglia. An important future direction will be to 
identify specific molecular/phenotypical markers for these two cell populations, since there
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is evidence that they may play a different role in the progression of brain injury (Ajami et 
al. 2011; Lalancette-Hebert et al. 2007; Lambertsen et al. 2009).
CD68 or macrosialin is a member of the lysosomal/endosomal-associated membrane 
glycoprotein (LAMP) family and a member of the scavenger receptor family which 
recognizes a wide range of anionic macromolecules such as oxidatively modified 
lipoprotein, apoptotic cells and cell surface antigens of microorganisms. Its localization 
and predominance in phagocytic macrophages implicates CD68 in phagocytosis (De Beer 
et al. 2003; Ramprasad et al. 1996). We observed that the early increase in CD68 
immunoreactivity is concentrated in the border zone and expressed in ramified CD llb 
positive cells. At later time points a dramatic increase in CD68 expression appears both in 
the border zone and the ischemic core and is apparent in globular CD llb cells. At both 
time points and in both zones, CDllb/CD68 double positive cells appear to physically 
interact with neurons and show a phagocytic-like morphology characterized by neuron 
engulfment. The phagocytic activity of alternatively activated M/M is associated to 
clearance of cells debris, of damaged or dying cells and of infiltrating neutrophils thus 
resulting in the elimination of several potentially cytotoxic substances (Denes et al. 2007; 
Jayadev et al. 2011; Jin et al. 2010; Michelucci et al. 2009; Raes et al. 2002). However the 
overall functional meaning of phagocytosis in acute brain injury is still an open question. 
Actually the protective effect of manipulations such as stem cell infusion may be 
associated with a decrease in CD68 expression (Zanier et al. 2011).
Yml belongs to the lectin family and is constitutively expressed by liver, lung and bone 
marrow, consistently with the fact that these are the original sources of myeloid cells 
(Chang and Karin 2001). It is synthesized and secreted by activated macrophages during 
inflammation and exhibits a pH-dependent, specific activity towards GlcN oligomers and 
heparin. Yml may control leukocyte trafficking by competing with them for binding sites 
on local extracellular matrix, an action resulting in down-regulation of inflammation. Our
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findings show that, similarly to what reported in peripheral macrophages, Yml is activated 
transiently suggesting that it may be involved in the establishment of an inflammatory 
management control of the injured region (Chang and Karin 2001). Its expression is 
restricted to the ischemic core and it colocalizes with CD1 lb globular cells and with some 
CD 68 cells at later times only. None of the CD1 lb/Yml double positive cells is associated 
with phagocytosis of neurons at 24h, whilst at 7d some of them show a phagocytic 
appearance and envelop neurons, coherently with their partially CD68 positive phenotype 
at this time point. An increase in Yml expression has been associated to the beneficial 
effect of stem cell infusion in mice subjected to global ischemia (Ohtaki et al. 2008), in 
line with a protective role in acute brain injury.
Another marker of alternatively activated macrophages is CD206 or mannose receptor 
(Jayadev et al. 2011; Porcheray et al. 2005). This is an endocytic receptor that binds both 
microbial glycans and self glycoproteins carrying terminal mannose, fucose and N- 
acetylglucosamine by interaction with its carbohydrate recognition domains (CRDs). Its 
known function is related to recognition and endocytosis of the carbohydrate portion of 
antigens for processing and presentation (Linehan et al. 2005). My results show that 
CD206 expression significantly increases over time and colocalizes with Yml positive 
cells and with a fraction of CD68 positive cells that increase at later time points.
We then assessed the presence of iNOS, a well defined marker of the classical activation of 
M/M. iNOS is a cytokine-inducible nitric oxide synthase produced in M/M. iNOS is 
involved in the immune response upon binding to calmodulin and produces large amounts 
of NO that may have detrimental effects after ischemic injury. Its expression is induced as 
early as 6h after pMCAo and has a peak at 48h after injury, thus trailing the peak of 
expression of the M2 marker Yml (24h).
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Lastly, our data have been obtained in a model of permanent ischemia and may not be 
extended to an ischemia with reperfusion paradigm. Notably the present data and previous 
results obtianed in our lab (Gesuete et al. 2009) indicate that the ratio of CD45hlgh/CD45low 
is dramatically different in these two conditions, being much higher after pMCAO. This 
may be due to either a higher number of infiltrating cells and/or a lower survival of 
resident cells, thus indicating that in transient ischemia the composition of the specific 
M/M populations in the lesioned area is different.
6.5 Conclusions
In the ischemic lesion M/M express markers that show distinct temporal expression, 
distribution and association with a definite cell morphology suggesting that different M/M 
populations are acting at the site of injury according to well defined phenotype, time of 
activation and pattern of localization. Conceivably, at 24h after insult, ramified and 
phagocytic M/M surround the lesion, possibly acting as a barrier against further expansion 
of the lesion, whilst globular M/M committed to a protective phenotype {i.e. expressing 
Yml and CD206 or iNOS) populate the ischemic core with the primary function of 
resolving inflammation and promoting wound healing. Interestingly, the peak of Yml and 
CD206 expression is observable at 24h, whilst that of iNOS is shifted to 48h after injury. 
At later time points (7d) the phagocytic behavior of M/M becomes prevalent in the whole 
lesioned area with numerous globular phagocytic M/M invading the core territory. The 
observed switch towards the phagocytic phenotype is accompanied by the progressive 
reduction of the expression of the protective Yml.
At 24h protective Yml positive cells do not appear to be involved in neuron phagocytosis, 
differently from CD68 positive cells that show a close physical interaction with neurons.
179
temporal pattern o f  expression and colocalization o f  M /M  markers 
At 7d, when neuronal damage becomes irreversible in the core area, Yml positive cells 
decrease and start to show phagocytic behavior being partially co-localized with CD68. 
These cells now show the ability to envelop neurons in a phagocytic-like manner. Overall 
this effect suggests that endogenous protective mechanisms take place soon after injury 
(24h-48h) and last at least up to 7d when phagocytosis of neurons and debris removal are 
prevalent. Whether this effect is beneficial or detrimental cannot be clearly established. 
Phagocytosis (CD68 positive cells) can result in a protective function if properly balanced. 
In normal brain, phagocytic function of microglia have been suggested to support 
neurogenesis (Sierra et al. 2010). After an acute injury microglia are supposed to remove 
cellular parts, as well as whole cells (Kettenmann 2007), an action that might be necessary 
to remove irreversibly damaged cells to make space for new neuronal projections and fresh 
connections or newly generated neurons.
The different states of M/M in the ischemic lesion reflect the complexity of these cells and 
their ability to differentiate towards a multitude of phenotypes depending on the 
surrounding microenvironmental signals that can change over time. The inflammatory 
response that follows cerebral ischemia is regarded as a promising target for stroke 
therapy. The data presented in this study provide a basis for understanding this complex 
response and for developing strategies resulting in promotion of a protective inflammatory 
phenotype.
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7. IN  VIVO IMAGING OF T-CELLS IN THE ISCHEMIC BRAIN
7.1 Background
T lymphocytes have been recently revealed as potential therapeutic targets in brain 
ischemia. Mice deficient in lymphocytes have been shown to exhibit reduced infarct 
volume after tMCAo by an intraluminal filament (Hum et al. 2007; Yilmaz et al. 2006) and 
after pMCAO by electrocoagulation (Liesz et al. 2009). Infarct volume after tMCAo has 
also reportedly been reduced by the immunosuppressant FTY720, which blocks T-cell 
infiltration into the brain (Shichita et al. 2009). Despite the deleterious effect of T-cells on 
stroke, subpopulations of T-cells may be harnessed to reduce tissue damage. 
Neuroprotective mucosal immunization is mediated by inducible regulatory lymphocytes 
(Gee et al. 2008) and regulatory T-cells have indeed been shown to be protective against 
delayed infarct expansion after both pMCAO and transient middle cerebral artery 
occlusion (Liesz et al. 2009).
Over the last years, a few in vivo imaging systems to study T-cell dynamism become 
available and have been applied to models of CNS diseases. In particular, the introduction 
of 2-PM allowed high-resolution visualization of T-cells within a three-dimensional space 
over time. This technique can image the movements of single T-cells at depths of hundreds 
of microns into living tissue (Helmchen and Denk 2005) and could provide fundamental 
insight into how T cells and antigen-presenting cells access and behave within the ischemic 
brain. This technique provided new information on T-cell dynamism in superfused slices 
of ischemic brain ex vivo and detailed quantitative measurements of the movements of T- 
cells (Ortolano et al. 2010; Ortolano et al. 2009b; Rush et al. 2009; Zinselmeyer et al. 
2005). However, immune cell mobility and activation are drastically altered in brain slice
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cultures, where the vascular system is not preserved. 2-PM has recently been used to image 
T-cell behavior in vivo in the lower spinal cord in models of cerebral autoimmune disease 
(Bartholomaus et al. 2009; Fliigel et al. 2007; Smorodchenko et al. 2007). However, 
considering the difficulties in localizing the ischemic area of interest and that there are far 
fewer T cells extravasated in stroke compared with autoimmune disease, this in vivo 
approach has to date never been applied to image T-cells after stroke.
I here report real-time in vivo 2-PM imaging and quantitative tracking of endogenous T- 
cell dynamics in the brain after a focal cerebral ischemic insult using transgenic mice 
whose T-cells express green fluorescent protein (GFP). To study T cells in the pMCAO 
model, it was necessary to image in and near the territory of the middle cerebral artery. To 
avoid performing a craniotomy, which has been shown to have pathological effects (Xu et 
al. 2007b), I imaged through the thinned skull (Yang et al. 2010). The imaging was 
performed 72 hours after pMCAO, because the results of Jander (Jander et al. 1995) and 
Schroeter (Schroeter et al. 1994) and my preliminary data suggested that the population of 
infiltrated T-cells was near its peak at this time point.
7.2 Specific methods in this chapter
7.2.1 Experimental plan
Experiments were performed according to the plan shown in figure 7.1.
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Figure 7.1 Experimental plan.
Mice with GFP+ T-cells were subjected to pMCAo or sham surgery and subsequently, after 3d, to 
craniotomy and in vivo 2-PM. Mice were sacrified at the end o f  imaging for immunofluorescence.
7.2.2 Thinned skull craniotomy for two-photon imaging (Fumagalli et al. 2011)
At Strathclyde University, Glasgow, UK: Seventy two hours post-MCAO the blood was 
labeled by injecting a red fluorescent marker in a tail vein, rhodamine B isothiocyanate- 
dextran (RhITC-dextran, 70 kD, Sigma; 5% in PBS, 150 pL). The mice (n=6) were 
anesthetized with isofluorane in oxygen and its rectal temperature maintained at 36.2 - 
37°C by an electrically heated plate. The left parietal skull was exposed and dried, a point 
near 2.5 mm lateral, 1 mm posterior to the bregma was marked with a felt tip pen and the 
coordinates of the mark measured. A stainless steel plate 0.4 mm thick with a 5 mm hole 
was glued to the skull with its centre over the mark. Initial adhesion was with a 
cyanoacrylate glue (Vetbond, 3M); a two-component rapid epoxy glue was then used to fill 
gaps and allowed 15 min to harden. The plate was clamped between two supports on a 
base plate. Under a dissecting microscope the skull was thinned using a NSK Vmax 
Volvere dental drill (Wright Cottrell) with a diamond bur (Diama Labcraft). When the pial
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vasculature could be clearly seen, the mouse on its base plate was moved to the imaging 
microscope. Imaging was performed soon after the craniotomy was created.
7.2.3 Imaging of GFP+ T-cells
7.2.3.1 GFP signal detection
To image GFP-expressing T cells we used the longest available excitation wavelength, 940 
nm. The blood marker used (RhITC-dextran) absorbs more strongly at 830 nm than at 940 
nm, therefore in few cases the vasculature was imaged separately from the T cells. In tests, 
the image shifted laterally by at a maximum of 3.1 pm over 1 hour. When the vasculature 
and T cells were imaged separately, the imaging period was usually less than 30 min. 
Although a single snapshot of a T cell did not always establish with certainty that it was 
extravascular, time series of images that included several cells left no doubt that they were 
indeed extravascular.
7.2.3.2 Image acquisition and processing
To track extravascular T cells, time series of z-stacks were obtained, i.e., x-y planes were 
imaged at a series of depths to give a 3D image and this was done repeatedly to give 4D. 
Typically, the area imaged was 284 pm x 284 pm at 512 x 512 pixels and 500 lines per 
sec, the z step was 2.0 pm, with a total depth of 16-20 stacks, and the repetition rate for the 
stacks was 34 sec per stack. 4D reconstructions were analyzed using Volocity 5 software 
(Improvision, UK) and Excel (Microsoft).
The location (centroid) of each GFP positive cell within each 3D image stack was 
determined manually by the operator. The x and y coordinates of the cell were determined
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in an extended focus view and the z coordinate was determined by examination of single 
planes. T cell movements were tracked in 3D by linking the consecutive xyz coordinates 
of the same object. T cell velocity was computed as the distance between xyz coordinates 
(cell centroids) in successive stacks, divided by the interstack time interval. Only tracks 
with at least 3 time points were included in the analysis. To quantify T cell behaviors, we 
calculated, for each cell, its mean velocity as it moved along its track, length covered, 
displacement (straight line distance from the first position in the track to the last), 
displacement rate (total displacement during the period of tracking divided by the time it 
was tracked) and meandering index (displacement rate/velocity, which provides a measure 
of a track’s deviation from a straight line. A meandering index of 1 indicates that the track 
is a perfect straight line; the smaller the value of the meandering index, the greater the 
meandering of the track). Figure 7.2 illustrates the tracking of T-cells over time and space. 
Images were processed using Adobe® Photoshop® CS3 (Adobe Systems Europe Ltd, 
United Kingdom).
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Figure 7.2 Tracking o f  T-cells by post-acquisition analysis.
To calculate track velocity, displacement rate and meandering index, xyz coordinates o f  cell centroid for each 
cell present in the imaged volume were identified. Centroids belonging to subsequent time points ( t l .. .t3) 
were connected. Motility parameters were calculated as shown in figure: track velocity=total distance moved/ 
total time o f  cell imaging; displacement rate=linear distance between first and last time points/ total time o f  
cell imaging; meandering index=linear distance between first and last time points/ total distance moved.
7.3 Results
I performed imaging through the thinned skull. To determine the coordinates of each 
recording site, I took photographs through the dissecting microscope. The sites of imaging 
were identified by their relation to blood vessels and the stereotaxic coordinates (Fig. 7.3). 
The green autofluorescence of the skull bone was used to determine the underside of the 
skull, which I defined as z=0.
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F igure 7.3 In vivo brain imaging protocol fo r  location o f  imaging fields.
A: coordinates are defined by an ink dot on the skull (2.5 mm lateral, 1.0 mm posterior to bregma), and the 
stainless steel plate is glued to the skull. A template constructed from A is used to determine the position 
corresponding to the ink dot on the vasculature seen through the thinned skull (cross in B). C: imaging 
coordinates o f T-cells in a representative sham animal; blue arrow indicates middle cerebral artery (MCA). 
No T-cells were observed in the extensive areas indicated by the green rectangles. The black cross indicates 
the standard coordinate position. D: high resolution two-photon image o f blood vessels from the black 
rectangle in C. Scales: (A. B) hole in plate is 5 mm diameter. Bars = 0.5 mm in C and 50 pm in D.
7.3.1 Characterization of the imaged area
As expected, a significant area of lesion was observed at 72 hours after pMCAO (Fig. 7.4
H). It was our aim to perform in vivo 2-PM imaging through the skull in an area not too far
from the midline but within the lesioned zone. We confirmed that the surface coordinates
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2.5 mm lateral, 1.0 mm posterior to bregma met these requirements. Intravenous injection 
of propidium iodide was used to label dead cells (Unal Cevik and Dalkara 2003) and 
produced little labeling of cells in sham-operated mice, showing that the procedure of 
thinning the skull caused no cell death or did not compromise the blood- brain barrier (Fig.
7.4 A, Hussain et al. 1985). After pMCAO, numerous cells were stained, particularly near 
the central coordinate point (Fig. 7.4 B-D). These results show that in the areas where T 
cells were imaged after pMCAO, propidium iodide could extravasate from perfused 
vessels and cross the membranes of many cells. This indicates opening of the blood- brain 
barrier and, perhaps, debility of the stained cells (Unal Cevik and Dalkara 2003). In 
addition, in vivo Evans blue staining at the image site (1 jiL of Evans blue injected at 1 mm 
posterior, 2.5 mm lateral from bregma and 1.5 mm ventral to the skull, 72 hours after 
pMCAO) was colocalized with the autofluorescence produced by the injured tissue 
providing clear confirmation that the imaging site is present inside the compromised area 
(Fig. 7.4 E-I).
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F igure 7.4 Confirmation o f  imaging over cortical area compromized by pMCAo.
A: sparse dead cells after sham injury. B: After pMCAo, many Pi-labeled cells were visualized at the center 
o f the area examined by 2-PM, and in other areas under the craniotomy (C, D) indicating many necrotic cells 
all over the exposed area to imaging. Bars= 150pm. E-G: signal from the intraparenchymal injection o f 
Evans Blue at reference coordinates (E) and green autofluorescence caused by the ischemic damage (F) 
showed co-localization (G). H: representative image o f cresyl violet staining showing coronal topography o f 
infarct (dashed line) at the level o f septal nucleus (0.145 mm from bregma) and (1) adjacent section showing 
coronal topography o f Evans Blue staining overlapping the lesioned area.
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7.3.2 Visualization of T-cells and quantification of their motility
Many areas scanned in sham mice revealed no T-cells or rarely more than 1 to 2 
extravascular T-cells per imaging volume and these were close to the skull (within 20 pm; 
Fig. 7.5 A, C). In contrast, in pMCAO mice, extravascular T-cells were observed in 
virtually all areas where the blood marker was present (Fig. 7.5 B, D). The number of 
extravascular T cells observed in each imaging field were normalized for the volume of the 
field and averaged for each mouse. The mean T-cell density was significantly (P<0.05) 
higher in pMCAO mice (5.1 ±1.2 thousand/mm3, n=6) compared with sham-operated mice 
(sham; 1.9±0.4 thousand/mm3, n=6). Note that the true ratio of the T-cell populations is 
greater than these numbers suggest, because the volumes in shams with no T-cells (green 
areas in Fig. 7.3) were not imaged and therefore excluded. With rare exceptions (1 animal 
in 6 analyzed), the sparse extravascular T-cells in sham animals moved slowly and 
meandered so that their displacement was small (Fig. 7.5 A, C). After pMCAO, most of the 
numerous T-cells (Fig. 7.5 B, D) patrolled up and down the perivascular surfaces of blood 
vessels (Fig. 7.5 E), sometimes moving from 1 vessel to another, and few T-cells were 
remote from blood vessels. T cells, detected in the bloodstream, moved with a similar 
velocity as erythrocytes (Fig 7.5 F,G). After pMCAO, some vessels were poorly perfused, 
as shown by an absence of fast-moving cells (Fig 7.5 G). Very few T-cells were observed 
on the luminal surface of the vascular endothelium in perfused vessels.
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Figure 7.5 Three-dimensional reconstructions showing extravasated T-cells.
A typical imaging volume includes only I T-cell after sham (A) and several cells after pMCAo (B). The cell 
in A hardly moved (C, time markers indicate minutes:seconds). Successive positions o f the cells in B were 
joined by white lines and images at 4 time points are shown in (D). 1 grid unit = 28.47 pm. E: in pMCAo 
mice T-cells often crawled along blood vessel abluminal space. F, G: T-cells found in the blood vessels 
flowed at the same velocity o f RBC in both sham (F) and ischemic (G, left panel: normo-perfused vessel; 
right panel: ischemic vessel).
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For each mouse, all available T-cell tracks were displayed in a single volume (Fig. 7.6, 
right panels). In the 6 sham-operated mice, the cell movement was generally confined 
within a radius of approximately 10 pm (Fig. 7.6), although a few longer displacements 
were seen. This behavior is also evident when the tracks were plotted so that their origins 
coincided (lefthand panels in Fig. 7.6). In contrast, T cells that moved over 10s of microns 
were observed in all 6 pMCAO mice (Fig. 7.7), although a subpopulation of almost 
stationary T-cells was also observed.
anterior anterior
lateral lateral
Figure 7.6 Three-dimensional p lots o f  T-cell movements in sham mice.
T-cell tracks from each imaged animal are presented in figure. The right-hand panels show the tracks in 
extended focus seen from above and from the posterior and medial sides o f  the imaging volumes. The plots 
in the left-hand panels were generated by putting the starting point o f  each track at the origin o f  the axes. The 
cells have been labeled with individual colors. The tracks show that scarce T-cells were found and in most 
cases they moved over little distances. Left-hand panels: axis lengths are expressed in microns. Scale bars=25 
pm, z projections=40 pm.
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Figure 7.7 Three-dimensional p lots o f  T-cell movements in pMCAo mice.
T-cell tracks from each imaged animal are presented in figure. The right-hand panels show the tracks in 
extended focus seen from above and from the posterior and medial sides o f  the imaging volumes. The plots 
in the left-hand panels were generated by putting the starting point o f  each track at the origin o f  the axes. The 
cells have been labeled with individual colors. The tracks show that many T-cells were present in ischemic 
mice. Part o f  the cells moved over long distances in both xy plane and z axis. Also stationary cells with 
minimum displacement were found. Left-hand panels: axis lengths are expressed in microns. Scale bars=25 
pm, z projections=40 pm.
In sham animals, cells moved with an average velocity of 4.78±0.63 pm/min (n=23 T-
cells) with 39% of them stationary (velocity <2 pm/min, Miller et al. 2002; Zinselmeyer et
al. 2005). Two main populations were found in pMCAO animals (Fig. 7.8 A); 1 population
was almost stationary (1.74±0.11 pm/min, n=23 T-cells, Population 1) and the other
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population was quickly moving (8.21±0.10 pm/min, n=25 T-cells, Population 2). In 
addition to exhibiting significantly increased track velocity (Fig. 7.8 B), Population 2 
showed significantly increased displacement rate (Fig. 7.8 C) compared with Population 1 
(PO.OOl) and sham (PO.Ol) and a higher meandering index (Fig. 7.8 C) compared with 
Population 1 (PO.OOl) but not sham. Interestingly, Population 1 showed significantly 
lower (PO.Ol) track velocity and displacement rate compared with sham (Fig. 7.8 B,C).
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Figure 7.8 Quantitative analysis o f  T-cell dynamics.
Two main populations (arrows in A) as track velocity (pm/min) were found in pMCAo mice (A), one near 
stationary (population 1) and one quickly moving (population 2). B: population 1 exhibited significanlty 
lower track velocity compared with sham and populations 2. Population 2 had significantly higher values 
compared with sham and population 1. Population 1 showed also significantly lower displacement rate (C) 
and meandering index (D) compared with population 2. Population 1 had also significantly lower 
displacement rate compared with sham (C). Populations 2 had significantly higher values compared with 
sham in all assessed parameters. Single data point and mens (bars) are presented. One-way ANOVA 
followed by Dunn’s post hoc test; **p<0.01 vs sham; ooop<0.001 vs pMCAo Population 1.
Finally, by using conventional post mortem immunofluorescence and confocal microscopy, 
we confirmed T-cell location in the perivascular space of vessels in contact with 
components of the neurovascular unit such as astrocytes (glial fibrillary acidic protein- 
positive) and perivascular macrophages (IB4+/CD1 lb+; Fig. 7.9).
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Figure 7.9 Post mortem confocal images o f  immunofluorescence showing T-cells in the perivascular space. 
A-F: immunofluorescence was performed for the markers IB4 (red, endothelium), GFP (white, T-cells) and 
GFAP (green, astrocytes). Single plan views with projections o f  the z axis (E, F) showed that T-cells were 
located between the endothelium (red) and astrocytic endfeet (green). G-L: immunofluorescence was 
performed for the markers IB4 (red, endothelium), GFP (white, T-cells) and C D llb  (green, 
microglia/macrophages). Single plan views with projections o f  the z axis (K, L) showed that T-cells made 
contact with microglia/macrophages (IB4/C Dllb double positive, yellow) in the perivascular space. An 
extravasated T-cell distant from blood vessels (L) interacted with microglia/macrophage cell (arrow in L) as 
evidenced in bottom projection. Bars = 20 pm.
7.4 Discussion
In this part of my project, I succedeed to visualize, define, and quantitatively analyze the 
movement and behavior of T-cells in vivo in real time after stroke. Specifically, I observed 
a higher number of extravasated T-cells in the subarachnoid space after pMCAO than 
sham and 2 distinct T-cell populations in pMCAO mice, 1 that was almost stationary and 
the second showing higher track velocity and displacement than sham. Infiltrated T-cells
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were observed to patrol along the perivascular surfaces of cerebral vessels. 2-PM 
technology has been previously exploited in infection or autoimmune diseases. Several 2- 
PM studies describe the dynamics of T cells participating in the development of pathology 
such as experimental autoimmune encephalomyelitis (Bartholomaus et al. 2009; Fliigel et 
al. 2007; Kim et al. 2010), toxoplasmic encephalitis (Wilson et al. 2009), and acute viral 
meningitis (Kim et al. 2009). These studies have provided important information on how 
T-cells access the central nervous system and factors that regulate their behavior once in 
the central nervous system. However, challenges lie ahead for providing insight into 
neurological diseases such as stroke.
The brain is unique in its development of inflammation because it has no lymphatic system 
and the blood- brain barrier limits antibody and immune cell entry (Cserr and Knopf 1992; 
Wilson et al. 2010). Therefore, T-cell access is tightly regulated and rare in the normal 
brain, and despite an increased expression of adhesion molecules during ischemia that 
facilitates T-cell infiltration, there are far fewer T-cells in the brain after stroke compared 
with autoimmune disease (Fliigel et al. 2007). To the best of my knowledge, realtime in 
vivo T-cell movements after stroke have never been successfully visualized and analyzed. 
We observed a high number of extravascular T-cells 72 hours after pMCAO and only a 
few T-cells after sham. I cannot exclude that the sham procedure (anesthesia, skull 
thinning) may have induced recruitment of these cells. On the contrary, increased T-cell 
infiltration after stroke is consistent with post mortem immunohistochemistry or flow 
cytometry studies (Frenkel et al. 2003; Stevens et al. 2002), although such techniques are 
limited by the removal, disruption, and processing of tissue at defined time points. A key 
observation from the 2-PM approach is the significant differences in motility, namely track 
velocity, displacement, and meandering, of extravasated T-cells between pMCAO and 
sham mice. Interestingly, 2 main populations were found in pMCAO mice; both 
populations showed significantly different dynamics compared with T-cells in sham mice.
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One population showed a mean displacement of 0.25±0.06 pm/min, the other population 
3.26±0.39 pm/min, and sham 1.4±0.4 pm/min. Cordiglieri and colleagues defined in the 
central nervous system motile cells with displacements >1 pm/min and stationary cells 
with displacements <1 pm/min (Cordiglieri et al. 2010); therefore, we consider Population 
1 stationary. On the contrary, Population 2 showed track velocity in the range of data 
already shown in other models of neuroinflammation (Bartholomaus et al. 2009; Kim et al.
2009). The reported differences in track velocities between Population 1 (1.74 pm/min) 
and Population 2 (8.21 pm/min), in the model here analyzed, are extremely relevant if 
compared with T-cell velocity in secondary lymphoid organs. It has been shown (Miller et 
al. 2002; Zinselmeyer et al. 2005) that nafve CD4 T-cells move at an average velocity 10 
pm/min. Both primed and tolerized T-cells show slower velocity of approximately 4 to 5 
pm/min and cells with velocities <2 pm/min are essentially stationary due to factors like 
centroid movement. Thus, the observed differences between Populations 1 and 2 and sham 
in my setting could clearly depend on the different activation status of these cells. The 
different motility of the 2 cell populations could reflect the evolution of T-cell response 
from a nafve population to effector/memory cells and/or the behavior of T-cells that, after 
antigen encounter, display an altered profile of adhesion molecules and chemokine 
receptors. One limitation of my experiments is that GFP expression was not restricted to a 
specific population of T-cells and therefore it is impossible to distinguish which T-cell 
subset was stationary or motile or if this was related to their antigen specificity. 
Interestingly, recent real-time imaging during recall responses in the lymph node have 
shown that, in contrast to CD4 T-cells, which show slower migration (Rush et al. 2009), 
memory CD8 T-cells move more rapidly than nafve cells (Chtanova et al. 2009), 
suggesting that faster migration could be a defining characteristic of CD8 versus CD4 
memory T-cells. Also key to my findings are the paths of these cells once extravasated and 
we could reveal 3 key locations: perivascular, moving from 1 vessel to another, and remote
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from vessels. The perivascular location of T-cells is in line with previous data by Owens 
(Owens et al. 2008) who elegantly describes the transmigration of immune cells into the 
perivascular space and movement of extravasated T-cells are likely to be in the 
perivascular space rather than in the brain parenchyma. We observed T cells patrolling up 
and down the perivascular surfaces of blood vessels. The object of their survey is unclear, 
but direct contact of T-cells with cellular components of the neurovascular unit has been 
shown in other inflammatory central nervous system conditions (Bartholomaus et al. 2009) 
and the perivascular space seems to be a location where immune cells could interact with 
potential antigen-presenting cells (Owens et al. 2008). The immunologic synapse could be 
formed with astrocytic end feet or perivascular phagocytes, all of which have the capacity 
to act as antigenpresenting cells (Fierz et al. 1985; Kivisakk et al. 2009). We have 
attempted to shed further light on these cellular interactions using immunofluorescence. 
Although this analysis was performed deeper in the parenchyma compared with the imaged 
area, we could confirm T-cells’ location between the endothelium and astrocytic end feet 
in the perivascular space with a direct contact among astrocytes, macrophages/microglial 
cells, and T-cells. Whether this direct contact is associated with the reported role of the 
neurovascular unit in stimulating inflammatory responses after stroke (Del Zoppo 2009) is 
yet to be elucidated, but this would explain the reason for some T-cells moving from 1 
vessel to another after pMCAO. Lastly, I observed T-cells remote from blood vessels in the 
in vivo imaging and again using immunofluorescence, we observed extravasated T-cells 
quite far from vessels interacting with a microglial cell. Whether T-cells’ contribution to 
cerebral ischemia depends on antigen recognition is still under debate (Kleinschnitz et al.
2010); therefore, a deeper understanding of the cellular interactions between T-cells to 
astrocytes and microglia would help to clarify this issue. By measuring parameters that are 
likely to influence the character of immune responses (eg, location of T-cell activation, 
location of immune cell interactions, duration and number of interactions, etc) and relating
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these to the parallel determination of immunologic parameters (eg, cytokine and 
costimulatory molecules production), a 2-PM strategy could help to analyze these 
interactions in vivo and hopefully help to elucidate the role of immune cells in stroke.
7.5 Conclusions
I have provided previously unavailable information on the dynamics of T lymphocytes 
recruited by the ischemic brain, which could reveal important mechanisms of immune 
surveillance after stroke. In addition, the imaging approach represents a major technical 
advance and an important research tool for the understanding of the complex interactions 
between the brain and immune cells after ischemia. Combining the development of 
strategies to deplete specific cell populations/subsets or modify their function and the 
application of available fluorescent reporters for antigen presenting cells should allow a 
dissection of how the behavior of immune cells relates to their function in the ischemic 
brain. It is hoped that these advances in imaging of immune cells after stroke could provide 
important information for the development and use of specific therapies for a better 
management of the immune response in the ischemic brain.
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It has long been recognized that brain ischemia induces a neuroinflammatory response that 
involves both the recruitment of circulating inflammatory cells into the CNS and the 
activation of resident microglia. Vascular remodelling and a direct involvement of the 
BBB are also part of the inflammatory process, as they can influence the recruitment of 
circulating cells (Bartholomaus et al. 2009; Owens et al. 2008) as well as determine the 
modification of the active status of resident microglia (Masuda et al. 2011). Vascular 
modifications, blood flow variations and motility of immune cells are all mechanisms 
acting in a very dynamic fashion (ranging from milliseconds to minutes) within a three- 
dimensional space (the brain). Obviously, these events require the action of solid objects, 
such as blood vessels and cells, which exert their specific function in intact tissues, where a 
complex network of interactions exists. Most of the information associated with spatial 
motility, time-dependent dynamics and tissue integrity {i.e. contemporary presence of all 
the cell types involved in the biological effect) is lost with conventional biochemical, 
biomolecular or histological techniques. The application of 2-PM to neurobiology offered a 
new perspective to tackle previously unexplored mechanisms in physiological or 
pathological conditions, due to its ability to provide a three-dimensional, high-resolution 
representation of the CNS over time in living animals.
Inflammation after brain ischemia stands as a promising therapeutical target. It is indeed
early induced after injury and has long-lasting effects, thus having a prominent role in
damage evolution over time. Believed for years to have only detrimental effects, over the
recent past inflammation has been demonstrated to exert also beneficial effects. In
particular two inflammatory populations, microglia/macrophages and T- lymphocytes,
caught the attention of neurobiologists, provided that these populations, although
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participating in the pro-inflammatory cascades, are also capable of protective and 
regenerative functions (Iadecola and Anrather 2011; Magnus et al. 2012). A detailed 
comprehension of the inflammatory mechanisms after brain ischemia is needed in order to 
develop future pharmacological tools to revert a detrimental inflammatory phenotype into 
a beneficial regenerative one. Such a pharmacological approach may be coupled with the 
thrombolytic therapy in order to ameliorate the ischemic outcome in patients by acting on 
long lasting secondary pathogenetic mechanisms.
The past two decades have seen remarkable advances in the comprehension of immune cell 
trafficking, activation and functions within the CNS, and many molecules involved in the 
protective functions have been identified. In vitro evidence for phenotype switching in 
response to different types and different degrees of injury has been indeed obtained 
(Hausler et al. 2002; Lai and Todd 2008; Magnus et al. 2001). This phenomenon has been 
little studied in a systematic way in appropriate in vivo models, that are certainly more 
informative. For this reason and for the complex nature of the inflammatory network, to 
date, many aspects of brain immunity still remain to be fully elucidated.
Great attention has been dedicated to microglia that gained increasing consideration as 
potential therapeutic targets. However, available information may be not transferred in a 
straighforward way to clinical settings yet, as many aspects of microglia functions remain 
elusive. The exact contribution to ischemic injury evolution of resident microglia versus 
that of recruited macrophages still needs to be determined. Microglia share with 
macrophages same myeloid origin, marker expression and ability of acquiring a polarized 
phenotype, however, new evidence on organotypic slice cultures indicate that M2 
polarized microglia have protective functions, whilst macrophages act in a cytotoxic way 
regardless of their polarization (Girard et al. 2013). This observation needs confirmation in 
the in vivo setting, in which, however, methodological limitations applies to properly 
distinguish the two populations.
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Data presented in my thesis rule out the detrimental function of the fractalkine:CX3CRl
pathway in ischemic damage evolution. Other pathways able to influence polarization of
microglia have been also identified in different models and by different strategies
(Ransohoff and Prinz 2013). However there is still little transferibility of this information
to the clinical setting, as 1) characterization of microglia function in humans is lacking; 2)
availablilty of molecules specifically targetting microglia polarization is limited.
Similar observations may apply to T-cells. They participate to ischemic injury
development by either toxic or protective action. While their toxic behavior does not seem
to need a proper priming (Kleinschnitz et al. 2010), protective effects are due to
tolerization or T-reg maturation (Liesz et al. 2009). However as far as their specific role in
pre-clinical and human studies is not completely understood, direct transferibility of this
information to clinical setting remains limited.
It should be stressed that inflammatory mechanisms after brain ischemia are still widely 
unknown, thus hampering the effective development of a therapeutic stategy. Most of pre- 
clinical studies focus on a specific mechanism, whilst it is clear that inflammation involves 
many different events and cell types, often with overlapping functions, that evolve over 
time. Furthermore, the impact of inflammatory states already in place before ischemia is 
often underestimated in animal models. Evidence that systemic inflammation is able to 
enhance ischemic damage has been provided in leptin deficient obese (ob/ob) mice (Terao 
et al. 2008). In humans, stroke is preceded by a variety of risk factors, many of those co­
exist. Most of co-morbidities are associated with the dysregulation of systemic 
inflammatory processess and imply either chronic or acute inflammation (Murray et al. 
2013). In future, animal model studies should consider the use of more clinically-relevant 
paradigms, which incorporate commonly recognized risk factors.
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In this thesis in vivo 2-PM and post mortem histochemical and immunohistochemical 
techniques were applied to dissect specific aspects related to vascular remodelling, immune 
cell dynamism and expression of markers of M/M polarization in two models of focal brain 
ischemia.
Key to the project has been to set up a reliable protocol for in vivo longitudinal 2-PM 
imaging. Animals should indeed be surgically prepared to imaging by the exposure of a 
cortical area of interest. Methods to expose brain to 2-PM imaging rely on the opening of a 
craniotomy that may be of two different kind: cranial window (Mostany and Portera- 
Cailliau 2008) and skull thinning (Yang et al. 2010). While cranial window allows a deeper 
laser penetration compared to skull thinning due to limited scattering effects, the surgical 
procedure for window preparation is invasive enough to induce synaptic rearrangements 
and inflammation (Xu et al. 2007b). For this reason cranial window was used to imaging of 
blood vessels, whereas skull thinning was used for imaging of GFP+ immune populations. 
Once selected the best option for craniotomy, a further major requirement to fullfil has 
been to verify whether the exposed area was affected by MCAo. The imaged area was 
actually ischemic, being: 1) the blood flow significantly reduced in the vessels pertinent to 
that area and 2) necrotic cells present all over the observed tissue after MCAo. Moreover 
imaging of the same area could be repeated on a same mouse at different time points from 
MCAo and up to 24h after insult.
In humans, the degree of reperfusion after brain ischemia, if present, is highly variable 
(Caplan et al. 2011; Lo 2008b). For this reason pre-clinical studies should consider the use 
of both transient and permanent models of brain ischemia. In the future, the number of 
patients undergoing reperfusion is likely to increase, since the time window for 
thrombolytic therapy has been recently widened from 3 to 4.5 h (Davis and Donnan 2009)
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and clinical studies are presently underway to further widen time window and patients’ 
accessibility to thrombolytic therapy (Sandercock et al. 2012). Thus, the exact 
comprehension of vascular dynamics at the level of the individual vessel in vivo during 
occlusion and when reperfusion is allowed represents a crucial issue for stroke therapy and 
improved recovery. The data presented in this thesis on vascular remodelling confirmed 
that, during ischemia, a massive blood flow decrease in the cortical region fed by MCA 
occurs, notably associated in few cases with blood flow reversion. This phenomenon, that 
had been described following permanent ischemia, could be the result of redundancy in the 
cortical vascular architecture that acts as endogenous protective response to occlusions 
(Schaffer et al. 2006). Extravasation appears as early as 20min from ischemic onset, and is 
accompanied by an irregular morphology of vessel edges. Single vessel analysis revealed 
that after reperfusion blood flow is incompletely re-established at 24h, and in some small 
vessels it is completely prevented. This suggests the existence of further pathogenetic 
mechanisms, induced by the occlusion, affecting vascular viability. Among these it is 
possible that the rapidly established edema causes increased parenchymal pressure leading 
to a relevant vascular compression, able to affect flow recovery in the microvasculature.
As discussed above, vasculature has a prominent role in regulating the recruitment and 
activation of immune populations, which, in turn, participate to the evolution of ischemic 
lesion. Immune cells act through a plaetora of different mechanisms, whose final effects 
can be of opposite nature.
In view of a therapeutic modulation of immunity after stroke, recent pre-clinical studies 
applied strategies aimed either at limiting the propagation of pro-inflammatory signals 
(Orsini et al. 2012; Pradillo et al. 2012) or at favouring the protective functions of immune 
cells (Lalancette-Hebert et al. 2007). Unfortunately, to date, all the attempts to translate the 
encouraging pre-clinical results on inflammatory modulation to the clinical setting have
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failed (Iadecola and Anrather 2011; del Zoppo 2004). One possible reason of these failures 
stands in the fact that many aspects of immunity after stroke still remain elusive.
In my research project, I focused on M/M, whose modulation has been proven to confer 
protection after experimental stroke (Lalancette-Hebert et al. 2007; Lambertsen et al. 
2009). After tMCAo, resident microglia rapidly change their morphology to become 
hypertrophic/ameboid at 24h after insult and macrophages are recruited to lesion site. 
Within the lesioned area, the expression of markers of active M/M, such as CD1 lb, CD68, 
CD45, Yml, CD206 and iNOS significantly increases, indicating that both Ml and M2 
polarization states are present in the ischemic territory. I found that deletion of CX3CR1 
prevents microglia from acquiring an ameboid phenotype, in association with decreased 
CD llb and CD68 immunoreactivity. Under these circumstances, the balance between 
toxic Ml and protective M2 polarization changes and, in particular, the absence of 
CX3CR1 favours the M2 polarization being Yml significantly increased and iNOS 
significantly decreased in cx3crrA mice at 24h after tMCAo. This effect results in a 
protective outcome, being the ischemic volume 25.5% lower in cx3crlv' mice compared to 
control mice.
Although M/M polarization markers have been extensively studied in many models of 
CNS diseases, such as AD (Reed-Geaghan et al. 2010; Shin et al. 2011), global ischemia 
(Ohtaki et al. 2008), EAE (Ponomarev et al. 2007) or spinal cord injury (David and Kroner 
2011; Kigerl et al. 2009), information on M/M polarization marker expression, 
coexpression and temporal evolution in the ischemic brain is lacking. Aa model of pMCAo 
was used to provide a characterization of the time course of activation and localization of a 
few M/M markers, either related to the Ml or the M2 polarization.
Different states of M/M activation are present in the ischemic lesion, reflecting the 
complexity of these cells and their ability to differentiate towards a multitude of 
phenotypes depending on the surrounding microenvironmental signals that can change
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over time. Detrimental Ml and protective M2 phenotypes have been classified on the basis 
of in vitro studies or in many cancer models that yielded the canonical definition of M I­
ME phenotypes. In the ischemic brain in vivo, activated M/M may escape the classical 
phenotypical categorization, due to the complex molecular and cellular network 
established soon after injury and evolving over time. The work presented here provides 
evidence of the different patterns of M/M polarization after brain ischemia, and suggests 
that they have a specific distribution which is dependent on time and distance from the 
lesion. A protective M2 polarization is rapidly activated (Yml expression peaks at 24h), 
precedes Ml polarization (iNOS expression peaks at 48h), but it is short-lasting, being 
significantly reduced as early as 48h after injury.
Phagocytosis is a key feature of M/M. Differently from other M/M markers, the phagocytic 
activity does not seem to be clearly linked to a specific Ml or M2 polarization state. 
Phagocytosis is needed to remove cell debris and dying cells, thus limiting the propagation 
of ‘eat-me’ signals, that can further exacerbate damage progression. Cells belonging to the 
M2c class of protective polarization as well as Ml toxic cells are endowed with phagocytic 
functions (David and Kroner 2011), suggesting that phagocytosis can serve either for 
scavenging of debris (protection) or killing cells (toxicity). The phagocytic activity was 
assessed by cell positivity to CD68. At early time points after pMCAo (6h-48h), the 
expression of CD68 is preferentially located at the ischemic borders, while at 7d after 
injury CD68 expression dramatically increases and involves all ischemic areas. 
Interestingly, this event is accompanied by the progressive reduction of the expression of 
the protective M2 marker Yml. Moreover after tMCAo, cx3crTA mice show significantly 
decreased CD68 expression and protection from ischemic injury (see above). These 
observations imply that phagocytosis may be needed for limiting the propagation of danger 
signals, but an excess of phagocytosis is detrimental if not counteracted early after injury. 
Actually, a similar decrease in CD68 expression has been previously reported following
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other protective manipulations such as stem cells infusion or ischemic preconditioning, 
where the observed protective effects were associated to a decrease of ameboid 
CD1 lb/CD68 positive cells (Longhi et al. 2011; Zanier et al. 2011).
Phagocytosis involves many molecules. Altough CD68 is expressed by phagocytic cells, it 
may provide a partial picture of the phagocytic events that take place within the brain. 
Further studies addressing the exact role of phagocytosis should also consider the use of 
different markers or different techniques, such as the measure of phagocytosed opsonized 
beads (Daigneault et al. 2010).
In the final part of the project I focused on T-cells recruited to the ischemic brain. T 
lymphocytes have been recently proposed as potential therapeutic targets in brain ischemia, 
proven that they have toxic effects and mice deficient in lymphocytes exhibit reduced 
ischemic infarct volume (Hum et al. 2007; Kleinschnitz et al. 2010; Yilmaz et al. 2006). 
However, T-cells may have also protective effects, by releasing IL-4 (Butovsky et al. 
2007) or by priming to T-regulatory cells (Liesz et al. 2009). In a clinical perspective, to 
modulate T-cells and promote their protective behavior, a deeper knowledge of the 
mechanims of T-cell recrutiment and activation after brain ischemia is needed.
T-cells were successfully visualized by in vivo 2-PM 3d after pMCAo and obtained 
information on their dynamic behavior after extravasation. T-cells increase significantly in 
number in the ischemic territory visualized and split into two distinct populations on the 
basis of their track velocity: one that was almost stationary and the second showing higher 
track velocity and displacement. Infiltrated T-cells patrol along the perivascular surfaces of 
cerebral vessels, where they come into contact with components of the BBB, such as 
astrocytic endfeet and perivascular macrophages, that may have ‘instructive’ functions to 
T-cells prior to invasion.
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This study may be limited by the short analysis of immune populations after brain 
ischemia, since 2-PM has been applied in a time frame ranging from before to 3d after 
ischemia. This limitation is due mainly to concerns related craniotomy, being very difficult 
to keep it clean for periods longer than 3d with no further surgery. 2-PM studies at later 
stages after ischemia should consider re-opening the craniotomy or avoiding baseline 
imaging (prior to ischemia) or opening the craniotomy only at the experimental time point 
of interest. In this study, where possible, I preferred to perform in vivo 2-PM at baseline in 
order to achieve a more reliable longitudinal study (each animal represented its own 
control).
The analysis of inflammation and immune cell behavior/phenotype at later stages of 
ischemic damage would be very informative. As discussed in section 5, events different 
from the ones here described may take place, including recruitment of a population of 
protective macrophages (Nahrendorf et al. 2007), further modifications of microglia 
morphology/phenotype and peak expression of adaptive immune responses, all able to 
deeply impact on ischemic damage evolution. Thus, possible future experiments could 
include the investigation on events at later time points from ischemia.
As discussed above, the use of more clinically-relevant animal models including common 
stroke risk factors should be considered. In this view, the project may be expanded by 
analyzing M/M behavior in aging or in ob/ob mice, in order to assess whether presence of 
Ml or M2 polarization markers differ depending on age or co-morbidities.
While M/M have been extensively studied in animal models, information on their 
activation and functions in humans needs to be widened. In humans imaging of M/M is 
possible by Positron Emission Tomography (PET), which remains limited for its elevated 
costs and long time of execution. In clinical scenarios MRI shows promises because, by
209
general conclusions and future perspectives 
magnectic spectroscopy, it is possible to detect metabolic patterns associated with specific
cellular functions. However, while some specific patterns for neuronal damage and gliosis
have already been set up, information on the metabolic pattern associated with M/M
activation is still lacking. A unit for MRI is available at Mario Negri Institute, thus future
developments of the project may regard the identification of new metabolic fingerprints of
M/M activation that could be visualized by MRI, in view of their application to patients’
imaging.
As previously discussed, the immune response can be modulated by different approaches 
capable of yielding protection after ischemia. To translate effectively the promising pre- 
clinical studies on inflammatory modulation to the clinical setting, however, a deeper 
knowledge of the complex network of inflammatory molecules and effector cells is 
needed. In this view, future development of this project would include simultaneous in vivo 
imaging of microglia and T-cells. Upon activation, T-cells give origin to a Thl or a 
Th2/Th3 response, responsible respectively for the secretion of proinflammatory cytokines 
such as IL-2, TNF-a and INF-y that promote toxic inflammation, or the release of IL-4, IL- 
10 and TGF-pl, that may favour protective brain immunity. Th2 have been described to 
activate microglia via IL-4, possibly pushing microglia towards a protective phenotype 
(Butovsky et al. 2007). In vivo 2-PM may help elucidating the dynamic interaction 
between these two immune populations and, in particular: 1) whether and to what extent 
they interact {i.e. time of contact); 2) ability of microglia to influence T-cell motility; 3) 
microglia morphological response to T-cell interaction; 4) effects of CX3CR1 deletion or 
of immunomodulatory strategies. Since in vivo 2-PM does not provide phenotype 
information, it should be paralleled by post mortem analysis of M/M phenotype, to 
investigate how T-cells may influence M/M polarization state.
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Other peripheral immune populations have been demonstrated to have a role in ischemic
injury progression. Among those, neutrophils have been clearly identified as neurotoxic
cells, able to infiltrate the brain after ischemia and to exert a detrimental function.
Neutrophils are mediators of the toxic effects elicited by IL-1, whose targeting has been
already shown to be protective (Allen et al. 2012; Pradillo et al. 2012). It has been
proposed that microglia protective functions may be also associated with phagocytosis of
infiltrated neutrophils (Denes et al. 2007). Future developments of this project should
consider the role of neutrophils and whether peaks of protective microglia polarization are
associated with decreased IL-1 production or neutrophil presence in the ischemic brain.
This will also help to better define the role of phagocytic microglia since, as discussed in
the thesis, phagocytic behavior may not be linked to a specific polarization state
straightforwardly.
Overall my study adds new insight on immunity after stroke, having: 1) investigated the 
dynamic behavior of M/M and T-cells within the ischemic brain; 2) provided information 
on M/M polarization after tMCAo and pMCAo. These data add previously unavailable 
information on the complex inflammatory response after stroke and may pave the way for 
developing strategies resulting in promotion of a protective inflammatory phenotype.
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